data_2bgo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2bgo _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 p . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.627 0.251 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.545 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . . . -71.0 -16.45 62.63 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.525 ' HA ' ' HG ' ' A' ' 24' ' ' LEU . . . -69.93 -27.77 65.03 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.604 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.74 -8.86 59.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.843 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.6 -171.12 3.08 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.705 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.6 m -106.83 103.71 13.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.689 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.48 HG12 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -80.88 94.63 2.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.255 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.8 m -91.97 128.3 37.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.95 146.27 2.83 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.133 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 36' ' ' SER . 80.6 Cg_endo -74.86 9.15 9.23 Favored 'Cis proline' 0 C--N 1.348 0.526 0 C-N-CA 123.84 -1.317 . . . . 0.0 113.583 0.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.403 ' CB ' ' CD2' ' A' ' 31' ' ' LEU . . . -59.47 143.46 49.87 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.342 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.43 120.06 10.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.397 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.525 ' HG ' ' HA ' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -79.14 114.79 18.36 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.94 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.2 m -134.75 117.62 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.918 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.47 37.29 92.55 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.286 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.75 27.91 11.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.753 0.311 . . . . 0.0 110.988 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.4 t -134.8 105.4 6.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.152 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.511 ' O ' ' HB ' ' A' ' 114' ' ' VAL . . . -75.53 106.87 2.19 Favored Glycine 0 C--O 1.223 -0.58 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.605 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 0.8 OUTLIER -105.59 118.38 36.43 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.971 0.415 . . . . 0.0 111.486 -179.196 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.674 ' CD2' HG21 ' A' ' 38' ' ' VAL . 69.7 mt -80.98 153.73 27.31 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.113 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.449 ' HA ' ' CD1' ' A' ' 111' ' ' TYR . 21.2 mt-30 -142.7 86.93 1.96 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.822 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.469 ' CA ' ' CE2' ' A' ' 111' ' ' TYR . . . 85.78 156.08 26.63 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.881 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.489 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . . . -47.21 157.46 0.19 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.835 0.317 . . . . 0.0 110.436 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 104' ' ' VAL . . . 100.47 -20.79 46.92 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.601 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.571 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.4 OUTLIER -81.98 152.13 26.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.585 0.231 . . . . 0.0 110.747 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.45 100.34 1.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.996 0.427 . . . . 0.0 112.051 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.674 HG21 ' CD2' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -89.08 88.54 2.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.46 ' HA ' ' HA2' ' A' ' 101' ' ' GLY . 29.2 mm -90.28 127.26 42.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.297 0.57 . . . . 0.0 112.408 -177.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.545 ' CZ2' ' HA ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -100.68 128.49 46.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.642 179.464 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -106.04 111.77 24.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.303 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.7 m -147.92 161.76 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.442 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -112.56 124.58 52.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.007 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.7 m -56.81 123.94 61.25 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.211 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -62.05 -66.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.57 2.18 . . . . 0.0 113.03 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.96 -171.95 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.127 0.489 . . . . 0.0 112.013 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.16 94.53 6.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.646 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -159.24 165.66 34.4 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.459 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 66.3 tt0 -77.4 108.65 10.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.777 0.322 . . . . 0.0 111.123 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.47 ' CE1' HD23 ' A' ' 121' ' ' LEU . 3.4 m-30 -104.19 119.9 39.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.014 0.435 . . . . 0.0 110.072 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.8 ptt180 -84.42 126.76 33.54 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.712 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.518 ' N ' ' O ' ' A' ' 89' ' ' GLN . 6.1 mm -78.58 118.75 26.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.448 -178.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.538 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 8.4 m-80 -120.06 110.18 16.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.119 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.553 ' HG ' ' CE ' ' A' ' 69' ' ' MET . 0.7 OUTLIER -99.24 122.36 42.31 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.388 0.613 . . . . 0.0 111.445 -178.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.85 116.07 28.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.377 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.466 ' CH2' ' HB3' ' A' ' 78' ' ' PHE . 11.5 p-90 -145.15 167.2 23.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.331 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.5 m -148.72 92.72 2.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.889 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 111' ' ' TYR . 0.2 OUTLIER -127.11 83.55 65.71 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.92 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.44 90.18 0.17 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.644 2.23 . . . . 0.0 112.213 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.33 -77.75 0.23 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.328 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 m 178.39 -63.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.804 0.335 . . . . 0.0 111.108 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.4 t -172.82 121.28 0.39 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.997 0.427 . . . . 0.0 111.429 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.443 ' HG3' ' CH2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -110.97 171.77 7.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.171 179.556 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 109' ' ' TRP . 57.4 t -117.09 86.8 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.222 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.472 ' OD1' ' HA2' ' A' ' 110' ' ' GLY . 1.7 m-80 -110.8 168.12 9.72 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.3 m -123.43 110.33 14.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.096 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.498 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 16.2 tp -79.55 127.17 31.82 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.837 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.427 ' O ' ' N ' ' A' ' 101' ' ' GLY . 13.0 t -99.68 103.92 15.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.433 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.553 ' CE ' ' HG ' ' A' ' 54' ' ' LEU . 8.3 mmt -137.92 140.84 40.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.86 0.362 . . . . 0.0 111.047 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 45.84 40.76 6.93 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.765 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.68 25.96 70.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.786 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.5 m -119.2 141.9 48.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.01 0.433 . . . . 0.0 111.075 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -100.31 74.02 1.71 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.495 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.498 ' CD1' ' HB3' ' A' ' 67' ' ' LEU . 1.4 pp -79.3 106.48 11.37 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.227 0.536 . . . . 0.0 110.978 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.0 t -82.82 131.91 35.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.089 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.44 ' OH ' ' CE1' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -160.28 151.18 18.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.628 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 63' ' ' LYS . . . -89.06 118.75 29.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.92 0.39 . . . . 0.0 111.177 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.466 ' HB3' ' CH2' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -58.54 93.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.944 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.41 140.15 28.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.764 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -37.51 101.59 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.444 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -128.18 165.88 19.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.225 0.536 . . . . 0.0 111.558 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.46 -48.92 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.651 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.572 ' O ' ' N ' ' A' ' 85' ' ' VAL . 6.9 t -80.13 141.54 54.27 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.217 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.468 ' HD2' ' CG1' ' A' ' 83' ' ' VAL . 43.5 Cg_exo -35.35 83.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.699 2.266 . . . . 0.0 112.922 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.572 ' N ' ' O ' ' A' ' 83' ' ' VAL . 79.4 t -97.37 126.3 50.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.643 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.36 99.82 10.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.217 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 53' ' ' ASN . 1.0 OUTLIER -62.92 103.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.858 179.269 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 23.1 t -79.89 121.37 33.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 52' ' ' ILE . 1.9 tt0 -137.11 112.66 9.37 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.1 p -79.09 118.07 20.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.404 0.621 . . . . 0.0 111.943 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -134.96 121.44 20.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.86 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -67.59 110.85 3.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.883 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.93 143.49 26.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.981 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 59.6 m -113.74 163.26 15.26 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.939 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.87 148.75 44.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.012 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 127.01 -112.86 1.63 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.503 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -141.81 130.0 22.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.829 0.347 . . . . 0.0 110.981 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -133.84 150.28 51.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.867 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 27.7 p -105.25 131.56 52.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.92 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -124.45 168.15 13.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.416 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 39' ' ' ILE . . . 152.35 -164.72 30.66 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 119.949 -1.12 . . . . 0.0 113.575 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.441 HG22 HG12 ' A' ' 114' ' ' VAL . 0.1 OUTLIER -148.23 123.2 2.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.562 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.408 ' HB3' ' CG2' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -122.22 143.44 49.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.36 0.6 . . . . 0.0 112.512 -178.24 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.489 ' HB ' ' HA ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -126.88 132.05 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.265 178.299 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -149.35 -172.99 19.53 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.603 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.87 -40.78 81.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.876 0.369 . . . . 0.0 110.507 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.3 t -70.62 -29.16 65.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.481 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 64' ' ' VAL . 0.6 OUTLIER -147.35 86.53 1.62 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.321 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.511 ' CE3' ' N ' ' A' ' 110' ' ' GLY . 9.7 p-90 -86.42 157.17 19.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.933 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.511 ' N ' ' CE3' ' A' ' 109' ' ' TRP . . . -155.01 -171.25 21.52 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.108 -1.044 . . . . 0.0 114.001 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.469 ' CE2' ' CA ' ' A' ' 33' ' ' GLY . 0.7 OUTLIER -176.61 79.2 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.419 ' HE3' ' CZ ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -146.61 -176.8 5.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.2 0.524 . . . . 0.0 111.744 -178.08 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 40.8 m-20 -107.74 131.32 54.56 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.095 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' A' ' 29' ' ' GLY . 3.3 t -104.14 85.6 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.028 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -54.13 -66.58 0.37 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.265 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.413 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -164.36 148.12 9.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.146 0.498 . . . . 0.0 111.526 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.519 ' CD1' ' CE3' ' A' ' 40' ' ' TRP . 0.4 OUTLIER -84.72 95.57 8.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.858 179.411 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 53' ' ' ASN . 1.0 OUTLIER -80.08 134.06 36.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.03 0.443 . . . . 0.0 111.704 -178.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.92 107.75 11.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.285 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -99.48 152.96 19.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 111.223 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.47 HD23 ' CE1' ' A' ' 50' ' ' TYR . 0.1 OUTLIER . . . . . 0 CA--C 1.516 -0.327 0 CA-C-O 121.299 0.571 . . . . 0.0 110.624 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.2 p . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 120.791 0.329 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.547 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . . . -68.57 -9.2 48.03 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.56 ' HA ' ' HG ' ' A' ' 24' ' ' LEU . . . -69.9 -29.53 66.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.9 0.381 . . . . 0.0 110.615 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.69 -2.36 53.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.99 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.86 -164.1 1.12 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.9 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.9 p -110.95 103.75 12.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.597 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.501 HD12 ' HG ' ' A' ' 24' ' ' LEU . 1.6 mp -87.53 91.48 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.53 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.4 m -90.72 134.72 34.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.653 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.28 145.21 5.56 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.159 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 36' ' ' SER . 86.5 Cg_endo -78.48 10.9 18.93 Favored 'Cis proline' 0 C--N 1.348 0.509 0 C-N-CA 123.64 -1.4 . . . . 0.0 113.447 0.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.53 143.66 49.52 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.43 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -147.67 118.88 7.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.051 0.453 . . . . 0.0 111.765 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.56 ' HG ' ' HA ' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -79.81 104.69 10.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.397 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.12 124.4 72.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.865 0.364 . . . . 0.0 111.598 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 58.79 46.62 93.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.391 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.0 20.59 9.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.837 0.351 . . . . 0.0 110.912 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.5 t -130.08 131.41 65.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.728 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.407 ' HA3' ' CD2' ' A' ' 24' ' ' LEU . . . -80.25 146.87 28.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.782 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 32.6 mt-10 -147.29 102.37 3.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.819 0.342 . . . . 0.0 110.807 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.612 ' CD2' HG21 ' A' ' 38' ' ' VAL . 94.9 mt -79.68 154.74 28.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.456 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.481 ' HG3' ' CE1' ' A' ' 111' ' ' TYR . 0.0 OUTLIER -123.59 -156.32 0.7 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 32' ' ' GLN . . . -37.02 152.9 0.01 OUTLIER Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.281 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.551 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . . . -39.22 158.14 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.744 0.307 . . . . 0.0 111.274 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.27 -22.81 30.23 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.661 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.45 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.7 OUTLIER -65.91 157.47 30.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.605 0.24 . . . . 0.0 110.664 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.88 96.21 1.46 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.612 HG21 ' CD2' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -90.55 88.77 2.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.171 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.438 ' HA ' ' HA2' ' A' ' 101' ' ' GLY . 26.7 mm -91.89 131.73 38.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.147 0.499 . . . . 0.0 111.905 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.567 ' CE3' ' HB2' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -103.62 126.52 50.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.357 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -94.27 119.06 32.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.862 0.363 . . . . 0.0 111.172 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.5 m -156.01 155.72 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.993 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -117.55 119.51 35.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.199 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.432 HG12 ' CD2' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -45.05 123.66 5.14 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.362 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -66.23 -52.62 0.81 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.462 2.108 . . . . 0.0 112.935 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.97 -171.26 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.192 0.52 . . . . 0.0 112.071 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.6 92.7 6.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.936 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -158.79 175.21 35.84 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.282 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 75.5 tt0 -89.38 117.87 28.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.689 0.28 . . . . 0.0 111.056 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.465 ' CE1' ' CD1' ' A' ' 121' ' ' LEU . 4.9 m-30 -115.07 117.41 30.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.156 0.503 . . . . 0.0 109.856 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 4.8 ptp180 -79.79 124.26 28.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.696 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 17.4 mm -78.54 148.23 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.739 -178.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -148.33 109.78 4.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.044 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.564 HD23 ' HG ' ' A' ' 117' ' ' LEU . 0.4 OUTLIER -99.53 119.76 38.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.292 0.568 . . . . 0.0 110.986 -179.625 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.41 117.6 31.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.832 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.463 ' CZ2' ' CB ' ' A' ' 81' ' ' ALA . 5.4 p-90 -142.73 165.2 28.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.035 0.445 . . . . 0.0 111.514 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 82' ' ' THR . 1.4 p -144.32 72.07 1.33 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.383 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.445 ' HB3' ' CZ3' ' A' ' 56' ' ' TRP . 31.1 t -115.99 91.78 32.64 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.109 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.68 105.89 1.37 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.791 2.327 . . . . 0.0 112.154 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.482 ' O ' ' CB ' ' A' ' 61' ' ' SER . 91.0 t80 -144.39 -86.89 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.128 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 1.2 m 155.51 64.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.884 0.373 . . . . 0.0 110.201 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.3 p 69.69 111.75 0.05 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.738 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.506 ' CB ' ' CH2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -123.61 169.36 11.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.513 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.407 ' O ' ' O ' ' A' ' 109' ' ' TRP . 26.0 t -110.64 102.95 14.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 120.75 0.31 . . . . 0.0 111.178 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.451 ' HB2' ' CD1' ' A' ' 78' ' ' PHE . 2.3 m-80 -128.02 149.97 50.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.165 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.452 ' OG1' ' HB2' ' A' ' 108' ' ' ASP . 0.2 OUTLIER -101.79 110.94 23.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.726 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.495 ' HB3' ' CD2' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -77.28 123.67 26.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.798 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 101' ' ' GLY . 34.9 t -100.09 96.55 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.37 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.512 ' CE ' ' HG ' ' A' ' 54' ' ' LEU . 3.8 mmt -138.28 137.39 37.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.858 0.361 . . . . 0.0 111.323 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.5 t70 56.54 35.58 26.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.949 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.92 15.54 60.42 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.269 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.1 m -106.39 148.32 28.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.969 0.414 . . . . 0.0 110.887 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.84 74.46 0.99 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.472 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.495 ' CD2' ' HB3' ' A' ' 67' ' ' LEU . 1.6 pp -79.28 112.5 16.57 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.221 0.534 . . . . 0.0 110.556 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.0 t -96.46 106.21 18.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.076 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.539 ' CE1' ' CE1' ' A' ' 78' ' ' PHE . 4.7 p90 -132.89 151.24 52.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.725 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 63' ' ' LYS . . . -79.69 101.58 8.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.946 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.539 ' CE1' ' CE1' ' A' ' 76' ' ' TYR . 2.5 m-85 -48.22 101.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.019 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.459 ' O ' ' CH2' ' A' ' 56' ' ' TRP . . . -56.93 140.94 46.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.245 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -38.0 108.94 0.09 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.207 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.463 ' CB ' ' CZ2' ' A' ' 56' ' ' TRP . . . -133.34 124.5 27.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.888 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.41 ' O ' ' CB ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -122.18 -51.5 1.99 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.609 178.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' A' ' 85' ' ' VAL . 1.9 m -79.74 163.23 59.52 Favored Pre-proline 0 N--CA 1.421 -1.887 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.496 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -45.47 86.5 0.02 OUTLIER 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.37 2.046 . . . . 0.0 112.686 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 83' ' ' VAL . 45.4 t -102.97 122.66 55.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.742 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.95 100.18 9.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.543 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 89' ' ' GLN . 6.0 t80 -67.46 99.94 0.8 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 20.4 t -79.73 119.01 28.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 7.4 tp60 -131.09 112.16 12.63 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 2.2 p -79.75 118.45 21.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.116 0.484 . . . . 0.0 111.532 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.2 mtpp -136.11 118.76 16.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.425 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -67.53 110.86 3.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.484 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.422 HD21 ' CD2' ' A' ' 98' ' ' HIS . 2.1 mt -89.51 148.11 23.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.377 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 p -114.22 163.3 15.43 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.931 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.92 150.15 46.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.35 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 126.66 -124.33 5.02 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.557 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.87 139.32 47.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.717 0.294 . . . . 0.0 110.487 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.432 ' CD2' HG12 ' A' ' 44' ' ' VAL . 1.7 m-70 -136.37 169.31 17.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.952 0.406 . . . . 0.0 111.344 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.72 104.74 6.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.86 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.436 ' CE2' HD12 ' A' ' 119' ' ' LEU . 39.8 m-85 -97.18 171.85 8.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.151 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 68' ' ' VAL . . . 151.32 -161.53 29.18 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.68 -1.248 . . . . 0.0 113.491 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.447 HG12 HD23 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -151.94 126.47 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.407 ' CD ' ' N ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -128.11 163.0 25.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.214 0.53 . . . . 0.0 112.23 -178.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.551 ' HB ' ' HA ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -139.46 142.94 31.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.516 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -151.45 177.69 29.23 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.649 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.4 t -49.47 -36.3 22.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 110.856 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.24 -29.15 53.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.513 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.452 ' HB2' ' OG1' ' A' ' 66' ' ' THR . 6.8 m-20 -134.28 72.87 1.47 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.137 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.542 ' C ' HG13 ' A' ' 104' ' ' VAL . 7.4 p-90 -47.99 153.12 0.69 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.252 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.471 ' N ' ' HE3' ' A' ' 109' ' ' TRP . . . -123.23 159.51 17.85 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.685 -0.769 . . . . 0.0 114.268 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.481 ' CE1' ' HG3' ' A' ' 32' ' ' GLN . 0.2 OUTLIER 163.6 58.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.719 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -137.53 -171.68 3.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.734 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 89.7 m-20 -119.06 131.1 55.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.307 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.434 HG22 ' HG ' ' A' ' 31' ' ' LEU . 6.1 t -103.98 86.6 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.519 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -52.23 -56.5 14.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.614 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.441 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 0.1 OUTLIER 175.74 151.94 0.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.174 0.511 . . . . 0.0 111.506 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.567 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -90.01 123.09 33.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.463 179.098 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -123.33 138.64 54.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.958 0.408 . . . . 0.0 111.923 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.436 HD12 ' CE2' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -123.81 128.86 50.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.234 178.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -112.84 107.45 16.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.474 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.465 ' CD1' ' CE1' ' A' ' 50' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.77 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.5 p . . . . . 0 CA--C 1.531 0.217 0 CA-C-O 120.702 0.287 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.589 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . . . -57.34 -21.51 35.98 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.55 ' HA ' ' HG ' ' A' ' 24' ' ' LEU . . . -73.13 -23.01 60.42 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.82 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.4 p -83.79 -2.48 56.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.009 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.58 -163.27 1.03 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.941 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -113.57 103.84 11.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.383 . . . . 0.0 110.84 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.473 HG22 ' HA ' ' A' ' 23' ' ' GLN . 1.5 mp -82.51 102.48 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.535 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.5 m -96.56 125.37 40.99 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.143 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.52 146.39 1.76 Allowed Pre-proline 0 CA--C 1.529 0.171 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.189 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.501 ' HD2' ' CA ' ' A' ' 36' ' ' SER . 95.4 Cg_endo -73.43 7.78 7.46 Favored 'Cis proline' 0 C--N 1.348 0.547 0 C-N-CA 124.045 -1.231 . . . . 0.0 113.558 0.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.24 143.47 49.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.882 0.373 . . . . 0.0 110.286 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.473 ' HA ' HG22 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -148.06 119.3 7.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.271 -179.154 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.55 ' HG ' ' HA ' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -79.06 114.03 17.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.34 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.4 m -123.83 113.29 36.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.699 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 58.28 39.11 92.09 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.289 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.401 ' HA ' ' CD1' ' A' ' 24' ' ' LEU . 7.6 m120 70.1 36.16 1.98 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.786 0.327 . . . . 0.0 111.006 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.18 104.62 9.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.411 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.426 ' HA3' ' CD2' ' A' ' 24' ' ' LEU . . . -70.47 83.75 0.35 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.091 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 83.5 mt-10 -88.29 99.92 12.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.683 0.278 . . . . 0.0 111.612 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.739 HD22 HG23 ' A' ' 38' ' ' VAL . 15.5 mt -79.93 150.68 30.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.075 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.458 ' O ' ' CG ' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -125.33 137.56 54.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.965 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 110' ' ' GLY . . . 40.64 -154.8 0.06 OUTLIER Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.762 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.602 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . . . -90.26 173.69 8.0 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.183 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 104' ' ' VAL . . . 88.65 -28.13 6.64 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.436 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.501 ' CA ' ' HD2' ' A' ' 21' ' ' PRO . 0.3 OUTLIER -67.43 163.79 20.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.879 0.339 . . . . 0.0 110.865 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 102' ' ' VAL . . . -169.28 103.7 0.36 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.739 HG23 HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -86.6 88.59 2.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 176.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.411 HG22 HD11 ' A' ' 39' ' ' ILE . 27.7 mm -90.83 113.02 25.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -177.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.589 ' CZ2' ' HA ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -83.27 148.46 27.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.582 179.168 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.03 111.91 15.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.644 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.4 m -149.36 -174.98 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.958 0.409 . . . . 0.0 111.567 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -139.15 128.21 23.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.48 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.447 HG22 ' CE1' ' A' ' 98' ' ' HIS . 91.8 t -57.28 123.33 60.3 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.146 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.19 -48.64 1.19 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.777 2.318 . . . . 0.0 113.171 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.4 176.63 2.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.157 0.503 . . . . 0.0 111.92 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.408 HG21 ' HA ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -88.13 97.59 11.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.27 179.511 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -157.43 178.56 33.72 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.639 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 65.1 tt0 -98.83 98.44 9.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.665 0.269 . . . . 0.0 111.227 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.505 ' CD2' ' CD2' ' A' ' 93' ' ' LEU . 1.4 m-30 -100.72 118.72 37.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 3.4 ptt180 -79.71 132.58 36.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.094 0.474 . . . . 0.0 110.584 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.515 ' CG2' ' HG2' ' A' ' 69' ' ' MET . 15.2 mm -78.16 131.0 35.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.875 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 0.9 OUTLIER -130.12 105.14 7.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.86 -1.063 . . . . 0.0 108.898 178.719 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.509 ' CD2' ' HE3' ' A' ' 69' ' ' MET . 0.5 OUTLIER -98.99 126.64 44.73 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.321 0.581 . . . . 0.0 110.781 -178.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 0.0 OUTLIER -93.48 131.05 39.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.269 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.498 ' CZ3' ' HB2' ' A' ' 81' ' ' ALA . 11.6 p-90 -157.18 167.43 30.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.036 0.446 . . . . 0.0 111.605 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.1 m -152.19 84.74 1.26 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.284 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.5 t -118.4 80.01 15.91 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.291 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.05 91.27 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.452 2.101 . . . . 0.0 111.86 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.92 -76.4 0.31 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.775 0.321 . . . . 0.0 111.436 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.513 ' HA ' ' HB2' ' A' ' 80' ' ' GLU . 11.7 t 173.28 -32.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.905 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 61' ' ' SER . 4.0 p 162.61 143.37 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.166 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -137.22 171.55 14.31 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.665 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 t -121.6 87.76 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-O 120.671 0.272 . . . . 0.0 110.309 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.444 ' ND2' ' HA3' ' A' ' 110' ' ' GLY . 0.3 OUTLIER -115.92 157.8 23.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.108 0.48 . . . . 0.0 111.624 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.2 m -107.38 110.67 22.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.227 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.531 HD12 ' CE ' ' A' ' 69' ' ' MET . 22.4 tp -78.79 121.99 25.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.517 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' A' ' 101' ' ' GLY . 38.9 t -96.5 101.6 12.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.977 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.531 ' CE ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -127.48 129.81 48.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.249 -179.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 44.5 50.83 8.1 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.757 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.75 14.64 58.58 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.698 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.2 m -104.56 130.16 52.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.072 0.463 . . . . 0.0 110.932 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.83 72.27 2.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.699 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.507 ' CD1' ' HB3' ' A' ' 67' ' ' LEU . 1.1 pp -79.46 105.48 10.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.306 0.574 . . . . 0.0 110.784 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.0 t -88.67 117.61 27.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.22 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.448 ' CZ ' ' CE1' ' A' ' 78' ' ' PHE . 1.2 p90 -144.82 151.15 38.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.11 0.481 . . . . 0.0 111.157 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.75 108.86 17.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.156 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.452 ' N ' ' O ' ' A' ' 63' ' ' LYS . 3.8 m-85 -50.79 176.08 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.017 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.03 176.94 5.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.191 0.52 . . . . 0.0 112.182 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.513 ' HB2' ' HA ' ' A' ' 61' ' ' SER . 33.7 tt0 -81.29 57.56 3.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.797 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.498 ' HB2' ' CZ3' ' A' ' 56' ' ' TRP . . . -84.92 162.54 19.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.137 0.494 . . . . 0.0 111.304 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.17 -49.78 0.12 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.01 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.546 ' O ' ' N ' ' A' ' 85' ' ' VAL . 4.2 t -79.79 141.23 55.25 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.448 ' HD2' ' CG1' ' A' ' 83' ' ' VAL . 52.0 Cg_exo -36.85 84.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.588 2.192 . . . . 0.0 112.998 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 83' ' ' VAL . 76.4 t -99.42 158.49 3.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.443 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.21 139.99 53.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.055 0.455 . . . . 0.0 111.539 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.532 ' CZ ' ' HB2' ' A' ' 89' ' ' GLN . 0.6 OUTLIER -102.21 107.44 18.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.672 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.3 t -82.68 126.37 40.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.292 0.568 . . . . 0.0 112.47 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 15.9 tt0 -145.36 113.63 6.6 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 14.9 p -78.59 116.77 19.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.706 0.765 . . . . 0.0 111.424 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.453 ' CD ' ' N ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -133.33 123.55 25.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.994 -179.221 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -93.55 110.81 22.39 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.858 0.361 . . . . 0.0 110.544 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.589 HD21 ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -109.66 149.64 29.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.175 0.512 . . . . 0.0 111.45 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.408 ' HA ' HG21 ' A' ' 47' ' ' THR . 35.0 m -97.31 156.41 16.45 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.574 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.27 135.76 57.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.253 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 141.72 -155.13 25.2 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.214 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -96.09 116.83 29.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.336 . . . . 0.0 110.745 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.447 ' CE1' HG22 ' A' ' 44' ' ' VAL . 9.0 m170 -119.04 169.06 10.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.551 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.3 p -121.67 118.25 28.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.975 0.417 . . . . 0.0 111.483 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.468 ' CZ ' HD12 ' A' ' 119' ' ' LEU . 55.0 m-85 -116.44 165.02 13.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.723 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 68' ' ' VAL . . . 154.0 -163.11 30.82 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 119.798 -1.191 . . . . 0.0 113.575 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -151.59 123.67 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.53 153.73 41.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.519 0.675 . . . . 0.0 112.751 -177.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.621 HG13 ' N ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -134.27 129.12 53.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.364 178.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 109' ' ' TRP . . . -129.24 163.84 22.38 Favored Glycine 0 C--O 1.228 -0.279 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.952 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.4 t -49.29 -28.44 4.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.85 0.357 . . . . 0.0 110.946 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.8 t -79.45 -29.26 41.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.782 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.522 ' O ' ' CD1' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -101.8 -67.53 0.86 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.914 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.534 ' HZ3' ' HB2' ' A' ' 111' ' ' TYR . 0.0 OUTLIER 79.01 133.72 0.06 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.621 ' N ' HG13 ' A' ' 104' ' ' VAL . . . -140.83 -169.78 11.88 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.18 -1.009 . . . . 0.0 114.319 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.534 ' HB2' ' HZ3' ' A' ' 109' ' ' TRP . 0.5 OUTLIER 168.8 75.55 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.457 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.3 -177.26 5.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.174 0.511 . . . . 0.0 112.066 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 1.6 m-80 -113.08 137.72 51.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.33 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.426 HG13 ' CH2' ' A' ' 40' ' ' TRP . 45.1 t -114.96 87.78 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.02 0.438 . . . . 0.0 110.582 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.416 ' HB3' ' HB ' ' A' ' 55' ' ' THR . 59.4 t-80 -57.31 -47.69 80.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.298 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.422 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 39.4 t -176.6 160.53 2.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.259 0.552 . . . . 0.0 111.866 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.555 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 0.9 OUTLIER -104.07 87.76 2.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.323 179.189 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.79 129.02 35.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.943 0.401 . . . . 0.0 111.801 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.468 HD12 ' CZ ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -115.98 107.21 14.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.134 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 50' ' ' TYR . 5.1 mt-10 -83.21 153.34 24.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.881 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.445 ' CD1' ' CE1' ' A' ' 50' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.934 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.3 p . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.524 0.202 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.601 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . . . -67.24 -28.74 68.3 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.536 ' HA ' ' HG ' ' A' ' 24' ' ' LEU . . . -69.85 -22.89 63.23 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.702 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.3 p -82.99 -4.54 58.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.033 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.88 -163.17 1.02 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.725 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.8 p -114.31 103.81 11.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.905 0.384 . . . . 0.0 110.873 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.459 HG22 ' HA ' ' A' ' 23' ' ' GLN . 1.7 mp -83.89 103.62 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.608 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.8 m -101.37 125.06 47.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.923 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.39 145.93 1.81 Allowed Pre-proline 0 N--CA 1.462 0.144 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.915 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 36' ' ' SER . 63.2 Cg_endo -69.67 2.72 4.61 Favored 'Cis proline' 0 C--N 1.348 0.551 0 C-N-CA 124.293 -1.128 . . . . 0.0 113.817 0.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.23 141.32 54.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.923 0.392 . . . . 0.0 110.359 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.459 ' HA ' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -146.5 120.36 9.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.212 -179.314 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.536 ' HG ' ' HA ' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -79.18 110.89 14.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.253 -179.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.1 m -124.25 116.43 47.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.499 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.03 38.71 93.35 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.211 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.43 37.28 3.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.87 0.367 . . . . 0.0 110.912 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.8 t -135.3 104.2 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.513 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.46 ' HA3' HD21 ' A' ' 24' ' ' LEU . . . -68.77 86.23 0.21 Allowed Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.153 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 53.3 mt-10 -84.59 99.44 10.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.777 0.322 . . . . 0.0 111.633 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.519 HD22 HG23 ' A' ' 38' ' ' VAL . 23.5 mt -80.0 149.62 30.7 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.474 ' O ' ' CG ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -129.21 132.5 47.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.876 0.37 . . . . 0.0 111.436 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 110' ' ' GLY . . . 43.32 -152.05 0.37 Allowed Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.557 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.522 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . . . -90.2 159.83 16.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.623 0.249 . . . . 0.0 110.594 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 104' ' ' VAL . . . 98.44 -24.41 32.1 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.883 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.546 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -71.52 155.31 40.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 0.0 111.191 -179.474 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . . . -162.75 113.66 1.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.075 0.464 . . . . 0.0 112.168 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.519 HG23 HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -103.16 87.91 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.44 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.5 mm -89.95 118.81 35.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.328 0.585 . . . . 0.0 112.114 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.601 ' CZ2' ' HA ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -86.57 145.64 26.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.698 179.636 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -121.34 111.85 17.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.458 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.5 m -145.05 -177.05 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.964 0.411 . . . . 0.0 111.66 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -136.85 123.5 21.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.614 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.422 HG22 ' CD2' ' A' ' 98' ' ' HIS . 45.3 t -53.61 123.89 39.43 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.265 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -65.52 -47.86 3.77 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.562 2.175 . . . . 0.0 112.755 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.33 -175.56 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.035 0.445 . . . . 0.0 111.678 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.18 99.14 11.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.352 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.46 -178.7 39.3 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.83 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 67.2 tt0 -90.85 117.52 29.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.059 0.429 . . . . 0.0 110.707 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.566 ' CD1' ' HB2' ' A' ' 93' ' ' LEU . 0.6 OUTLIER -110.87 115.86 30.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.923 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -79.62 128.85 33.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.049 0.452 . . . . 0.0 110.517 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.534 ' CG2' ' CE ' ' A' ' 69' ' ' MET . 12.1 mm -78.76 133.36 30.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.8 -178.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 0.8 OUTLIER -133.04 109.08 9.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.177 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.571 ' HG ' ' CE ' ' A' ' 69' ' ' MET . 1.3 mt -99.95 123.49 44.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.281 0.562 . . . . 0.0 111.466 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.85 118.04 31.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.262 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.544 ' CD2' ' CE2' ' A' ' 78' ' ' PHE . 3.4 p-90 -139.66 167.02 23.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.056 0.455 . . . . 0.0 111.412 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.62 72.88 0.99 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.184 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.468 ' HB2' ' HA ' ' A' ' 112' ' ' MET . 23.2 t -114.43 93.92 33.88 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.034 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.19 86.97 1.47 Allowed 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.987 2.458 . . . . 0.0 111.878 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -126.31 -82.8 0.62 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.456 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 62' ' ' SER . 1.5 p 178.85 -32.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.172 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 61' ' ' SER . 4.0 t 157.88 130.1 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.428 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 2.2 mttp -129.56 171.07 12.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.679 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 109' ' ' TRP . 38.3 t -124.82 83.61 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 CA-C-O 120.559 0.219 . . . . 0.0 110.832 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.446 ' ND2' ' CA ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -104.92 169.09 8.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.002 0.429 . . . . 0.0 111.529 -179.42 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.0 m -117.68 110.65 18.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.851 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.643 HD12 ' CE ' ' A' ' 69' ' ' MET . 11.8 tp -79.05 125.37 29.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.671 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.5 t -101.01 97.45 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.174 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.643 ' CE ' HD12 ' A' ' 67' ' ' LEU . 6.4 mmt -132.79 131.53 41.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.926 0.393 . . . . 0.0 111.482 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.1 t70 61.46 38.99 15.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.821 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.81 15.69 60.39 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.273 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.7 m -107.05 150.44 26.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.079 0.466 . . . . 0.0 111.014 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.56 74.72 0.91 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.312 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.51 ' CD1' ' HB3' ' A' ' 67' ' ' LEU . 1.5 pp -79.25 105.85 10.86 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.188 0.518 . . . . 0.0 110.943 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.9 t -82.61 134.33 35.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.59 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.446 ' CZ ' ' CE1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -160.35 151.23 18.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.207 0.527 . . . . 0.0 111.761 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . . . -88.19 102.11 14.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.071 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.544 ' CE2' ' CD2' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -59.15 145.91 40.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.107 0.48 . . . . 0.0 110.808 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.1 -178.73 7.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.797 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.433 ' HB3' ' CA ' ' A' ' 61' ' ' SER . 1.1 pt-20 -89.13 38.48 0.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.562 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.444 ' HB2' ' CZ3' ' A' ' 56' ' ' TRP . . . -51.14 172.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.176 0.512 . . . . 0.0 112.013 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.5 -48.77 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.877 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 85' ' ' VAL . 2.3 t -82.97 143.78 46.56 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.074 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.469 ' HD2' ' CG1' ' A' ' 83' ' ' VAL . 71.6 Cg_exo -41.56 84.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.269 1.979 . . . . 0.0 112.992 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 83' ' ' VAL . 46.3 t -101.79 141.47 18.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.566 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.33 127.51 53.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.931 0.396 . . . . 0.0 111.547 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.488 ' CZ ' ' HB2' ' A' ' 89' ' ' GLN . 0.6 OUTLIER -93.33 110.25 21.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.993 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.2 t -80.04 122.75 35.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 52' ' ' ILE . 21.0 tp60 -136.45 113.33 10.36 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.8 p -78.43 116.73 19.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.456 0.646 . . . . 0.0 111.544 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.3 111.66 9.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.24 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -64.77 110.82 2.52 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 120.963 0.411 . . . . 0.0 110.817 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.566 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 4.8 mt -88.78 141.88 28.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.443 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.3 m -115.24 152.38 32.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.933 0.397 . . . . 0.0 111.323 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.67 138.43 55.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.211 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 125.56 -159.77 20.06 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.561 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.62 116.98 29.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 0.0 110.866 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.422 ' CD2' HG22 ' A' ' 44' ' ' VAL . 9.8 m-70 -118.71 169.13 10.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.804 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 53.9 p -122.57 124.8 44.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.054 0.454 . . . . 0.0 111.588 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.436 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 25.6 m-85 -120.54 167.65 12.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.59 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 68' ' ' VAL . . . 151.49 -163.22 29.86 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 119.384 -1.389 . . . . 0.0 114.253 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.436 HG12 HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -149.55 154.67 9.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.821 -0.689 . . . . 0.0 109.15 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.543 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -160.3 162.78 33.65 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.136 -0.625 . . . . 0.0 112.311 -179.563 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.522 ' HB ' ' HA ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -139.02 142.05 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.466 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -154.45 173.93 32.88 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.808 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.2 m -54.12 -24.82 19.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.787 0.327 . . . . 0.0 111.005 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.01 5.22 26.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.372 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.481 ' O ' ' CD1' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -152.88 -70.28 0.15 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.782 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.526 ' CE3' ' N ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER 77.82 133.54 0.06 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.521 179.666 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.526 ' N ' ' CE3' ' A' ' 109' ' ' TRP . . . -146.07 -169.14 13.83 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.472 -0.871 . . . . 0.0 113.703 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.467 ' CE1' ' HG3' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -179.37 76.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.468 ' HA ' ' HB2' ' A' ' 58' ' ' SER . 0.0 OUTLIER -148.78 175.14 11.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.166 0.508 . . . . 0.0 112.149 -177.599 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 61.2 m-80 -108.16 131.77 54.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.828 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.466 HG13 ' CZ3' ' A' ' 40' ' ' TRP . 42.9 t -100.0 85.87 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.101 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.91 -47.86 76.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.94 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.5 p -177.59 167.28 2.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.239 0.542 . . . . 0.0 111.228 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.554 ' CD1' ' CE3' ' A' ' 40' ' ' TRP . 1.1 tt -111.61 77.98 1.08 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.79 118.53 20.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.208 0.528 . . . . 0.0 111.38 -177.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.425 HD13 ' CE2' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -101.92 143.83 31.31 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.795 179.473 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.431 ' N ' ' OE2' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -129.36 166.46 19.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.513 -179.341 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.432 HD21 ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.928 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 p . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.788 0.328 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.551 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . . . -68.71 -18.1 64.18 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.557 ' HA ' ' HG ' ' A' ' 24' ' ' LEU . . . -69.76 -23.75 63.42 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.785 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.76 0.5 54.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.903 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.51 -163.57 1.04 Allowed 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.785 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.9 t -110.44 103.73 12.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.82 0.343 . . . . 0.0 110.972 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.495 HD13 HD22 ' A' ' 24' ' ' LEU . 1.6 mp -88.03 91.62 3.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.654 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.6 m -89.83 132.34 35.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.689 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.55 147.05 3.19 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.287 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 36' ' ' SER . 89.9 Cg_endo -75.98 10.01 11.72 Favored 'Cis proline' 0 C--N 1.347 0.475 0 C-N-CA 123.723 -1.365 . . . . 0.0 113.34 0.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.443 ' C ' ' HG3' ' A' ' 23' ' ' GLN . . . -59.43 140.34 56.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.937 0.399 . . . . 0.0 110.884 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.443 ' HG3' ' C ' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -142.9 116.73 9.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.324 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.557 ' HG ' ' HA ' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -80.03 111.35 16.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.343 179.161 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.46 87.99 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.85 0.357 . . . . 0.0 111.173 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.82 -54.98 2.15 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.006 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -155.33 -36.02 0.09 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.705 0.288 . . . . 0.0 110.757 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.1 t -81.29 126.22 39.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.906 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.414 ' CA ' HD23 ' A' ' 24' ' ' LEU . . . -79.48 157.07 41.87 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.693 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 38.5 mt-10 -149.28 101.14 3.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.806 0.336 . . . . 0.0 111.145 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.657 ' CD2' HG21 ' A' ' 38' ' ' VAL . 95.4 mt -80.76 158.38 25.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.612 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.46 ' CG ' ' CE1' ' A' ' 111' ' ' TYR . 0.0 OUTLIER -127.64 -155.87 0.72 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.66 164.04 0.02 OUTLIER Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.269 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.621 ' HB2' ' HA ' ' A' ' 109' ' ' TRP . . . -40.57 163.19 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.906 0.353 . . . . 0.0 111.193 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 104' ' ' VAL . . . 99.83 -27.16 21.51 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.688 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.518 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.2 OUTLIER -67.78 150.47 48.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.819 0.342 . . . . 0.0 110.727 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . . . -158.28 96.53 1.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.979 0.418 . . . . 0.0 111.902 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.657 HG21 ' CD2' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -86.16 88.74 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.018 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.509 ' HA ' ' HA2' ' A' ' 101' ' ' GLY . 31.6 mm -93.37 114.56 30.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.225 0.536 . . . . 0.0 112.297 -178.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.602 ' CE3' ' HB2' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -82.72 146.74 28.85 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.207 179.055 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -110.71 113.86 26.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.829 0.347 . . . . 0.0 111.146 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.0 m -149.53 155.41 8.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.962 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -119.22 117.29 28.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.974 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.536 HG23 ' NE2' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -35.0 110.09 0.39 Allowed Pre-proline 0 N--CA 1.47 0.569 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.716 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 44' ' ' VAL . 17.3 Cg_endo -57.75 -43.8 46.64 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.351 2.034 . . . . 0.0 112.626 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.94 -172.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.106 0.479 . . . . 0.0 111.75 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.3 98.61 9.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.147 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.95 -145.23 4.25 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.434 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 62.5 tt0 -126.73 108.24 10.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.764 0.316 . . . . 0.0 110.905 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.506 ' CD1' HD23 ' A' ' 121' ' ' LEU . 1.3 m-30 -108.89 122.65 47.65 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 3.7 ptt180 -84.19 131.47 34.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.303 0.573 . . . . 0.0 111.341 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.473 ' N ' ' O ' ' A' ' 89' ' ' GLN . 11.4 mm -78.83 133.31 30.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.843 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 1.6 m120 -134.51 105.02 6.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.016 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.558 ' HG ' ' CE ' ' A' ' 69' ' ' MET . 0.6 OUTLIER -99.35 118.71 36.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.223 0.535 . . . . 0.0 111.309 -179.374 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 0.2 OUTLIER -91.93 123.87 35.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.594 179.154 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TRP . . . . . 0.468 ' CH2' ' O ' ' A' ' 79' ' ' ALA . 1.5 p-90 -146.11 167.28 23.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.989 0.424 . . . . 0.0 111.49 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 p -155.25 83.45 1.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.677 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.7 t -117.67 82.94 16.79 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.75 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . 0.409 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 27.5 Cg_exo -61.91 100.28 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.827 2.351 . . . . 0.0 112.309 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.409 ' CD1' ' O ' ' A' ' 59' ' ' PRO . 89.8 m-85 -156.07 -83.37 0.06 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.706 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.431 ' HA ' ' HG3' ' A' ' 80' ' ' GLU . 2.3 m -173.81 -45.15 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.894 0.378 . . . . 0.0 111.662 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 169.57 109.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.631 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.601 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -93.22 170.14 9.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.294 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.488 ' O ' ' O ' ' A' ' 109' ' ' TRP . 36.2 t -115.84 79.06 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.454 ' OD1' HG12 ' A' ' 104' ' ' VAL . 1.5 m-80 -112.86 155.75 24.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.1 0.476 . . . . 0.0 112.043 -178.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.0 m -114.41 111.04 20.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.075 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.588 HD12 ' CE ' ' A' ' 69' ' ' MET . 8.2 tp -74.17 133.92 42.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.934 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.444 ' CG2' ' HB3' ' A' ' 103' ' ' ARG . 38.5 t -108.67 106.94 21.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.64 -178.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.588 ' CE ' HD12 ' A' ' 67' ' ' LEU . 3.7 mmt -137.34 122.09 18.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.915 0.388 . . . . 0.0 111.228 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 46.3 t0 63.51 43.83 5.66 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.233 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.82 15.01 59.44 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.571 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.6 m -99.93 146.73 26.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.898 0.38 . . . . 0.0 110.827 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.94 73.47 0.82 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.779 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.491 ' CD1' ' HB3' ' A' ' 67' ' ' LEU . 1.1 pp -79.74 106.11 11.53 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.209 0.528 . . . . 0.0 110.923 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.5 t -86.41 127.72 34.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.922 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.439 ' OH ' ' CZ ' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -160.19 151.44 19.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.26 0.553 . . . . 0.0 111.327 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 63' ' ' LYS . . . -79.66 109.01 13.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.912 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.439 ' CZ ' ' OH ' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -59.23 99.42 0.05 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.161 0.505 . . . . 0.0 111.142 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.468 ' O ' ' CH2' ' A' ' 56' ' ' TRP . . . -41.46 168.07 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.978 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.431 ' HG3' ' HA ' ' A' ' 61' ' ' SER . 2.8 tm-20 -71.77 65.51 0.51 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.96 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.432 ' HB3' ' CZ2' ' A' ' 56' ' ' TRP . . . -85.73 143.34 28.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.983 0.42 . . . . 0.0 111.602 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.45 -49.04 0.65 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.239 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 85' ' ' VAL . 1.9 t -79.87 145.3 61.54 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.193 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.449 ' HD2' ' CG1' ' A' ' 83' ' ' VAL . 95.5 Cg_exo -44.29 82.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.196 1.931 . . . . 0.0 112.579 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.563 ' N ' ' O ' ' A' ' 83' ' ' VAL . 44.3 t -98.58 125.46 51.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.644 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.9 103.36 15.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.708 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.504 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -64.99 106.48 1.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.029 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.6 t -84.39 123.34 38.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 56.9 tt0 -139.1 112.46 8.18 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 6.2 p -79.12 116.98 19.74 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.344 0.593 . . . . 0.0 111.75 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -131.45 123.11 27.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.183 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -69.81 111.12 5.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.563 -179.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.518 HD12 ' CE1' ' A' ' 98' ' ' HIS . 2.3 mt -93.11 141.19 28.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.952 0.406 . . . . 0.0 111.185 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 p -116.59 146.37 42.72 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.578 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.07 150.14 2.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.55 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 135.38 -115.31 1.35 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.403 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -166.2 144.07 5.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 110.997 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.536 ' NE2' HG23 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -160.45 169.39 23.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.056 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.4 p -119.78 114.6 22.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.451 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.45 ' O ' ' N ' ' A' ' 40' ' ' TRP . 47.5 m-85 -92.02 175.75 6.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.552 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 39' ' ' ILE . . . 151.53 -153.36 24.9 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.252 -1.452 . . . . 0.0 114.172 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -153.13 124.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 114.999 -0.601 . . . . 0.0 109.699 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.444 ' HB3' ' CG2' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -122.38 152.25 40.38 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.403 0.621 . . . . 0.0 112.29 -178.371 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.74 HG13 ' C ' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -137.44 137.73 45.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.074 178.673 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -149.02 -171.06 17.36 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.905 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.0 p -53.43 -42.98 67.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.805 0.336 . . . . 0.0 110.891 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.7 m -73.13 -16.16 61.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.053 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.405 ' O ' HG13 ' A' ' 104' ' ' VAL . 3.7 p-10 -155.11 79.85 1.05 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.617 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TRP . . . . . 0.74 ' C ' HG13 ' A' ' 104' ' ' VAL . 20.5 p-90 -61.94 157.23 19.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.49 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.514 ' N ' HG13 ' A' ' 104' ' ' VAL . . . -120.69 170.3 14.39 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.215 -0.993 . . . . 0.0 114.066 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.463 ' CD2' ' O ' ' A' ' 110' ' ' GLY . 0.6 OUTLIER 165.34 57.72 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.496 ' CE ' HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -141.1 -170.82 3.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.742 -178.758 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 82.9 m-20 -116.77 131.36 56.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.814 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.496 HG21 ' CE ' ' A' ' 112' ' ' MET . 68.6 t -103.43 85.63 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.064 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' HIS . . . . . 0.427 ' HB3' ' HB ' ' A' ' 55' ' ' THR . 35.4 t-80 -57.93 -52.26 66.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.262 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.423 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 5.6 t -176.08 169.59 2.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.164 0.507 . . . . 0.0 111.964 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.602 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 1.1 tt -115.05 90.34 3.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.55 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.0 tttm -87.91 139.61 30.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.12 0.486 . . . . 0.0 111.78 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.437 ' CD2' ' CB ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -132.76 127.85 35.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.897 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -115.84 150.99 36.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.218 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.506 HD23 ' CD1' ' A' ' 50' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.207 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.774 0.321 . . . . 0.0 111.322 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.432 ' NE1' ' CB ' ' A' ' 119' ' ' LEU . 2.4 p90 -130.06 146.97 51.76 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.914 0.388 . . . . 0.0 111.241 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.65 97.3 9.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.489 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.477 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 4.1 m-85 -74.75 97.04 3.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.312 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 p -51.1 131.93 27.6 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.665 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.545 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . . . -71.0 -16.45 62.63 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.525 ' HA ' ' HG ' ' A' ' 24' ' ' LEU . . . -69.93 -27.77 65.03 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.604 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.74 -8.86 59.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.843 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -89.6 -171.12 3.08 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.705 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.6 m -106.83 103.71 13.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.689 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.48 HG12 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -80.88 94.63 2.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.255 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.8 m -91.97 128.3 37.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.95 146.27 2.83 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.133 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 36' ' ' SER . 80.6 Cg_endo -74.86 9.15 9.23 Favored 'Cis proline' 0 C--N 1.348 0.526 0 C-N-CA 123.84 -1.317 . . . . 0.0 113.583 0.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.403 ' CB ' ' CD2' ' A' ' 31' ' ' LEU . . . -59.47 143.46 49.87 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.342 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.43 120.06 10.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.397 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.525 ' HG ' ' HA ' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -79.14 114.79 18.36 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.94 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.2 m -134.75 117.62 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.918 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.47 37.29 92.55 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.286 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.75 27.91 11.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.753 0.311 . . . . 0.0 110.988 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.4 t -134.8 105.4 6.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.152 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.511 ' O ' ' HB ' ' A' ' 114' ' ' VAL . . . -75.53 106.87 2.19 Favored Glycine 0 C--O 1.223 -0.58 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.605 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 0.8 OUTLIER -105.59 118.38 36.43 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.971 0.415 . . . . 0.0 111.486 -179.196 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.674 ' CD2' HG21 ' A' ' 38' ' ' VAL . 69.7 mt -80.98 153.73 27.31 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.113 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.449 ' HA ' ' CD1' ' A' ' 111' ' ' TYR . 21.2 mt-30 -142.7 86.93 1.96 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.822 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.469 ' CA ' ' CE2' ' A' ' 111' ' ' TYR . . . 85.78 156.08 26.63 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.881 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.489 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . . . -47.21 157.46 0.19 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.835 0.317 . . . . 0.0 110.436 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 104' ' ' VAL . . . 100.47 -20.79 46.92 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.601 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.571 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.4 OUTLIER -81.98 152.13 26.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.585 0.231 . . . . 0.0 110.747 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.45 100.34 1.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.996 0.427 . . . . 0.0 112.051 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.674 HG21 ' CD2' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -89.08 88.54 2.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.46 ' HA ' ' HA2' ' A' ' 101' ' ' GLY . 29.2 mm -90.28 127.26 42.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.297 0.57 . . . . 0.0 112.408 -177.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.545 ' CZ2' ' HA ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -100.68 128.49 46.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.642 179.464 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -106.04 111.77 24.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.303 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.465 HG12 ' CZ ' ' A' ' 11' ' ' TYR . 15.7 m -147.92 161.76 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.442 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -112.56 124.58 52.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.007 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.7 m -56.81 123.94 61.25 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.211 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -62.05 -66.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.57 2.18 . . . . 0.0 113.03 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.96 -171.95 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.127 0.489 . . . . 0.0 112.013 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.16 94.53 6.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.646 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -159.24 165.66 34.4 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.459 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 66.3 tt0 -77.4 108.65 10.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.777 0.322 . . . . 0.0 111.123 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.47 ' CE1' HD23 ' A' ' 121' ' ' LEU . 3.4 m-30 -104.19 119.9 39.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.014 0.435 . . . . 0.0 110.072 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.8 ptt180 -84.42 126.76 33.54 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.712 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.518 ' N ' ' O ' ' A' ' 89' ' ' GLN . 6.1 mm -78.58 118.75 26.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.448 -178.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.538 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 8.4 m-80 -120.06 110.18 16.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.119 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.553 ' HG ' ' CE ' ' A' ' 69' ' ' MET . 0.7 OUTLIER -99.24 122.36 42.31 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.388 0.613 . . . . 0.0 111.445 -178.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.85 116.07 28.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.377 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.466 ' CH2' ' HB3' ' A' ' 78' ' ' PHE . 11.5 p-90 -145.15 167.2 23.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.331 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.5 m -148.72 92.72 2.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.889 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 111' ' ' TYR . 0.2 OUTLIER -127.11 83.55 65.71 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.92 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.44 90.18 0.17 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.644 2.23 . . . . 0.0 112.213 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.33 -77.75 0.23 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.328 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 m 178.39 -63.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.804 0.335 . . . . 0.0 111.108 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.4 t -172.82 121.28 0.39 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.997 0.427 . . . . 0.0 111.429 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.443 ' HG3' ' CH2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -110.97 171.77 7.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.171 179.556 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 109' ' ' TRP . 57.4 t -117.09 86.8 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.222 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.472 ' OD1' ' HA2' ' A' ' 110' ' ' GLY . 1.7 m-80 -110.8 168.12 9.72 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.3 m -123.43 110.33 14.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.096 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.498 ' HB3' ' CD1' ' A' ' 74' ' ' LEU . 16.2 tp -79.55 127.17 31.82 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.837 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.427 ' O ' ' N ' ' A' ' 101' ' ' GLY . 13.0 t -99.68 103.92 15.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.433 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.553 ' CE ' ' HG ' ' A' ' 54' ' ' LEU . 8.3 mmt -137.92 140.84 40.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.86 0.362 . . . . 0.0 111.047 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 45.84 40.76 6.93 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.765 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.68 25.96 70.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.786 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.5 m -119.2 141.9 48.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.01 0.433 . . . . 0.0 111.075 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -100.31 74.02 1.71 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.495 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.498 ' CD1' ' HB3' ' A' ' 67' ' ' LEU . 1.4 pp -79.3 106.48 11.37 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.227 0.536 . . . . 0.0 110.978 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.0 t -82.82 131.91 35.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.089 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.44 ' OH ' ' CE1' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -160.28 151.18 18.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.628 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 63' ' ' LYS . . . -89.06 118.75 29.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.92 0.39 . . . . 0.0 111.177 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.466 ' HB3' ' CH2' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -58.54 93.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.944 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.41 140.15 28.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.764 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -37.51 101.59 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.444 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -128.18 165.88 19.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.225 0.536 . . . . 0.0 111.558 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.46 -48.92 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.651 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.572 ' O ' ' N ' ' A' ' 85' ' ' VAL . 6.9 t -80.13 141.54 54.27 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.217 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.468 ' HD2' ' CG1' ' A' ' 83' ' ' VAL . 43.5 Cg_exo -35.35 83.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.699 2.266 . . . . 0.0 112.922 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.572 ' N ' ' O ' ' A' ' 83' ' ' VAL . 79.4 t -97.37 126.3 50.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.643 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.36 99.82 10.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.217 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.538 ' O ' ' HA ' ' A' ' 53' ' ' ASN . 1.0 OUTLIER -62.92 103.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.858 179.269 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 23.1 t -79.89 121.37 33.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 52' ' ' ILE . 1.9 tt0 -137.11 112.66 9.37 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 12.1 p -79.09 118.07 20.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.404 0.621 . . . . 0.0 111.943 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -134.96 121.44 20.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.86 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -67.59 110.85 3.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.883 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -93.93 143.49 26.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.981 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 59.6 m -113.74 163.26 15.26 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.939 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.87 148.75 44.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.012 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 127.01 -112.86 1.63 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.503 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -141.81 130.0 22.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.829 0.347 . . . . 0.0 110.981 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -133.84 150.28 51.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.867 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 27.7 p -105.25 131.56 52.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.92 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -124.45 168.15 13.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.416 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 39' ' ' ILE . . . 152.35 -164.72 30.66 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 119.949 -1.12 . . . . 0.0 113.575 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.441 HG22 HG12 ' A' ' 114' ' ' VAL . 0.1 OUTLIER -148.23 123.2 2.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.562 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.408 ' HB3' ' CG2' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -122.22 143.44 49.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.36 0.6 . . . . 0.0 112.512 -178.24 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.489 ' HB ' ' HA ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -126.88 132.05 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.265 178.299 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -149.35 -172.99 19.53 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.603 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.87 -40.78 81.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.876 0.369 . . . . 0.0 110.507 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.3 t -70.62 -29.16 65.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.481 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 64' ' ' VAL . 0.6 OUTLIER -147.35 86.53 1.62 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.321 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.511 ' CE3' ' N ' ' A' ' 110' ' ' GLY . 9.7 p-90 -86.42 157.17 19.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.933 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.511 ' N ' ' CE3' ' A' ' 109' ' ' TRP . . . -155.01 -171.25 21.52 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.108 -1.044 . . . . 0.0 114.001 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.469 ' CE2' ' CA ' ' A' ' 33' ' ' GLY . 0.7 OUTLIER -176.61 79.2 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.419 ' HE3' ' CZ ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -146.61 -176.8 5.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.2 0.524 . . . . 0.0 111.744 -178.08 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 40.8 m-20 -107.74 131.32 54.56 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.095 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' A' ' 29' ' ' GLY . 3.3 t -104.14 85.6 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.028 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -54.13 -66.58 0.37 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.265 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.413 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -164.36 148.12 9.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.146 0.498 . . . . 0.0 111.526 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.519 ' CD1' ' CE3' ' A' ' 40' ' ' TRP . 0.4 OUTLIER -84.72 95.57 8.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.858 179.411 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 53' ' ' ASN . 1.0 OUTLIER -80.08 134.06 36.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.03 0.443 . . . . 0.0 111.704 -178.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.506 ' O ' ' HA ' ' A' ' 8' ' ' SER . 0.0 OUTLIER -124.92 107.75 11.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.285 179.426 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -99.48 152.96 19.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 111.223 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.47 HD23 ' CE1' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -87.2 90.55 8.4 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.299 0.571 . . . . 0.0 110.624 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.11 -65.14 0.73 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.737 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.535 179.894 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.8 p . . . . . 0 C--O 1.231 0.108 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 10.9 p90 -156.59 151.64 26.24 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.08 0.467 . . . . 0.0 112.017 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.409 ' CG2' ' HB2' ' A' ' 116' ' ' SER . 0.2 OUTLIER -98.48 145.36 26.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.254 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.623 ' OH ' ' HB2' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -122.02 101.72 7.72 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.243 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.2 p -47.38 144.04 3.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.882 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.547 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . . . -68.57 -9.2 48.03 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.56 ' HA ' ' HG ' ' A' ' 24' ' ' LEU . . . -69.9 -29.53 66.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.9 0.381 . . . . 0.0 110.615 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.69 -2.36 53.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.99 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -96.86 -164.1 1.12 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.9 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.9 p -110.95 103.75 12.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.597 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.501 HD12 ' HG ' ' A' ' 24' ' ' LEU . 1.6 mp -87.53 91.48 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.53 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.4 m -90.72 134.72 34.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.653 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.28 145.21 5.56 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.159 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 36' ' ' SER . 86.5 Cg_endo -78.48 10.9 18.93 Favored 'Cis proline' 0 C--N 1.348 0.509 0 C-N-CA 123.64 -1.4 . . . . 0.0 113.447 0.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.53 143.66 49.52 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.43 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -147.67 118.88 7.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.051 0.453 . . . . 0.0 111.765 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.56 ' HG ' ' HA ' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -79.81 104.69 10.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.397 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.12 124.4 72.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.865 0.364 . . . . 0.0 111.598 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 58.79 46.62 93.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.391 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.0 20.59 9.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.837 0.351 . . . . 0.0 110.912 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.5 t -130.08 131.41 65.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.728 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.407 ' HA3' ' CD2' ' A' ' 24' ' ' LEU . . . -80.25 146.87 28.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.782 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 32.6 mt-10 -147.29 102.37 3.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.819 0.342 . . . . 0.0 110.807 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.612 ' CD2' HG21 ' A' ' 38' ' ' VAL . 94.9 mt -79.68 154.74 28.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.456 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.481 ' HG3' ' CE1' ' A' ' 111' ' ' TYR . 0.0 OUTLIER -123.59 -156.32 0.7 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.815 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 32' ' ' GLN . . . -37.02 152.9 0.01 OUTLIER Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.281 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.551 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . . . -39.22 158.14 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.744 0.307 . . . . 0.0 111.274 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.27 -22.81 30.23 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.661 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.45 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.7 OUTLIER -65.91 157.47 30.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.605 0.24 . . . . 0.0 110.664 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.88 96.21 1.46 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.612 HG21 ' CD2' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -90.55 88.77 2.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.171 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.438 ' HA ' ' HA2' ' A' ' 101' ' ' GLY . 26.7 mm -91.89 131.73 38.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.147 0.499 . . . . 0.0 111.905 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.567 ' CE3' ' HB2' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -103.62 126.52 50.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.357 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -94.27 119.06 32.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.862 0.363 . . . . 0.0 111.172 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.5 m -156.01 155.72 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.993 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -117.55 119.51 35.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.199 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.432 HG12 ' CD2' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -45.05 123.66 5.14 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.362 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -66.23 -52.62 0.81 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.462 2.108 . . . . 0.0 112.935 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.97 -171.26 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.192 0.52 . . . . 0.0 112.071 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.6 92.7 6.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.936 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -158.79 175.21 35.84 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.282 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 75.5 tt0 -89.38 117.87 28.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.689 0.28 . . . . 0.0 111.056 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.465 ' CE1' ' CD1' ' A' ' 121' ' ' LEU . 4.9 m-30 -115.07 117.41 30.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.156 0.503 . . . . 0.0 109.856 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 4.8 ptp180 -79.79 124.26 28.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.696 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 17.4 mm -78.54 148.23 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.739 -178.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -148.33 109.78 4.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.044 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.564 HD23 ' HG ' ' A' ' 117' ' ' LEU . 0.4 OUTLIER -99.53 119.76 38.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.292 0.568 . . . . 0.0 110.986 -179.625 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.41 117.6 31.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.832 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.463 ' CZ2' ' CB ' ' A' ' 81' ' ' ALA . 5.4 p-90 -142.73 165.2 28.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.035 0.445 . . . . 0.0 111.514 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 82' ' ' THR . 1.4 p -144.32 72.07 1.33 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.383 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.445 ' HB3' ' CZ3' ' A' ' 56' ' ' TRP . 31.1 t -115.99 91.78 32.64 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.109 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.68 105.89 1.37 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.791 2.327 . . . . 0.0 112.154 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.482 ' O ' ' CB ' ' A' ' 61' ' ' SER . 91.0 t80 -144.39 -86.89 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.128 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 1.2 m 155.51 64.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.884 0.373 . . . . 0.0 110.201 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.3 p 69.69 111.75 0.05 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.738 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.506 ' CB ' ' CH2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -123.61 169.36 11.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.513 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.407 ' O ' ' O ' ' A' ' 109' ' ' TRP . 26.0 t -110.64 102.95 14.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 120.75 0.31 . . . . 0.0 111.178 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.451 ' HB2' ' CD1' ' A' ' 78' ' ' PHE . 2.3 m-80 -128.02 149.97 50.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.165 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.452 ' OG1' ' HB2' ' A' ' 108' ' ' ASP . 0.2 OUTLIER -101.79 110.94 23.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.726 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.495 ' HB3' ' CD2' ' A' ' 74' ' ' LEU . 0.2 OUTLIER -77.28 123.67 26.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.798 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 101' ' ' GLY . 34.9 t -100.09 96.55 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.37 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.512 ' CE ' ' HG ' ' A' ' 54' ' ' LEU . 3.8 mmt -138.28 137.39 37.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.858 0.361 . . . . 0.0 111.323 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.5 t70 56.54 35.58 26.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.949 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.92 15.54 60.42 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.269 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.1 m -106.39 148.32 28.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.969 0.414 . . . . 0.0 110.887 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.84 74.46 0.99 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.472 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.495 ' CD2' ' HB3' ' A' ' 67' ' ' LEU . 1.6 pp -79.28 112.5 16.57 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.221 0.534 . . . . 0.0 110.556 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.0 t -96.46 106.21 18.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.076 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.539 ' CE1' ' CE1' ' A' ' 78' ' ' PHE . 4.7 p90 -132.89 151.24 52.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.725 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 63' ' ' LYS . . . -79.69 101.58 8.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.946 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.539 ' CE1' ' CE1' ' A' ' 76' ' ' TYR . 2.5 m-85 -48.22 101.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.019 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.459 ' O ' ' CH2' ' A' ' 56' ' ' TRP . . . -56.93 140.94 46.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.245 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -38.0 108.94 0.09 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.207 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.463 ' CB ' ' CZ2' ' A' ' 56' ' ' TRP . . . -133.34 124.5 27.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.888 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.41 ' O ' ' CB ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -122.18 -51.5 1.99 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.609 178.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.47 ' O ' ' N ' ' A' ' 85' ' ' VAL . 1.9 m -79.74 163.23 59.52 Favored Pre-proline 0 N--CA 1.421 -1.887 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.496 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -45.47 86.5 0.02 OUTLIER 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.37 2.046 . . . . 0.0 112.686 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.47 ' N ' ' O ' ' A' ' 83' ' ' VAL . 45.4 t -102.97 122.66 55.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.742 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.95 100.18 9.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.543 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.434 ' CZ ' ' HB2' ' A' ' 89' ' ' GLN . 6.0 t80 -67.46 99.94 0.8 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 20.4 t -79.73 119.01 28.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 7.4 tp60 -131.09 112.16 12.63 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 2.2 p -79.75 118.45 21.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.116 0.484 . . . . 0.0 111.532 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.2 mtpp -136.11 118.76 16.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.425 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -67.53 110.86 3.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.484 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.422 HD21 ' CD2' ' A' ' 98' ' ' HIS . 2.1 mt -89.51 148.11 23.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.377 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.3 p -114.22 163.3 15.43 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.931 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.92 150.15 46.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.35 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 126.66 -124.33 5.02 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.557 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.87 139.32 47.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.717 0.294 . . . . 0.0 110.487 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.432 ' CD2' HG12 ' A' ' 44' ' ' VAL . 1.7 m-70 -136.37 169.31 17.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.952 0.406 . . . . 0.0 111.344 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.72 104.74 6.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.86 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.436 ' CE2' HD12 ' A' ' 119' ' ' LEU . 39.8 m-85 -97.18 171.85 8.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.151 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 68' ' ' VAL . . . 151.32 -161.53 29.18 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.68 -1.248 . . . . 0.0 113.491 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.447 HG12 HD23 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -151.94 126.47 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.407 ' CD ' ' N ' ' A' ' 104' ' ' VAL . 0.0 OUTLIER -128.11 163.0 25.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.214 0.53 . . . . 0.0 112.23 -178.919 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.551 ' HB ' ' HA ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -139.46 142.94 31.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.516 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -151.45 177.69 29.23 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.649 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.4 t -49.47 -36.3 22.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 110.856 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.24 -29.15 53.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.513 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.452 ' HB2' ' OG1' ' A' ' 66' ' ' THR . 6.8 m-20 -134.28 72.87 1.47 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.137 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.542 ' C ' HG13 ' A' ' 104' ' ' VAL . 7.4 p-90 -47.99 153.12 0.69 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.252 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.471 ' N ' ' HE3' ' A' ' 109' ' ' TRP . . . -123.23 159.51 17.85 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.685 -0.769 . . . . 0.0 114.268 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.481 ' CE1' ' HG3' ' A' ' 32' ' ' GLN . 0.2 OUTLIER 163.6 58.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.719 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -137.53 -171.68 3.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.734 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 89.7 m-20 -119.06 131.1 55.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.307 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.434 HG22 ' HG ' ' A' ' 31' ' ' LEU . 6.1 t -103.98 86.6 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.519 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -52.23 -56.5 14.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.614 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.441 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 0.1 OUTLIER 175.74 151.94 0.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.174 0.511 . . . . 0.0 111.506 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.611 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -90.01 123.09 33.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.463 179.098 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -123.33 138.64 54.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.958 0.408 . . . . 0.0 111.923 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.623 ' HB2' ' OH ' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -123.81 128.86 50.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.234 178.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 122' ' ' LEU . 1.2 tm-20 -112.84 107.45 16.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.474 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.465 ' CD1' ' CE1' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -52.73 90.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.77 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 120' ' ' GLU . 0.4 OUTLIER -46.03 163.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.287 -179.542 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.333 0 C-N-CA 121.104 -0.569 . . . . 0.0 113.213 -179.706 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 52.3 p . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.823 0.344 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.496 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -73.77 103.95 4.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.325 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.52 96.11 6.51 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.34 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.495 ' O ' ' NE1' ' A' ' 40' ' ' TRP . 5.4 m-85 -83.65 110.06 17.96 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.5 p -55.69 131.93 47.79 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.388 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.589 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . . . -57.34 -21.51 35.98 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.55 ' HA ' ' HG ' ' A' ' 24' ' ' LEU . . . -73.13 -23.01 60.42 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.82 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.4 p -83.79 -2.48 56.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.009 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -95.58 -163.27 1.03 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.941 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -113.57 103.84 11.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.383 . . . . 0.0 110.84 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.473 HG22 ' HA ' ' A' ' 23' ' ' GLN . 1.5 mp -82.51 102.48 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.535 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 26.5 m -96.56 125.37 40.99 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.143 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.52 146.39 1.76 Allowed Pre-proline 0 CA--C 1.529 0.171 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.189 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.501 ' HD2' ' CA ' ' A' ' 36' ' ' SER . 95.4 Cg_endo -73.43 7.78 7.46 Favored 'Cis proline' 0 C--N 1.348 0.547 0 C-N-CA 124.045 -1.231 . . . . 0.0 113.558 0.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.24 143.47 49.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.882 0.373 . . . . 0.0 110.286 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.473 ' HA ' HG22 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -148.06 119.3 7.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.271 -179.154 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.55 ' HG ' ' HA ' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -79.06 114.03 17.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.34 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.4 m -123.83 113.29 36.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.699 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 58.28 39.11 92.09 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.289 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.401 ' HA ' ' CD1' ' A' ' 24' ' ' LEU . 7.6 m120 70.1 36.16 1.98 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.786 0.327 . . . . 0.0 111.006 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.18 104.62 9.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.411 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.426 ' HA3' ' CD2' ' A' ' 24' ' ' LEU . . . -70.47 83.75 0.35 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.091 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 83.5 mt-10 -88.29 99.92 12.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.683 0.278 . . . . 0.0 111.612 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.739 HD22 HG23 ' A' ' 38' ' ' VAL . 15.5 mt -79.93 150.68 30.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.075 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.458 ' O ' ' CG ' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -125.33 137.56 54.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.965 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 110' ' ' GLY . . . 40.64 -154.8 0.06 OUTLIER Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.762 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.602 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . . . -90.26 173.69 8.0 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.183 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 104' ' ' VAL . . . 88.65 -28.13 6.64 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.436 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.501 ' CA ' ' HD2' ' A' ' 21' ' ' PRO . 0.3 OUTLIER -67.43 163.79 20.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.879 0.339 . . . . 0.0 110.865 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' A' ' 102' ' ' VAL . . . -169.28 103.7 0.36 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.739 HG23 HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -86.6 88.59 2.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 176.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.411 HG22 HD11 ' A' ' 39' ' ' ILE . 27.7 mm -90.83 113.02 25.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -177.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.589 ' CZ2' ' HA ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -83.27 148.46 27.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.582 179.168 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.03 111.91 15.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.644 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.475 HG12 ' CD1' ' A' ' 11' ' ' TYR . 16.4 m -149.36 -174.98 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.958 0.409 . . . . 0.0 111.567 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -139.15 128.21 23.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.48 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.447 HG22 ' CE1' ' A' ' 98' ' ' HIS . 91.8 t -57.28 123.33 60.3 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.146 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.19 -48.64 1.19 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.777 2.318 . . . . 0.0 113.171 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.4 176.63 2.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.157 0.503 . . . . 0.0 111.92 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.408 HG21 ' HA ' ' A' ' 94' ' ' SER . 0.1 OUTLIER -88.13 97.59 11.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.27 179.511 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -157.43 178.56 33.72 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.639 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 65.1 tt0 -98.83 98.44 9.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.665 0.269 . . . . 0.0 111.227 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.505 ' CD2' ' CD2' ' A' ' 93' ' ' LEU . 1.4 m-30 -100.72 118.72 37.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.436 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 3.4 ptt180 -79.71 132.58 36.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.094 0.474 . . . . 0.0 110.584 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.515 ' CG2' ' HG2' ' A' ' 69' ' ' MET . 15.2 mm -78.16 131.0 35.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.875 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 0.9 OUTLIER -130.12 105.14 7.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.86 -1.063 . . . . 0.0 108.898 178.719 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.509 ' CD2' ' HE3' ' A' ' 69' ' ' MET . 0.5 OUTLIER -98.99 126.64 44.73 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.321 0.581 . . . . 0.0 110.781 -178.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 0.0 OUTLIER -93.48 131.05 39.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.269 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.498 ' CZ3' ' HB2' ' A' ' 81' ' ' ALA . 11.6 p-90 -157.18 167.43 30.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.036 0.446 . . . . 0.0 111.605 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.1 m -152.19 84.74 1.26 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.284 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.5 t -118.4 80.01 15.91 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.291 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.05 91.27 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.452 2.101 . . . . 0.0 111.86 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.92 -76.4 0.31 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.775 0.321 . . . . 0.0 111.436 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.513 ' HA ' ' HB2' ' A' ' 80' ' ' GLU . 11.7 t 173.28 -32.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.905 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 61' ' ' SER . 4.0 p 162.61 143.37 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.166 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -137.22 171.55 14.31 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.665 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 t -121.6 87.76 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-O 120.671 0.272 . . . . 0.0 110.309 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.444 ' ND2' ' HA3' ' A' ' 110' ' ' GLY . 0.3 OUTLIER -115.92 157.8 23.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.108 0.48 . . . . 0.0 111.624 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.2 m -107.38 110.67 22.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.227 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.531 HD12 ' CE ' ' A' ' 69' ' ' MET . 22.4 tp -78.79 121.99 25.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.517 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' A' ' 101' ' ' GLY . 38.9 t -96.5 101.6 12.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.977 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.531 ' CE ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -127.48 129.81 48.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.249 -179.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 44.5 50.83 8.1 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.757 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.75 14.64 58.58 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.698 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.2 m -104.56 130.16 52.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.072 0.463 . . . . 0.0 110.932 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.83 72.27 2.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.699 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.507 ' CD1' ' HB3' ' A' ' 67' ' ' LEU . 1.1 pp -79.46 105.48 10.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.306 0.574 . . . . 0.0 110.784 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.0 t -88.67 117.61 27.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.22 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.448 ' CZ ' ' CE1' ' A' ' 78' ' ' PHE . 1.2 p90 -144.82 151.15 38.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.11 0.481 . . . . 0.0 111.157 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.75 108.86 17.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.156 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.452 ' N ' ' O ' ' A' ' 63' ' ' LYS . 3.8 m-85 -50.79 176.08 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.017 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.03 176.94 5.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.191 0.52 . . . . 0.0 112.182 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.513 ' HB2' ' HA ' ' A' ' 61' ' ' SER . 33.7 tt0 -81.29 57.56 3.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.797 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.498 ' HB2' ' CZ3' ' A' ' 56' ' ' TRP . . . -84.92 162.54 19.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.137 0.494 . . . . 0.0 111.304 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.17 -49.78 0.12 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.01 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.546 ' O ' ' N ' ' A' ' 85' ' ' VAL . 4.2 t -79.79 141.23 55.25 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.448 ' HD2' ' CG1' ' A' ' 83' ' ' VAL . 52.0 Cg_exo -36.85 84.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.588 2.192 . . . . 0.0 112.998 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 83' ' ' VAL . 76.4 t -99.42 158.49 3.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.443 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.21 139.99 53.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.055 0.455 . . . . 0.0 111.539 -179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.532 ' CZ ' ' HB2' ' A' ' 89' ' ' GLN . 0.6 OUTLIER -102.21 107.44 18.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.672 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.3 t -82.68 126.37 40.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.292 0.568 . . . . 0.0 112.47 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.532 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 15.9 tt0 -145.36 113.63 6.6 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 14.9 p -78.59 116.77 19.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.706 0.765 . . . . 0.0 111.424 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.453 ' CD ' ' N ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -133.33 123.55 25.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.994 -179.221 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.521 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -93.55 110.81 22.39 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.858 0.361 . . . . 0.0 110.544 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.589 HD21 ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -109.66 149.64 29.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.175 0.512 . . . . 0.0 111.45 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.408 ' HA ' HG21 ' A' ' 47' ' ' THR . 35.0 m -97.31 156.41 16.45 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.574 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.27 135.76 57.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.253 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 141.72 -155.13 25.2 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.214 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -96.09 116.83 29.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.336 . . . . 0.0 110.745 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.447 ' CE1' HG22 ' A' ' 44' ' ' VAL . 9.0 m170 -119.04 169.06 10.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.551 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.3 p -121.67 118.25 28.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.975 0.417 . . . . 0.0 111.483 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.468 ' CZ ' HD12 ' A' ' 119' ' ' LEU . 55.0 m-85 -116.44 165.02 13.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.723 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 68' ' ' VAL . . . 154.0 -163.11 30.82 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 119.798 -1.191 . . . . 0.0 113.575 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -151.59 123.67 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -124.53 153.73 41.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.519 0.675 . . . . 0.0 112.751 -177.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.621 HG13 ' N ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -134.27 129.12 53.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.364 178.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 109' ' ' TRP . . . -129.24 163.84 22.38 Favored Glycine 0 C--O 1.228 -0.279 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.952 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.4 t -49.29 -28.44 4.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.85 0.357 . . . . 0.0 110.946 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.8 t -79.45 -29.26 41.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.782 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.522 ' O ' ' CD1' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -101.8 -67.53 0.86 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.914 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.534 ' HZ3' ' HB2' ' A' ' 111' ' ' TYR . 0.0 OUTLIER 79.01 133.72 0.06 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.621 ' N ' HG13 ' A' ' 104' ' ' VAL . . . -140.83 -169.78 11.88 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.18 -1.009 . . . . 0.0 114.319 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.534 ' HB2' ' HZ3' ' A' ' 109' ' ' TRP . 0.5 OUTLIER 168.8 75.55 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.457 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.3 -177.26 5.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.174 0.511 . . . . 0.0 112.066 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.528 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 1.6 m-80 -113.08 137.72 51.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.33 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.426 HG13 ' CH2' ' A' ' 40' ' ' TRP . 45.1 t -114.96 87.78 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.02 0.438 . . . . 0.0 110.582 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.416 ' HB3' ' HB ' ' A' ' 55' ' ' THR . 59.4 t-80 -57.31 -47.69 80.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.298 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.422 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 39.4 t -176.6 160.53 2.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.259 0.552 . . . . 0.0 111.866 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.555 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 0.9 OUTLIER -104.07 87.76 2.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.323 179.189 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 9' ' ' TRP . 0.3 OUTLIER -87.79 129.02 35.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.943 0.401 . . . . 0.0 111.801 -178.719 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.468 HD12 ' CZ ' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -115.98 107.21 14.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.134 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.446 ' O ' ' HA ' ' A' ' 50' ' ' TYR . 5.1 mt-10 -83.21 153.34 24.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.881 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.445 ' CD1' ' CE1' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -92.14 27.49 2.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.934 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.6 mt 48.85 89.83 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.931 0.396 . . . . 0.0 111.1 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.222 -179.717 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.462 ' HA ' ' CE3' ' A' ' 9' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.128 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.607 ' HE3' ' O ' ' A' ' 119' ' ' LEU . 0.1 OUTLIER -137.09 103.82 5.25 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.686 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.65 95.78 9.79 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.68 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.954 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 7.5 m-30 -77.09 94.86 4.1 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.0 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.3 p -64.25 133.43 52.76 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.644 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.601 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . . . -67.24 -28.74 68.3 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.536 ' HA ' ' HG ' ' A' ' 24' ' ' LEU . . . -69.85 -22.89 63.23 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.702 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.3 p -82.99 -4.54 58.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.033 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.88 -163.17 1.02 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.725 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.8 p -114.31 103.81 11.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.905 0.384 . . . . 0.0 110.873 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.459 HG22 ' HA ' ' A' ' 23' ' ' GLN . 1.7 mp -83.89 103.62 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.608 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.8 m -101.37 125.06 47.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.923 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.39 145.93 1.81 Allowed Pre-proline 0 N--CA 1.462 0.144 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.915 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 36' ' ' SER . 63.2 Cg_endo -69.67 2.72 4.61 Favored 'Cis proline' 0 C--N 1.348 0.551 0 C-N-CA 124.293 -1.128 . . . . 0.0 113.817 0.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.23 141.32 54.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.923 0.392 . . . . 0.0 110.359 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.459 ' HA ' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -146.5 120.36 9.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.212 -179.314 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.536 ' HG ' ' HA ' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -79.18 110.89 14.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.253 -179.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.1 m -124.25 116.43 47.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.499 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.03 38.71 93.35 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.211 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 67.43 37.28 3.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.87 0.367 . . . . 0.0 110.912 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.8 t -135.3 104.2 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.513 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.46 ' HA3' HD21 ' A' ' 24' ' ' LEU . . . -68.77 86.23 0.21 Allowed Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.153 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 53.3 mt-10 -84.59 99.44 10.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.777 0.322 . . . . 0.0 111.633 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.519 HD22 HG23 ' A' ' 38' ' ' VAL . 23.5 mt -80.0 149.62 30.7 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.474 ' O ' ' CG ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -129.21 132.5 47.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.876 0.37 . . . . 0.0 111.436 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 110' ' ' GLY . . . 43.32 -152.05 0.37 Allowed Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.557 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.522 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . . . -90.2 159.83 16.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.623 0.249 . . . . 0.0 110.594 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 104' ' ' VAL . . . 98.44 -24.41 32.1 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.883 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.546 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -71.52 155.31 40.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 0.0 111.191 -179.474 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.543 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . . . -162.75 113.66 1.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.075 0.464 . . . . 0.0 112.168 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.519 HG23 HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -103.16 87.91 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.44 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.5 mm -89.95 118.81 35.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.328 0.585 . . . . 0.0 112.114 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.601 ' CZ2' ' HA ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -86.57 145.64 26.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.698 179.636 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -121.34 111.85 17.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.458 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.491 ' CG2' ' CE2' ' A' ' 11' ' ' TYR . 26.5 m -145.05 -177.05 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.964 0.411 . . . . 0.0 111.66 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -136.85 123.5 21.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.614 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.422 HG22 ' CD2' ' A' ' 98' ' ' HIS . 45.3 t -53.61 123.89 39.43 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.265 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -65.52 -47.86 3.77 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.562 2.175 . . . . 0.0 112.755 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.33 -175.56 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.035 0.445 . . . . 0.0 111.678 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.18 99.14 11.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.352 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.46 -178.7 39.3 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.83 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.51 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 67.2 tt0 -90.85 117.52 29.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.059 0.429 . . . . 0.0 110.707 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.566 ' CD1' ' HB2' ' A' ' 93' ' ' LEU . 0.6 OUTLIER -110.87 115.86 30.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.923 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -79.62 128.85 33.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.049 0.452 . . . . 0.0 110.517 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.534 ' CG2' ' CE ' ' A' ' 69' ' ' MET . 12.1 mm -78.76 133.36 30.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.8 -178.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 0.8 OUTLIER -133.04 109.08 9.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.177 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.571 ' HG ' ' CE ' ' A' ' 69' ' ' MET . 1.3 mt -99.95 123.49 44.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.281 0.562 . . . . 0.0 111.466 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.85 118.04 31.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.262 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.544 ' CD2' ' CE2' ' A' ' 78' ' ' PHE . 3.4 p-90 -139.66 167.02 23.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.056 0.455 . . . . 0.0 111.412 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.62 72.88 0.99 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.184 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.468 ' HB2' ' HA ' ' A' ' 112' ' ' MET . 23.2 t -114.43 93.92 33.88 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.034 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.19 86.97 1.47 Allowed 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.987 2.458 . . . . 0.0 111.878 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -126.31 -82.8 0.62 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.456 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 62' ' ' SER . 1.5 p 178.85 -32.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.172 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 61' ' ' SER . 4.0 t 157.88 130.1 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.428 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.402 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 2.2 mttp -129.56 171.07 12.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.679 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 109' ' ' TRP . 38.3 t -124.82 83.61 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 CA-C-O 120.559 0.219 . . . . 0.0 110.832 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.446 ' ND2' ' CA ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -104.92 169.09 8.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.002 0.429 . . . . 0.0 111.529 -179.42 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.0 m -117.68 110.65 18.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.851 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.643 HD12 ' CE ' ' A' ' 69' ' ' MET . 11.8 tp -79.05 125.37 29.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.671 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.5 t -101.01 97.45 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.174 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.643 ' CE ' HD12 ' A' ' 67' ' ' LEU . 6.4 mmt -132.79 131.53 41.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.926 0.393 . . . . 0.0 111.482 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.1 t70 61.46 38.99 15.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.821 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.81 15.69 60.39 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.273 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.7 m -107.05 150.44 26.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.079 0.466 . . . . 0.0 111.014 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.56 74.72 0.91 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.312 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.51 ' CD1' ' HB3' ' A' ' 67' ' ' LEU . 1.5 pp -79.25 105.85 10.86 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.188 0.518 . . . . 0.0 110.943 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.9 t -82.61 134.33 35.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.59 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.446 ' CZ ' ' CE1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -160.35 151.23 18.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.207 0.527 . . . . 0.0 111.761 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . . . -88.19 102.11 14.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.071 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.544 ' CE2' ' CD2' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -59.15 145.91 40.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.107 0.48 . . . . 0.0 110.808 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.1 -178.73 7.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.797 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.433 ' HB3' ' CA ' ' A' ' 61' ' ' SER . 1.1 pt-20 -89.13 38.48 0.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.562 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.444 ' HB2' ' CZ3' ' A' ' 56' ' ' TRP . . . -51.14 172.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.176 0.512 . . . . 0.0 112.013 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.5 -48.77 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.877 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 85' ' ' VAL . 2.3 t -82.97 143.78 46.56 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.074 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.469 ' HD2' ' CG1' ' A' ' 83' ' ' VAL . 71.6 Cg_exo -41.56 84.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.269 1.979 . . . . 0.0 112.992 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 83' ' ' VAL . 46.3 t -101.79 141.47 18.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.566 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.33 127.51 53.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.931 0.396 . . . . 0.0 111.547 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.488 ' CZ ' ' HB2' ' A' ' 89' ' ' GLN . 0.6 OUTLIER -93.33 110.25 21.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.993 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.2 t -80.04 122.75 35.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.504 ' O ' ' N ' ' A' ' 52' ' ' ILE . 21.0 tp60 -136.45 113.33 10.36 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.8 p -78.43 116.73 19.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.456 0.646 . . . . 0.0 111.544 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.3 111.66 9.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.24 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -64.77 110.82 2.52 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 120.963 0.411 . . . . 0.0 110.817 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.566 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 4.8 mt -88.78 141.88 28.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.443 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.3 m -115.24 152.38 32.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.933 0.397 . . . . 0.0 111.323 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.67 138.43 55.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.211 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 125.56 -159.77 20.06 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.561 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.62 116.98 29.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 0.0 110.866 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.422 ' CD2' HG22 ' A' ' 44' ' ' VAL . 9.8 m-70 -118.71 169.13 10.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.804 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 53.9 p -122.57 124.8 44.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.054 0.454 . . . . 0.0 111.588 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.436 ' CZ ' HD13 ' A' ' 93' ' ' LEU . 25.6 m-85 -120.54 167.65 12.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.59 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 68' ' ' VAL . . . 151.49 -163.22 29.86 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 119.384 -1.389 . . . . 0.0 114.253 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.436 HG12 HD12 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -149.55 154.67 9.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.821 -0.689 . . . . 0.0 109.15 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.543 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -160.3 162.78 33.65 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.136 -0.625 . . . . 0.0 112.311 -179.563 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.522 ' HB ' ' HA ' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -139.02 142.05 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.466 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -154.45 173.93 32.88 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.808 -179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.2 m -54.12 -24.82 19.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.787 0.327 . . . . 0.0 111.005 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.01 5.22 26.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.372 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.481 ' O ' ' CD1' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -152.88 -70.28 0.15 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.782 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.526 ' CE3' ' N ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER 77.82 133.54 0.06 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.521 179.666 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.526 ' N ' ' CE3' ' A' ' 109' ' ' TRP . . . -146.07 -169.14 13.83 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.472 -0.871 . . . . 0.0 113.703 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.467 ' CE1' ' HG3' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -179.37 76.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.468 ' HA ' ' HB2' ' A' ' 58' ' ' SER . 0.0 OUTLIER -148.78 175.14 11.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.166 0.508 . . . . 0.0 112.149 -177.599 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 61.2 m-80 -108.16 131.77 54.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.828 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.466 HG13 ' CZ3' ' A' ' 40' ' ' TRP . 42.9 t -100.0 85.87 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.101 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.91 -47.86 76.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.94 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.5 p -177.59 167.28 2.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.239 0.542 . . . . 0.0 111.228 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.954 ' O ' ' HB2' ' A' ' 11' ' ' TYR . 1.1 tt -111.61 77.98 1.08 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.79 118.53 20.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.208 0.528 . . . . 0.0 111.38 -177.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.607 ' O ' ' HE3' ' A' ' 9' ' ' TRP . 0.2 OUTLIER -101.92 143.83 31.31 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.795 179.473 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.431 ' N ' ' OE2' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -129.36 166.46 19.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.513 -179.341 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.432 HD21 ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -98.51 26.45 5.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.928 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.4 mt 60.34 -165.99 0.2 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.669 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.453 179.978 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.529 0.167 0 CA-C-O 120.706 0.288 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . 0.427 ' CE3' ' N ' ' A' ' 9' ' ' TRP . 1.5 p90 -155.84 151.05 26.69 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.17 0.51 . . . . 0.0 111.43 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.413 ' CG2' ' HB3' ' A' ' 116' ' ' SER . 0.6 OUTLIER -83.93 140.24 32.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.74 -179.1 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.442 ' O ' ' CZ2' ' A' ' 40' ' ' TRP . 1.7 m-30 -106.1 103.26 12.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.539 178.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 p -52.25 134.74 33.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.788 0.328 . . . . 0.0 110.839 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.551 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . . . -68.71 -18.1 64.18 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.557 ' HA ' ' HG ' ' A' ' 24' ' ' LEU . . . -69.76 -23.75 63.42 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.785 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.76 0.5 54.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.903 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.51 -163.57 1.04 Allowed 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.785 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.9 t -110.44 103.73 12.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.82 0.343 . . . . 0.0 110.972 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.495 HD13 HD22 ' A' ' 24' ' ' LEU . 1.6 mp -88.03 91.62 3.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.654 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.6 m -89.83 132.34 35.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.689 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.55 147.05 3.19 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.287 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 36' ' ' SER . 89.9 Cg_endo -75.98 10.01 11.72 Favored 'Cis proline' 0 C--N 1.347 0.475 0 C-N-CA 123.723 -1.365 . . . . 0.0 113.34 0.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.443 ' C ' ' HG3' ' A' ' 23' ' ' GLN . . . -59.43 140.34 56.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.937 0.399 . . . . 0.0 110.884 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.443 ' HG3' ' C ' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -142.9 116.73 9.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.324 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.557 ' HG ' ' HA ' ' A' ' 14' ' ' ALA . 0.2 OUTLIER -80.03 111.35 16.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.343 179.161 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.46 87.99 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.85 0.357 . . . . 0.0 111.173 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.82 -54.98 2.15 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.006 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -155.33 -36.02 0.09 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.705 0.288 . . . . 0.0 110.757 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.1 t -81.29 126.22 39.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.906 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.414 ' CA ' HD23 ' A' ' 24' ' ' LEU . . . -79.48 157.07 41.87 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.693 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 38.5 mt-10 -149.28 101.14 3.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.806 0.336 . . . . 0.0 111.145 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.657 ' CD2' HG21 ' A' ' 38' ' ' VAL . 95.4 mt -80.76 158.38 25.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.612 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.46 ' CG ' ' CE1' ' A' ' 111' ' ' TYR . 0.0 OUTLIER -127.64 -155.87 0.72 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.66 164.04 0.02 OUTLIER Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.269 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.621 ' HB2' ' HA ' ' A' ' 109' ' ' TRP . . . -40.57 163.19 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.906 0.353 . . . . 0.0 111.193 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 104' ' ' VAL . . . 99.83 -27.16 21.51 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.688 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.518 ' N ' ' HD2' ' A' ' 21' ' ' PRO . 0.2 OUTLIER -67.78 150.47 48.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.819 0.342 . . . . 0.0 110.727 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . . . -158.28 96.53 1.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.979 0.418 . . . . 0.0 111.902 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.657 HG21 ' CD2' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -86.16 88.74 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.018 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.509 ' HA ' ' HA2' ' A' ' 101' ' ' GLY . 31.6 mm -93.37 114.56 30.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.225 0.536 . . . . 0.0 112.297 -178.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.602 ' CE3' ' HB2' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -82.72 146.74 28.85 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.207 179.055 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -110.71 113.86 26.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.829 0.347 . . . . 0.0 111.146 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.0 m -149.53 155.41 8.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.962 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -119.22 117.29 28.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.974 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.536 HG23 ' NE2' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -35.0 110.09 0.39 Allowed Pre-proline 0 N--CA 1.47 0.569 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.716 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 44' ' ' VAL . 17.3 Cg_endo -57.75 -43.8 46.64 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.351 2.034 . . . . 0.0 112.626 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.94 -172.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.106 0.479 . . . . 0.0 111.75 -179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.3 98.61 9.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.147 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.95 -145.23 4.25 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.434 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 62.5 tt0 -126.73 108.24 10.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.764 0.316 . . . . 0.0 110.905 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.506 ' CD1' HD23 ' A' ' 121' ' ' LEU . 1.3 m-30 -108.89 122.65 47.65 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 3.7 ptt180 -84.19 131.47 34.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.303 0.573 . . . . 0.0 111.341 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.473 ' N ' ' O ' ' A' ' 89' ' ' GLN . 11.4 mm -78.83 133.31 30.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.843 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 1.6 m120 -134.51 105.02 6.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.016 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.558 ' HG ' ' CE ' ' A' ' 69' ' ' MET . 0.6 OUTLIER -99.35 118.71 36.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.223 0.535 . . . . 0.0 111.309 -179.374 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 0.2 OUTLIER -91.93 123.87 35.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.594 179.154 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TRP . . . . . 0.468 ' CH2' ' O ' ' A' ' 79' ' ' ALA . 1.5 p-90 -146.11 167.28 23.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.989 0.424 . . . . 0.0 111.49 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 p -155.25 83.45 1.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.677 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.7 t -117.67 82.94 16.79 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.75 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . 0.409 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 27.5 Cg_exo -61.91 100.28 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.827 2.351 . . . . 0.0 112.309 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.409 ' CD1' ' O ' ' A' ' 59' ' ' PRO . 89.8 m-85 -156.07 -83.37 0.06 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.706 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.431 ' HA ' ' HG3' ' A' ' 80' ' ' GLU . 2.3 m -173.81 -45.15 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.894 0.378 . . . . 0.0 111.662 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 169.57 109.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.631 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.601 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -93.22 170.14 9.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.294 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.488 ' O ' ' O ' ' A' ' 109' ' ' TRP . 36.2 t -115.84 79.06 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.454 ' OD1' HG12 ' A' ' 104' ' ' VAL . 1.5 m-80 -112.86 155.75 24.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.1 0.476 . . . . 0.0 112.043 -178.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.0 m -114.41 111.04 20.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.075 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.588 HD12 ' CE ' ' A' ' 69' ' ' MET . 8.2 tp -74.17 133.92 42.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.934 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.444 ' CG2' ' HB3' ' A' ' 103' ' ' ARG . 38.5 t -108.67 106.94 21.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.64 -178.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.588 ' CE ' HD12 ' A' ' 67' ' ' LEU . 3.7 mmt -137.34 122.09 18.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.915 0.388 . . . . 0.0 111.228 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 46.3 t0 63.51 43.83 5.66 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.233 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.82 15.01 59.44 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.571 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.6 m -99.93 146.73 26.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.898 0.38 . . . . 0.0 110.827 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.94 73.47 0.82 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.779 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.491 ' CD1' ' HB3' ' A' ' 67' ' ' LEU . 1.1 pp -79.74 106.11 11.53 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.209 0.528 . . . . 0.0 110.923 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.5 t -86.41 127.72 34.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.922 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.439 ' OH ' ' CZ ' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -160.19 151.44 19.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.26 0.553 . . . . 0.0 111.327 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.519 ' HA ' ' O ' ' A' ' 63' ' ' LYS . . . -79.66 109.01 13.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.912 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.439 ' CZ ' ' OH ' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -59.23 99.42 0.05 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.161 0.505 . . . . 0.0 111.142 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.468 ' O ' ' CH2' ' A' ' 56' ' ' TRP . . . -41.46 168.07 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.978 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.431 ' HG3' ' HA ' ' A' ' 61' ' ' SER . 2.8 tm-20 -71.77 65.51 0.51 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.96 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.432 ' HB3' ' CZ2' ' A' ' 56' ' ' TRP . . . -85.73 143.34 28.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.983 0.42 . . . . 0.0 111.602 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.45 -49.04 0.65 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.239 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 85' ' ' VAL . 1.9 t -79.87 145.3 61.54 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.193 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.449 ' HD2' ' CG1' ' A' ' 83' ' ' VAL . 95.5 Cg_exo -44.29 82.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.196 1.931 . . . . 0.0 112.579 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.563 ' N ' ' O ' ' A' ' 83' ' ' VAL . 44.3 t -98.58 125.46 51.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.644 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.9 103.36 15.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.708 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.504 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -64.99 106.48 1.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.029 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.6 t -84.39 123.34 38.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 56.9 tt0 -139.1 112.46 8.18 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 6.2 p -79.12 116.98 19.74 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.344 0.593 . . . . 0.0 111.75 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -131.45 123.11 27.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.183 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.544 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -69.81 111.12 5.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.563 -179.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.518 HD12 ' CE1' ' A' ' 98' ' ' HIS . 2.3 mt -93.11 141.19 28.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.952 0.406 . . . . 0.0 111.185 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 p -116.59 146.37 42.72 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.578 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -50.07 150.14 2.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.55 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 135.38 -115.31 1.35 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.403 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -166.2 144.07 5.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 110.997 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.536 ' NE2' HG23 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -160.45 169.39 23.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.056 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.4 p -119.78 114.6 22.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.451 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.45 ' O ' ' N ' ' A' ' 40' ' ' TRP . 47.5 m-85 -92.02 175.75 6.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.552 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 39' ' ' ILE . . . 151.53 -153.36 24.9 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.252 -1.452 . . . . 0.0 114.172 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -153.13 124.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 114.999 -0.601 . . . . 0.0 109.699 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.444 ' HB3' ' CG2' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -122.38 152.25 40.38 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.403 0.621 . . . . 0.0 112.29 -178.371 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.74 HG13 ' C ' ' A' ' 109' ' ' TRP . 0.1 OUTLIER -137.44 137.73 45.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.074 178.673 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -149.02 -171.06 17.36 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.905 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.0 p -53.43 -42.98 67.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.805 0.336 . . . . 0.0 110.891 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.7 m -73.13 -16.16 61.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.053 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.405 ' O ' HG13 ' A' ' 104' ' ' VAL . 3.7 p-10 -155.11 79.85 1.05 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.617 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.74 ' C ' HG13 ' A' ' 104' ' ' VAL . 20.5 p-90 -61.94 157.23 19.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.49 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.514 ' N ' HG13 ' A' ' 104' ' ' VAL . . . -120.69 170.3 14.39 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.215 -0.993 . . . . 0.0 114.066 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.463 ' CD2' ' O ' ' A' ' 110' ' ' GLY . 0.6 OUTLIER 165.34 57.72 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.496 ' CE ' HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -141.1 -170.82 3.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.742 -178.758 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 82.9 m-20 -116.77 131.36 56.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.814 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.496 HG21 ' CE ' ' A' ' 112' ' ' MET . 68.6 t -103.43 85.63 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.064 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' HIS . . . . . 0.427 ' HB3' ' HB ' ' A' ' 55' ' ' THR . 35.4 t-80 -57.93 -52.26 66.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.262 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.423 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 5.6 t -176.08 169.59 2.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.164 0.507 . . . . 0.0 111.964 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.602 ' HB2' ' CE3' ' A' ' 40' ' ' TRP . 1.1 tt -115.05 90.34 3.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.55 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.0 tttm -87.91 139.61 30.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.12 0.486 . . . . 0.0 111.78 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.437 ' CD2' ' CB ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -132.76 127.85 35.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.897 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -115.84 150.99 36.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.218 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.506 HD23 ' CD1' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -89.59 38.13 0.9 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.207 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.2 mt 47.53 28.48 1.19 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.325 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.46 179.968 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 p . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.627 0.251 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.53 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . . . -71.0 -16.45 62.63 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.79 ' HB2' HD11 ' A' ' 24' ' ' LEU . . . -69.93 -27.77 65.03 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.604 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.74 -8.86 59.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.843 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.725 ' HB1' ' O ' ' A' ' 39' ' ' ILE . . . -89.6 -171.12 3.08 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.705 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.6 m -106.83 103.71 13.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.689 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.955 HD11 HD23 ' A' ' 24' ' ' LEU . 1.7 mp -80.88 94.63 2.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.255 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.515 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 63.8 m -91.97 128.3 37.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.95 146.27 2.83 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.133 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 36' ' ' SER . 80.6 Cg_endo -74.86 9.15 9.23 Favored 'Cis proline' 0 C--N 1.348 0.526 0 C-N-CA 123.84 -1.317 . . . . 0.0 113.583 0.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.707 ' HB2' ' CD2' ' A' ' 31' ' ' LEU . . . -59.47 143.46 49.87 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.342 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.43 120.06 10.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.397 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.955 HD23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -79.14 114.79 18.36 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.94 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.2 m -134.75 117.62 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.918 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.47 37.29 92.55 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.286 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.75 27.91 11.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.753 0.311 . . . . 0.0 110.988 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.733 HG13 ' HA ' ' A' ' 115' ' ' HIS . 25.4 t -134.8 105.4 6.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.152 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.523 ' O ' ' HB ' ' A' ' 114' ' ' VAL . . . -75.53 106.87 2.19 Favored Glycine 0 C--O 1.223 -0.58 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.605 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 0.8 OUTLIER -105.59 118.38 36.43 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.971 0.415 . . . . 0.0 111.486 -179.196 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.037 HD21 HG22 ' A' ' 38' ' ' VAL . 69.7 mt -80.98 153.73 27.31 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.113 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.459 ' HA ' ' CD1' ' A' ' 111' ' ' TYR . 21.2 mt-30 -142.7 86.93 1.96 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.822 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.469 ' CA ' ' CE2' ' A' ' 111' ' ' TYR . . . 85.78 156.08 26.63 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.881 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.538 ' HB1' ' C ' ' A' ' 105' ' ' GLY . . . -47.21 157.46 0.19 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.835 0.317 . . . . 0.0 110.436 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 104' ' ' VAL . . . 100.47 -20.79 46.92 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.601 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.834 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -81.98 152.13 26.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.585 0.231 . . . . 0.0 110.747 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.422 ' HB2' ' HD3' ' A' ' 103' ' ' ARG . . . -156.45 100.34 1.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.996 0.427 . . . . 0.0 112.051 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 1.061 HG21 HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -89.08 88.54 2.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.063 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.725 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 29.2 mm -90.28 127.26 42.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.297 0.57 . . . . 0.0 112.408 -177.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.849 ' CE3' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -100.68 128.49 46.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.642 179.464 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -106.04 111.77 24.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.303 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.7 m -147.92 161.76 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.442 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -112.56 124.58 52.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.007 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.873 ' CG1' HD13 ' A' ' 93' ' ' LEU . 1.7 m -56.81 123.94 61.25 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.211 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -62.05 -66.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.57 2.18 . . . . 0.0 113.03 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.96 -171.95 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.127 0.489 . . . . 0.0 112.013 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.751 HG23 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -98.16 94.53 6.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.646 179.804 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -159.24 165.66 34.4 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.459 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 66.3 tt0 -77.4 108.65 10.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.777 0.322 . . . . 0.0 111.123 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.871 ' HD2' HD12 ' A' ' 93' ' ' LEU . 3.4 m-30 -104.19 119.9 39.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.014 0.435 . . . . 0.0 110.072 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.457 ' HB3' HG22 ' A' ' 90' ' ' THR . 4.8 ptt180 -84.42 126.76 33.54 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.712 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.81 HG21 ' HG3' ' A' ' 69' ' ' MET . 6.1 mm -78.58 118.75 26.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.448 -178.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.544 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 8.4 m-80 -120.06 110.18 16.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.119 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.699 HD21 ' HG ' ' A' ' 117' ' ' LEU . 0.7 OUTLIER -99.24 122.36 42.31 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.388 0.613 . . . . 0.0 111.445 -178.854 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.433 ' HB ' ' HB2' ' A' ' 115' ' ' HIS . 0.2 OUTLIER -92.85 116.07 28.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.377 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.463 ' CH2' ' HB3' ' A' ' 78' ' ' PHE . 11.5 p-90 -145.15 167.2 23.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.331 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.5 m -148.72 92.72 2.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.889 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 111' ' ' TYR . 0.2 OUTLIER -127.11 83.55 65.71 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.92 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.44 90.18 0.17 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.644 2.23 . . . . 0.0 112.213 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.33 -77.75 0.23 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.328 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 m 178.39 -63.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.804 0.335 . . . . 0.0 111.108 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.4 t -172.82 121.28 0.39 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.997 0.427 . . . . 0.0 111.429 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.466 ' HG3' ' CH2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -110.97 171.77 7.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.171 179.556 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 108' ' ' ASP . 57.4 t -117.09 86.8 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.222 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.817 HD22 ' HA3' ' A' ' 110' ' ' GLY . 4.4 m120 -110.8 168.12 9.72 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.3 m -123.43 110.33 14.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.096 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.974 HD11 ' CE ' ' A' ' 69' ' ' MET . 16.2 tp -79.55 127.17 31.82 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.837 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.428 ' CG2' ' HB3' ' A' ' 103' ' ' ARG . 13.0 t -99.68 103.92 15.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.433 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.974 ' CE ' HD11 ' A' ' 67' ' ' LEU . 8.3 mmt -137.92 140.84 40.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.86 0.362 . . . . 0.0 111.047 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.473 ' HB3' HD21 ' A' ' 93' ' ' LEU . 6.2 p-10 45.84 40.76 6.93 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.765 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.68 25.96 70.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.786 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.5 m -119.2 141.9 48.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.01 0.433 . . . . 0.0 111.075 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -100.31 74.02 1.71 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.495 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.763 HD11 HD23 ' A' ' 67' ' ' LEU . 1.4 pp -79.3 106.48 11.37 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.227 0.536 . . . . 0.0 110.978 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.0 t -82.82 131.91 35.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.089 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.459 ' CE1' ' HB2' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -160.28 151.18 18.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.628 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 63' ' ' LYS . . . -89.06 118.75 29.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.92 0.39 . . . . 0.0 111.177 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.463 ' HB3' ' CH2' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -58.54 93.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.944 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.41 140.15 28.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.764 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -37.51 101.59 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.444 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.45 ' HB3' ' CH2' ' A' ' 56' ' ' TRP . . . -128.18 165.88 19.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.225 0.536 . . . . 0.0 111.558 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.621 HG23 HG23 ' A' ' 83' ' ' VAL . 0.8 OUTLIER -160.46 -48.92 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.651 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.949 ' O ' HG23 ' A' ' 85' ' ' VAL . 6.9 t -80.13 141.54 54.27 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.217 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.479 ' HD2' ' CG1' ' A' ' 83' ' ' VAL . 43.5 Cg_exo -35.35 83.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.699 2.266 . . . . 0.0 112.922 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.949 HG23 ' O ' ' A' ' 83' ' ' VAL . 79.4 t -97.37 126.3 50.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.643 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.416 HG22 ' HB3' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -100.36 99.82 10.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.217 -179.677 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.619 ' OH ' HD13 ' A' ' 74' ' ' LEU . 1.0 OUTLIER -62.92 103.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.858 179.269 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 23.1 t -79.89 121.37 33.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 1.9 tt0 -137.11 112.66 9.37 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.457 HG22 ' HB3' ' A' ' 51' ' ' ARG . 12.1 p -79.09 118.07 20.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.404 0.621 . . . . 0.0 111.943 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -134.96 121.44 20.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.86 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -67.59 110.85 3.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.883 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.873 HD13 ' CG1' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -93.93 143.49 26.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.981 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.666 ' O ' HG21 ' A' ' 44' ' ' VAL . 59.6 m -113.74 163.26 15.26 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.939 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.751 ' H ' HG23 ' A' ' 47' ' ' THR . . . -72.87 148.75 44.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.012 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 127.01 -112.86 1.63 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.503 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -141.81 130.0 22.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.829 0.347 . . . . 0.0 110.981 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.419 ' ND1' HD22 ' A' ' 93' ' ' LEU . 10.6 m-70 -133.84 150.28 51.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.867 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 27.7 p -105.25 131.56 52.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.92 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.844 ' HZ ' HD11 ' A' ' 93' ' ' LEU . 49.9 m-85 -124.45 168.15 13.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.416 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 39' ' ' ILE . . . 152.35 -164.72 30.66 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 119.949 -1.12 . . . . 0.0 113.575 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.426 HG21 HG11 ' A' ' 114' ' ' VAL . 0.1 OUTLIER -148.23 123.2 2.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.562 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.428 ' HB3' ' CG2' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -122.22 143.44 49.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.36 0.6 . . . . 0.0 112.512 -178.24 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.712 HG22 HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -126.88 132.05 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.265 178.299 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.538 ' C ' ' HB1' ' A' ' 34' ' ' ALA . . . -149.35 -172.99 19.53 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.603 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.87 -40.78 81.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.876 0.369 . . . . 0.0 110.507 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.3 t -70.62 -29.16 65.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.481 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 64' ' ' VAL . 0.6 OUTLIER -147.35 86.53 1.62 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.321 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.511 ' CE3' ' N ' ' A' ' 110' ' ' GLY . 9.7 p-90 -86.42 157.17 19.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.933 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.817 ' HA3' HD22 ' A' ' 65' ' ' ASN . . . -155.01 -171.25 21.52 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.108 -1.044 . . . . 0.0 114.001 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.469 ' CE2' ' CA ' ' A' ' 33' ' ' GLY . 0.7 OUTLIER -176.61 79.2 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.793 ' CE ' HG22 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -146.61 -176.8 5.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.2 0.524 . . . . 0.0 111.744 -178.08 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 40.8 m-20 -107.74 131.32 54.56 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.095 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 1.061 HG21 HG21 ' A' ' 38' ' ' VAL . 3.3 t -104.14 85.6 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.028 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.733 ' HA ' HG13 ' A' ' 28' ' ' VAL . 2.0 m80 -54.13 -66.58 0.37 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.265 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.428 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -164.36 148.12 9.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.146 0.498 . . . . 0.0 111.526 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.849 HD12 ' CE3' ' A' ' 40' ' ' TRP . 0.4 OUTLIER -84.72 95.57 8.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.858 179.411 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 53' ' ' ASN . 1.0 OUTLIER -80.08 134.06 36.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.03 0.443 . . . . 0.0 111.704 -178.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.731 HD23 ' HB3' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -124.92 107.75 11.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.285 179.426 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -99.48 152.96 19.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 111.223 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.516 -0.327 0 CA-C-O 121.299 0.571 . . . . 0.0 110.624 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.2 p . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 120.791 0.329 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.703 ' HB3' HD21 ' A' ' 24' ' ' LEU . . . -68.57 -9.2 48.03 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.571 ' HA ' ' HG ' ' A' ' 24' ' ' LEU . . . -69.9 -29.53 66.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.9 0.381 . . . . 0.0 110.615 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.69 -2.36 53.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.99 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.686 ' HB1' ' O ' ' A' ' 39' ' ' ILE . . . -96.86 -164.1 1.12 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.9 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.9 p -110.95 103.75 12.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.597 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.693 HD11 HD23 ' A' ' 24' ' ' LEU . 1.6 mp -87.53 91.48 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.53 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.518 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 27.4 m -90.72 134.72 34.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.653 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.28 145.21 5.56 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.159 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 36' ' ' SER . 86.5 Cg_endo -78.48 10.9 18.93 Favored 'Cis proline' 0 C--N 1.348 0.509 0 C-N-CA 123.64 -1.4 . . . . 0.0 113.447 0.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.647 ' HB2' ' CD2' ' A' ' 31' ' ' LEU . . . -59.53 143.66 49.52 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.43 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -147.67 118.88 7.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.051 0.453 . . . . 0.0 111.765 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.791 HD22 ' HA2' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -79.81 104.69 10.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.397 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 25' ' ' VAL . 27.6 m -116.12 124.4 72.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.865 0.364 . . . . 0.0 111.598 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.58 ' O ' HG23 ' A' ' 28' ' ' VAL . . . 58.79 46.62 93.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.391 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 60.0 20.59 9.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.837 0.351 . . . . 0.0 110.912 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 26' ' ' GLY . 38.5 t -130.08 131.41 65.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.728 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.791 ' HA2' HD22 ' A' ' 24' ' ' LEU . . . -80.25 146.87 28.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.782 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.55 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 32.6 mt-10 -147.29 102.37 3.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.819 0.342 . . . . 0.0 110.807 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.979 HD21 HG22 ' A' ' 38' ' ' VAL . 94.9 mt -79.68 154.74 28.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.456 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.508 ' HG3' ' CE1' ' A' ' 111' ' ' TYR . 0.0 OUTLIER -123.59 -156.32 0.7 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.815 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 32' ' ' GLN . . . -37.02 152.9 0.01 OUTLIER Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.281 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.926 ' HB2' ' HA ' ' A' ' 109' ' ' TRP . . . -39.22 158.14 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.744 0.307 . . . . 0.0 111.274 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.27 -22.81 30.23 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.661 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.858 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.7 OUTLIER -65.91 157.47 30.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.605 0.24 . . . . 0.0 110.664 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.88 96.21 1.46 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 1.061 HG21 HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -90.55 88.77 2.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.171 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.686 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 26.7 mm -91.89 131.73 38.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.147 0.499 . . . . 0.0 111.905 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.747 ' CE3' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -103.62 126.52 50.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.357 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -94.27 119.06 32.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.862 0.363 . . . . 0.0 111.172 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.5 m -156.01 155.72 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.993 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -117.55 119.51 35.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.199 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.715 ' CG1' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -45.05 123.66 5.14 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.362 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -66.23 -52.62 0.81 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.462 2.108 . . . . 0.0 112.935 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.97 -171.26 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.192 0.52 . . . . 0.0 112.071 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.6 92.7 6.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.936 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -158.79 175.21 35.84 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.282 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 75.5 tt0 -89.38 117.87 28.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.689 0.28 . . . . 0.0 111.056 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.954 ' CE1' HD13 ' A' ' 121' ' ' LEU . 4.9 m-30 -115.07 117.41 30.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.156 0.503 . . . . 0.0 109.856 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 4.8 ptp180 -79.79 124.26 28.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.696 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 17.4 mm -78.54 148.23 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.739 -178.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.445 ' HB3' HG22 ' A' ' 86' ' ' THR . 2.0 m-80 -148.33 109.78 4.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.044 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.975 HD12 HD21 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -99.53 119.76 38.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.292 0.568 . . . . 0.0 110.986 -179.625 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 0.2 OUTLIER -96.41 117.6 31.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.832 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.59 ' CH2' ' HB3' ' A' ' 81' ' ' ALA . 5.4 p-90 -142.73 165.2 28.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.035 0.445 . . . . 0.0 111.514 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 82' ' ' THR . 1.4 p -144.32 72.07 1.33 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.383 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.455 ' HB3' ' CZ3' ' A' ' 56' ' ' TRP . 31.1 t -115.99 91.78 32.64 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.109 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.68 105.89 1.37 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.791 2.327 . . . . 0.0 112.154 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.482 ' O ' ' CB ' ' A' ' 61' ' ' SER . 91.0 t80 -144.39 -86.89 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.128 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 1.2 m 155.51 64.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.884 0.373 . . . . 0.0 110.201 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.3 p 69.69 111.75 0.05 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.738 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.506 ' CB ' ' CH2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -123.61 169.36 11.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.513 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.526 HG12 ' OD1' ' A' ' 108' ' ' ASP . 26.0 t -110.64 102.95 14.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 120.75 0.31 . . . . 0.0 111.178 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.472 ' HB2' ' CD1' ' A' ' 78' ' ' PHE . 2.3 m-80 -128.02 149.97 50.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.165 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.469 ' OG1' ' HB2' ' A' ' 108' ' ' ASP . 0.2 OUTLIER -101.79 110.94 23.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.726 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.975 HD21 HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -77.28 123.67 26.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.798 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.544 HG21 ' HB3' ' A' ' 103' ' ' ARG . 34.9 t -100.09 96.55 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.37 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.873 ' SD ' HD21 ' A' ' 117' ' ' LEU . 3.8 mmt -138.28 137.39 37.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.858 0.361 . . . . 0.0 111.323 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.5 t70 56.54 35.58 26.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.949 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.92 15.54 60.42 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.269 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.1 m -106.39 148.32 28.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.969 0.414 . . . . 0.0 110.887 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.84 74.46 0.99 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.472 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.534 HD21 ' HB3' ' A' ' 67' ' ' LEU . 1.6 pp -79.28 112.5 16.57 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.221 0.534 . . . . 0.0 110.556 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.0 t -96.46 106.21 18.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.076 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.588 ' HE1' HD23 ' A' ' 67' ' ' LEU . 4.7 p90 -132.89 151.24 52.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.725 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 63' ' ' LYS . . . -79.69 101.58 8.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.946 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.558 ' HE1' HD23 ' A' ' 67' ' ' LEU . 2.5 m-85 -48.22 101.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.019 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.459 ' O ' ' CH2' ' A' ' 56' ' ' TRP . . . -56.93 140.94 46.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.245 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -38.0 108.94 0.09 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.207 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.59 ' HB3' ' CH2' ' A' ' 56' ' ' TRP . . . -133.34 124.5 27.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.888 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.41 ' O ' ' CB ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -122.18 -51.5 1.99 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.609 178.811 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.895 ' O ' HG23 ' A' ' 85' ' ' VAL . 1.9 m -79.74 163.23 59.52 Favored Pre-proline 0 N--CA 1.421 -1.887 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.496 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.409 ' N ' HG23 ' A' ' 83' ' ' VAL . 84.3 Cg_exo -45.47 86.5 0.02 OUTLIER 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.37 2.046 . . . . 0.0 112.686 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 83' ' ' VAL . 45.4 t -102.97 122.66 55.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.742 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.445 HG22 ' HB3' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -103.95 100.18 9.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.543 -179.484 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 89' ' ' GLN . 6.0 t80 -67.46 99.94 0.8 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 20.4 t -79.73 119.01 28.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 7.4 tp60 -131.09 112.16 12.63 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 2.2 p -79.75 118.45 21.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.116 0.484 . . . . 0.0 111.532 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.2 mtpp -136.11 118.76 16.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.425 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -67.53 110.86 3.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.484 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.743 HD11 ' CZ ' ' A' ' 100' ' ' PHE . 2.1 mt -89.51 148.11 23.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.377 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.524 ' O ' HG21 ' A' ' 44' ' ' VAL . 1.3 p -114.22 163.3 15.43 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.931 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.92 150.15 46.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.35 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 126.66 -124.33 5.02 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.557 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.87 139.32 47.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.717 0.294 . . . . 0.0 110.487 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.717 ' CD2' HD22 ' A' ' 93' ' ' LEU . 1.7 m-70 -136.37 169.31 17.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.952 0.406 . . . . 0.0 111.344 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.72 104.74 6.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.86 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.743 ' CZ ' HD11 ' A' ' 93' ' ' LEU . 39.8 m-85 -97.18 171.85 8.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.151 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 39' ' ' ILE . . . 151.32 -161.53 29.18 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.68 -1.248 . . . . 0.0 113.491 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.485 HG13 HD22 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -151.94 126.47 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.544 ' HB3' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -128.11 163.0 25.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.214 0.53 . . . . 0.0 112.23 -178.919 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.894 HG11 ' CA ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -139.46 142.94 31.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.516 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.453 ' C ' ' HB1' ' A' ' 34' ' ' ALA . . . -151.45 177.69 29.23 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.649 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.4 t -49.47 -36.3 22.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 110.856 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.24 -29.15 53.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.513 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.636 ' O ' HG12 ' A' ' 104' ' ' VAL . 6.8 m-20 -134.28 72.87 1.47 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.137 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.926 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . 7.4 p-90 -47.99 153.12 0.69 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.252 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.894 ' CA ' HG11 ' A' ' 104' ' ' VAL . . . -123.23 159.51 17.85 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.685 -0.769 . . . . 0.0 114.268 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.508 ' CE1' ' HG3' ' A' ' 32' ' ' GLN . 0.2 OUTLIER 163.6 58.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.719 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.745 ' CE ' HG22 ' A' ' 114' ' ' VAL . 0.3 OUTLIER -137.53 -171.68 3.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.734 -178.936 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 89.7 m-20 -119.06 131.1 55.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.307 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 1.061 HG21 HG21 ' A' ' 38' ' ' VAL . 6.1 t -103.98 86.6 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.519 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -52.23 -56.5 14.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.614 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.455 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 0.1 OUTLIER 175.74 151.94 0.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.174 0.511 . . . . 0.0 111.506 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.873 HD21 ' SD ' ' A' ' 69' ' ' MET . 0.3 OUTLIER -90.01 123.09 33.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.463 179.098 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -123.33 138.64 54.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.958 0.408 . . . . 0.0 111.923 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.541 HD23 ' HB3' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -123.81 128.86 50.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.234 178.97 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -112.84 107.45 16.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.474 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.954 HD13 ' CE1' ' A' ' 50' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.77 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.5 p . . . . . 0 CA--C 1.531 0.217 0 CA-C-O 120.702 0.287 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.573 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . . . -57.34 -21.51 35.98 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.557 ' HA ' ' HG ' ' A' ' 24' ' ' LEU . . . -73.13 -23.01 60.42 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.82 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.4 p -83.79 -2.48 56.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.009 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.427 ' HB2' ' CD1' ' A' ' 40' ' ' TRP . . . -95.58 -163.27 1.03 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.941 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -113.57 103.84 11.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.383 . . . . 0.0 110.84 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.959 HD11 HD23 ' A' ' 24' ' ' LEU . 1.5 mp -82.51 102.48 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.535 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.508 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 26.5 m -96.56 125.37 40.99 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.143 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.52 146.39 1.76 Allowed Pre-proline 0 CA--C 1.529 0.171 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.189 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 36' ' ' SER . 95.4 Cg_endo -73.43 7.78 7.46 Favored 'Cis proline' 0 C--N 1.348 0.547 0 C-N-CA 124.045 -1.231 . . . . 0.0 113.558 0.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.961 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -59.24 143.47 49.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.882 0.373 . . . . 0.0 110.286 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.419 ' HA ' HG21 ' A' ' 18' ' ' ILE . 1.1 pt20 -148.06 119.3 7.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.271 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.959 HD23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -79.06 114.03 17.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.34 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.4 m -123.83 113.29 36.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.699 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 58.28 39.11 92.09 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.289 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.409 ' HA ' ' CD1' ' A' ' 24' ' ' LEU . 7.6 m120 70.1 36.16 1.98 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.786 0.327 . . . . 0.0 111.006 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.18 104.62 9.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.411 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.442 ' HA2' ' CD2' ' A' ' 24' ' ' LEU . . . -70.47 83.75 0.35 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.091 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 83.5 mt-10 -88.29 99.92 12.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.683 0.278 . . . . 0.0 111.612 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.961 HD23 ' HB2' ' A' ' 22' ' ' ALA . 15.5 mt -79.93 150.68 30.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.075 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.458 ' O ' ' CG ' ' A' ' 21' ' ' PRO . 1.8 mp0 -125.33 137.56 54.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.965 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 110' ' ' GLY . . . 40.64 -154.8 0.06 OUTLIER Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.762 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.75 ' HB2' ' HA ' ' A' ' 109' ' ' TRP . . . -90.26 173.69 8.0 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.183 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.65 -28.13 6.64 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.436 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.814 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -67.43 163.79 20.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.879 0.339 . . . . 0.0 110.865 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.479 ' HB2' ' HD3' ' A' ' 103' ' ' ARG . . . -169.28 103.7 0.36 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.876 HG22 HD21 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -86.6 88.59 2.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 176.831 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.441 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 27.7 mm -90.83 113.02 25.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -177.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.85 ' CE3' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -83.27 148.46 27.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.582 179.168 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.03 111.91 15.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.644 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.4 m -149.36 -174.98 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.958 0.409 . . . . 0.0 111.567 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -139.15 128.21 23.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.48 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.516 HG23 ' CG ' ' A' ' 98' ' ' HIS . 91.8 t -57.28 123.33 60.3 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.146 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.19 -48.64 1.19 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.777 2.318 . . . . 0.0 113.171 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.446 HG23 ' OH ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -144.4 176.63 2.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.157 0.503 . . . . 0.0 111.92 -179.28 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.13 97.59 11.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.27 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -157.43 178.56 33.72 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.639 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 65.1 tt0 -98.83 98.44 9.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.665 0.269 . . . . 0.0 111.227 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.949 ' CD2' HD21 ' A' ' 93' ' ' LEU . 1.4 m-30 -100.72 118.72 37.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 3.4 ptt180 -79.71 132.58 36.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.094 0.474 . . . . 0.0 110.584 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.853 HG21 ' HG2' ' A' ' 69' ' ' MET . 15.2 mm -78.16 131.0 35.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.875 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.647 HD21 HG22 ' A' ' 88' ' ' VAL . 0.9 OUTLIER -130.12 105.14 7.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.86 -1.063 . . . . 0.0 108.898 178.719 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.711 ' CD1' HD13 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -98.99 126.64 44.73 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.321 0.581 . . . . 0.0 110.781 -178.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.48 131.05 39.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.269 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.69 ' CZ3' ' HB3' ' A' ' 81' ' ' ALA . 11.6 p-90 -157.18 167.43 30.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.036 0.446 . . . . 0.0 111.605 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.1 m -152.19 84.74 1.26 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.284 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.5 t -118.4 80.01 15.91 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.291 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.05 91.27 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.452 2.101 . . . . 0.0 111.86 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.92 -76.4 0.31 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.775 0.321 . . . . 0.0 111.436 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.523 ' HA ' ' HB2' ' A' ' 80' ' ' GLU . 11.7 t 173.28 -32.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.905 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 61' ' ' SER . 4.0 p 162.61 143.37 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.166 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -137.22 171.55 14.31 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.665 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 t -121.6 87.76 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-O 120.671 0.272 . . . . 0.0 110.309 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.58 ' ND2' ' CD1' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -115.92 157.8 23.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.108 0.48 . . . . 0.0 111.624 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.2 m -107.38 110.67 22.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.227 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.849 HD11 ' CE ' ' A' ' 69' ' ' MET . 22.4 tp -78.79 121.99 25.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.517 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' A' ' 101' ' ' GLY . 38.9 t -96.5 101.6 12.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.977 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.853 ' HG2' HG21 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -127.48 129.81 48.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.249 -179.515 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.413 ' OD1' ' HG3' ' A' ' 91' ' ' LYS . 6.4 p-10 44.5 50.83 8.1 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.757 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.75 14.64 58.58 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.698 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.2 m -104.56 130.16 52.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.072 0.463 . . . . 0.0 110.932 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.83 72.27 2.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.699 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.637 HD11 HD23 ' A' ' 67' ' ' LEU . 1.1 pp -79.46 105.48 10.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.306 0.574 . . . . 0.0 110.784 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.0 t -88.67 117.61 27.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.22 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.448 ' CZ ' ' CE1' ' A' ' 78' ' ' PHE . 1.2 p90 -144.82 151.15 38.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.11 0.481 . . . . 0.0 111.157 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.75 108.86 17.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.156 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.58 ' CD1' ' ND2' ' A' ' 65' ' ' ASN . 3.8 m-85 -50.79 176.08 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.017 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.03 176.94 5.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.191 0.52 . . . . 0.0 112.182 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 61' ' ' SER . 33.7 tt0 -81.29 57.56 3.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.797 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.69 ' HB3' ' CZ3' ' A' ' 56' ' ' TRP . . . -84.92 162.54 19.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.137 0.494 . . . . 0.0 111.304 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.563 HG23 HG23 ' A' ' 83' ' ' VAL . 0.6 OUTLIER -151.17 -49.78 0.12 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.01 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.966 ' O ' HG23 ' A' ' 85' ' ' VAL . 4.2 t -79.79 141.23 55.25 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.463 ' HD2' ' CG1' ' A' ' 83' ' ' VAL . 52.0 Cg_exo -36.85 84.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.588 2.192 . . . . 0.0 112.998 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.966 HG23 ' O ' ' A' ' 83' ' ' VAL . 76.4 t -99.42 158.49 3.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.443 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.488 ' N ' HG12 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -125.21 139.99 53.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.055 0.455 . . . . 0.0 111.539 -179.508 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.548 ' CZ ' ' HB2' ' A' ' 89' ' ' GLN . 0.6 OUTLIER -102.21 107.44 18.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.672 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.647 HG22 HD21 ' A' ' 53' ' ' ASN . 22.3 t -82.68 126.37 40.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.292 0.568 . . . . 0.0 112.47 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.548 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 15.9 tt0 -145.36 113.63 6.6 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 14.9 p -78.59 116.77 19.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.706 0.765 . . . . 0.0 111.424 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.453 ' CD ' ' N ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -133.33 123.55 25.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.994 -179.221 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -93.55 110.81 22.39 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.858 0.361 . . . . 0.0 110.544 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.949 HD21 ' CD2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -109.66 149.64 29.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.175 0.512 . . . . 0.0 111.45 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.405 ' C ' HG11 ' A' ' 44' ' ' VAL . 35.0 m -97.31 156.41 16.45 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.574 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.27 135.76 57.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.253 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 141.72 -155.13 25.2 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.214 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -96.09 116.83 29.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.336 . . . . 0.0 110.745 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.516 ' CG ' HG23 ' A' ' 44' ' ' VAL . 9.0 m170 -119.04 169.06 10.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.551 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.3 p -121.67 118.25 28.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.975 0.417 . . . . 0.0 111.483 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.867 ' CE1' HD11 ' A' ' 119' ' ' LEU . 55.0 m-85 -116.44 165.02 13.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.723 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 68' ' ' VAL . . . 154.0 -163.11 30.82 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 119.798 -1.191 . . . . 0.0 113.575 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -151.59 123.67 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.479 ' HD3' ' HB2' ' A' ' 37' ' ' ALA . 1.0 OUTLIER -124.53 153.73 41.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.519 0.675 . . . . 0.0 112.751 -177.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.751 HG11 ' HA3' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -134.27 129.12 53.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.364 178.619 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 109' ' ' TRP . . . -129.24 163.84 22.38 Favored Glycine 0 C--O 1.228 -0.279 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.952 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.4 t -49.29 -28.44 4.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.85 0.357 . . . . 0.0 110.946 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.8 t -79.45 -29.26 41.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.782 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.522 ' O ' ' CD1' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -101.8 -67.53 0.86 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.914 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.75 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 79.01 133.72 0.06 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.751 ' HA3' HG11 ' A' ' 104' ' ' VAL . . . -140.83 -169.78 11.88 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.18 -1.009 . . . . 0.0 114.319 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.547 ' HB2' ' HZ3' ' A' ' 109' ' ' TRP . 0.5 OUTLIER 168.8 75.55 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.457 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.3 -177.26 5.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.174 0.511 . . . . 0.0 112.066 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 1.6 m-80 -113.08 137.72 51.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.33 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.619 HG21 HG21 ' A' ' 38' ' ' VAL . 45.1 t -114.96 87.78 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.02 0.438 . . . . 0.0 110.582 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -57.31 -47.69 80.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.298 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.441 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 39.4 t -176.6 160.53 2.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.259 0.552 . . . . 0.0 111.866 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.85 HD12 ' CE3' ' A' ' 40' ' ' TRP . 0.9 OUTLIER -104.07 87.76 2.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.323 179.189 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -87.79 129.02 35.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.943 0.401 . . . . 0.0 111.801 -178.719 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.867 HD11 ' CE1' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -115.98 107.21 14.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.134 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 50' ' ' TYR . 5.1 mt-10 -83.21 153.34 24.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.881 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.729 HD13 ' CE1' ' A' ' 50' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.934 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.3 p . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.524 0.202 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.592 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . . . -67.24 -28.74 68.3 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.563 ' HB2' HD11 ' A' ' 24' ' ' LEU . . . -69.85 -22.89 63.23 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.702 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.3 p -82.99 -4.54 58.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.033 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.88 -163.17 1.02 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.725 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.8 p -114.31 103.81 11.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.905 0.384 . . . . 0.0 110.873 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.905 HD11 HD23 ' A' ' 24' ' ' LEU . 1.7 mp -83.89 103.62 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.608 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.538 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 80.8 m -101.37 125.06 47.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.923 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.406 ' HA ' ' C ' ' A' ' 21' ' ' PRO . . . -45.39 145.93 1.81 Allowed Pre-proline 0 N--CA 1.462 0.144 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.915 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 36' ' ' SER . 63.2 Cg_endo -69.67 2.72 4.61 Favored 'Cis proline' 0 C--N 1.348 0.551 0 C-N-CA 124.293 -1.128 . . . . 0.0 113.817 0.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.903 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -59.23 141.32 54.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.923 0.392 . . . . 0.0 110.359 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.42 ' HA ' HG21 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -146.5 120.36 9.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.212 -179.314 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.905 HD23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -79.18 110.89 14.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.253 -179.836 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.1 m -124.25 116.43 47.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.499 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.03 38.71 93.35 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.211 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.402 ' HA ' HD11 ' A' ' 24' ' ' LEU . 0.8 OUTLIER 67.43 37.28 3.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.87 0.367 . . . . 0.0 110.912 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.8 t -135.3 104.2 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.513 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.482 ' O ' HG23 ' A' ' 114' ' ' VAL . . . -68.77 86.23 0.21 Allowed Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.153 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 53.3 mt-10 -84.59 99.44 10.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.777 0.322 . . . . 0.0 111.633 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.062 HD21 HG22 ' A' ' 38' ' ' VAL . 23.5 mt -80.0 149.62 30.7 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.488 ' HG3' ' CZ ' ' A' ' 111' ' ' TYR . 0.9 OUTLIER -129.21 132.5 47.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.876 0.37 . . . . 0.0 111.436 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 110' ' ' GLY . . . 43.32 -152.05 0.37 Allowed Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.557 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.536 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . . . -90.2 159.83 16.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.623 0.249 . . . . 0.0 110.594 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.44 -24.41 32.1 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.883 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.785 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -71.52 155.31 40.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 0.0 111.191 -179.474 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . . . -162.75 113.66 1.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.075 0.464 . . . . 0.0 112.168 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 1.062 HG22 HD21 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -103.16 87.91 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.44 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.5 mm -89.95 118.81 35.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.328 0.585 . . . . 0.0 112.114 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.877 ' CE3' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -86.57 145.64 26.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.698 179.636 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -121.34 111.85 17.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.458 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.5 m -145.05 -177.05 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.964 0.411 . . . . 0.0 111.66 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -136.85 123.5 21.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.614 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.606 HG21 ' O ' ' A' ' 94' ' ' SER . 45.3 t -53.61 123.89 39.43 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.265 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -65.52 -47.86 3.77 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.562 2.175 . . . . 0.0 112.755 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.579 HG23 ' OH ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -148.33 -175.56 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.035 0.445 . . . . 0.0 111.678 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.18 99.14 11.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.352 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.46 -178.7 39.3 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.83 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 67.2 tt0 -90.85 117.52 29.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.059 0.429 . . . . 0.0 110.707 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.586 ' CD1' ' HB2' ' A' ' 93' ' ' LEU . 0.6 OUTLIER -110.87 115.86 30.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.923 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -79.62 128.85 33.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.049 0.452 . . . . 0.0 110.517 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.534 ' CG2' ' CE ' ' A' ' 69' ' ' MET . 12.1 mm -78.76 133.36 30.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.8 -178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 1.2 m120 -133.04 109.08 9.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.177 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.695 HD21 ' HG ' ' A' ' 117' ' ' LEU . 1.3 mt -99.95 123.49 44.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.281 0.562 . . . . 0.0 111.466 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.85 118.04 31.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.262 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.601 ' CZ3' ' HB3' ' A' ' 81' ' ' ALA . 3.4 p-90 -139.66 167.02 23.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.056 0.455 . . . . 0.0 111.412 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.62 72.88 0.99 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.184 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 23.2 t -114.43 93.92 33.88 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.034 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.19 86.97 1.47 Allowed 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.987 2.458 . . . . 0.0 111.878 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -126.31 -82.8 0.62 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.456 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 62' ' ' SER . 1.5 p 178.85 -32.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.172 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 61' ' ' SER . 4.0 t 157.88 130.1 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.428 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 2.2 mttp -129.56 171.07 12.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.679 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 38.3 t -124.82 83.61 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 CA-C-O 120.559 0.219 . . . . 0.0 110.832 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -104.92 169.09 8.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.002 0.429 . . . . 0.0 111.529 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.0 m -117.68 110.65 18.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.851 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.742 ' HG ' HD21 ' A' ' 74' ' ' LEU . 11.8 tp -79.05 125.37 29.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.671 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.5 t -101.01 97.45 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.174 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.898 ' SD ' HD21 ' A' ' 117' ' ' LEU . 6.4 mmt -132.79 131.53 41.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.926 0.393 . . . . 0.0 111.482 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.1 t70 61.46 38.99 15.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.821 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.81 15.69 60.39 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.273 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.7 m -107.05 150.44 26.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.079 0.466 . . . . 0.0 111.014 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.56 74.72 0.91 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.312 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.742 HD21 ' HG ' ' A' ' 67' ' ' LEU . 1.5 pp -79.25 105.85 10.86 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.188 0.518 . . . . 0.0 110.943 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.9 t -82.61 134.33 35.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.59 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.446 ' CZ ' ' CE1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -160.35 151.23 18.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.207 0.527 . . . . 0.0 111.761 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . . . -88.19 102.11 14.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.071 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.544 ' CE2' ' CD2' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -59.15 145.91 40.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.107 0.48 . . . . 0.0 110.808 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.1 -178.73 7.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.797 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.462 ' HB3' ' CA ' ' A' ' 61' ' ' SER . 1.1 pt-20 -89.13 38.48 0.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.562 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.601 ' HB3' ' CZ3' ' A' ' 56' ' ' TRP . . . -51.14 172.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.176 0.512 . . . . 0.0 112.013 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.527 HG23 HG23 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -160.5 -48.77 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.877 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.952 ' O ' HG23 ' A' ' 85' ' ' VAL . 2.3 t -82.97 143.78 46.56 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.074 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.626 ' HD2' HG12 ' A' ' 83' ' ' VAL . 71.6 Cg_exo -41.56 84.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.269 1.979 . . . . 0.0 112.992 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.952 HG23 ' O ' ' A' ' 83' ' ' VAL . 46.3 t -101.79 141.47 18.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.566 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.666 HG21 ' HD3' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -108.33 127.51 53.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.931 0.396 . . . . 0.0 111.547 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 89' ' ' GLN . 0.6 OUTLIER -93.33 110.25 21.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.993 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.2 t -80.04 122.75 35.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 21.0 tp60 -136.45 113.33 10.36 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.8 p -78.43 116.73 19.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.456 0.646 . . . . 0.0 111.544 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.3 111.66 9.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.24 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -64.77 110.82 2.52 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 120.963 0.411 . . . . 0.0 110.817 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.707 HD11 ' CE2' ' A' ' 100' ' ' PHE . 4.8 mt -88.78 141.88 28.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.443 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.606 ' O ' HG21 ' A' ' 44' ' ' VAL . 66.3 m -115.24 152.38 32.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.933 0.397 . . . . 0.0 111.323 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.67 138.43 55.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.211 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 125.56 -159.77 20.06 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.561 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.62 116.98 29.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 0.0 110.866 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -118.71 169.13 10.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.804 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 53.9 p -122.57 124.8 44.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.054 0.454 . . . . 0.0 111.588 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.707 ' CE2' HD11 ' A' ' 93' ' ' LEU . 25.6 m-85 -120.54 167.65 12.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.59 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 68' ' ' VAL . . . 151.49 -163.22 29.86 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 119.384 -1.389 . . . . 0.0 114.253 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.439 HG13 HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -149.55 154.67 9.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.821 -0.689 . . . . 0.0 109.15 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.554 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -160.3 162.78 33.65 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.136 -0.625 . . . . 0.0 112.311 -179.563 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.617 HG11 ' N ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -139.02 142.05 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.466 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.452 ' C ' ' HB1' ' A' ' 34' ' ' ALA . . . -154.45 173.93 32.88 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.808 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.2 m -54.12 -24.82 19.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.787 0.327 . . . . 0.0 111.005 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.01 5.22 26.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.372 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.481 ' O ' ' CD1' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -152.88 -70.28 0.15 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.782 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.526 ' CE3' ' N ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER 77.82 133.54 0.06 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.521 179.666 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.617 ' N ' HG11 ' A' ' 104' ' ' VAL . . . -146.07 -169.14 13.83 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.472 -0.871 . . . . 0.0 113.703 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.488 ' CZ ' ' HG3' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -179.37 76.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.574 ' HE1' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -148.78 175.14 11.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.166 0.508 . . . . 0.0 112.149 -177.599 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.563 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 61.2 m-80 -108.16 131.77 54.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.828 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.89 HG21 HG21 ' A' ' 38' ' ' VAL . 42.9 t -100.0 85.87 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.101 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.91 -47.86 76.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.94 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.5 p -177.59 167.28 2.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.239 0.542 . . . . 0.0 111.228 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.898 HD21 ' SD ' ' A' ' 69' ' ' MET . 1.1 tt -111.61 77.98 1.08 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.666 ' HD3' HG21 ' A' ' 86' ' ' THR . 0.2 OUTLIER -78.79 118.53 20.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.208 0.528 . . . . 0.0 111.38 -177.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.547 HD23 ' HB3' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -101.92 143.83 31.31 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.795 179.473 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.431 ' OE2' ' N ' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -129.36 166.46 19.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.513 -179.341 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.552 HD22 ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.928 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 p . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.788 0.328 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.577 ' HB3' HD21 ' A' ' 24' ' ' LEU . . . -68.71 -18.1 64.18 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.563 ' HA ' ' HG ' ' A' ' 24' ' ' LEU . . . -69.76 -23.75 63.42 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.785 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.76 0.5 54.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.903 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.51 -163.57 1.04 Allowed 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.785 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.9 t -110.44 103.73 12.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.82 0.343 . . . . 0.0 110.972 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.633 HD11 HD23 ' A' ' 24' ' ' LEU . 1.6 mp -88.03 91.62 3.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.654 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.509 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 6.6 m -89.83 132.34 35.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.689 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.55 147.05 3.19 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.287 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 36' ' ' SER . 89.9 Cg_endo -75.98 10.01 11.72 Favored 'Cis proline' 0 C--N 1.347 0.475 0 C-N-CA 123.723 -1.365 . . . . 0.0 113.34 0.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.674 ' HB2' ' CD2' ' A' ' 31' ' ' LEU . . . -59.43 140.34 56.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.937 0.399 . . . . 0.0 110.884 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.442 ' HG3' ' C ' ' A' ' 22' ' ' ALA . 1.2 mp0 -142.9 116.73 9.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.324 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.85 HD22 ' HA2' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -80.03 111.35 16.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.343 179.161 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.46 87.99 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.85 0.357 . . . . 0.0 111.173 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.82 -54.98 2.15 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.006 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -155.33 -36.02 0.09 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.705 0.288 . . . . 0.0 110.757 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.703 HG13 ' HA ' ' A' ' 115' ' ' HIS . 4.1 t -81.29 126.22 39.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.906 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.85 ' HA2' HD22 ' A' ' 24' ' ' LEU . . . -79.48 157.07 41.87 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.693 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 38.5 mt-10 -149.28 101.14 3.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.806 0.336 . . . . 0.0 111.145 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.002 HD21 HG22 ' A' ' 38' ' ' VAL . 95.4 mt -80.76 158.38 25.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.612 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.46 ' CG ' ' CE1' ' A' ' 111' ' ' TYR . 0.5 OUTLIER -127.64 -155.87 0.72 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.873 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.66 164.04 0.02 OUTLIER Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.269 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.579 ' HB2' ' HA ' ' A' ' 109' ' ' TRP . . . -40.57 163.19 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.906 0.353 . . . . 0.0 111.193 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.83 -27.16 21.51 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.688 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.878 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -67.78 150.47 48.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.819 0.342 . . . . 0.0 110.727 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.491 ' HB2' ' HD3' ' A' ' 103' ' ' ARG . . . -158.28 96.53 1.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.979 0.418 . . . . 0.0 111.902 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 1.002 HG22 HD21 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -86.16 88.74 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.018 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.545 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 31.6 mm -93.37 114.56 30.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.225 0.536 . . . . 0.0 112.297 -178.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.814 ' CE3' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -82.72 146.74 28.85 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.207 179.055 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -110.71 113.86 26.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.829 0.347 . . . . 0.0 111.146 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.0 m -149.53 155.41 8.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.962 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -119.22 117.29 28.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.974 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.95 HG13 ' CE1' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -35.0 110.09 0.39 Allowed Pre-proline 0 N--CA 1.47 0.569 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.716 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 44' ' ' VAL . 17.3 Cg_endo -57.75 -43.8 46.64 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.351 2.034 . . . . 0.0 112.626 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.532 ' C ' ' HH ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -156.94 -172.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.106 0.479 . . . . 0.0 111.75 -179.518 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.707 HG23 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -99.3 98.61 9.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.147 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.95 -145.23 4.25 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.434 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 62.5 tt0 -126.73 108.24 10.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.764 0.316 . . . . 0.0 110.905 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.883 ' HD2' HD12 ' A' ' 93' ' ' LEU . 1.3 m-30 -108.89 122.65 47.65 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.501 ' HB3' HG22 ' A' ' 90' ' ' THR . 3.7 ptt180 -84.19 131.47 34.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.303 0.573 . . . . 0.0 111.341 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.895 HG21 ' HG3' ' A' ' 69' ' ' MET . 11.4 mm -78.83 133.31 30.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.843 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 1.6 m120 -134.51 105.02 6.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.016 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.71 ' CD1' HD13 ' A' ' 67' ' ' LEU . 0.6 OUTLIER -99.35 118.71 36.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.223 0.535 . . . . 0.0 111.309 -179.374 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 0.2 OUTLIER -91.93 123.87 35.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.594 179.154 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TRP . . . . . 0.529 ' CZ3' ' HB3' ' A' ' 81' ' ' ALA . 1.5 p-90 -146.11 167.28 23.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.989 0.424 . . . . 0.0 111.49 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 p -155.25 83.45 1.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.677 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.7 t -117.67 82.94 16.79 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.75 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.409 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 27.5 Cg_exo -61.91 100.28 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.827 2.351 . . . . 0.0 112.309 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.409 ' CD1' ' O ' ' A' ' 59' ' ' PRO . 89.8 m-85 -156.07 -83.37 0.06 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.706 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.453 ' HA ' ' HG3' ' A' ' 80' ' ' GLU . 2.3 m -173.81 -45.15 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.894 0.378 . . . . 0.0 111.662 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 78' ' ' PHE . 0.2 OUTLIER 169.57 109.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.631 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.594 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -93.22 170.14 9.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.294 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.488 ' O ' ' O ' ' A' ' 109' ' ' TRP . 36.2 t -115.84 79.06 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -112.86 155.75 24.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.1 0.476 . . . . 0.0 112.043 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.0 m -114.41 111.04 20.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.075 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.86 ' HG ' HD21 ' A' ' 74' ' ' LEU . 8.2 tp -74.17 133.92 42.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.934 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.516 ' N ' HD12 ' A' ' 67' ' ' LEU . 38.5 t -108.67 106.94 21.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.64 -178.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.895 ' HG3' HG21 ' A' ' 52' ' ' ILE . 3.7 mmt -137.34 122.09 18.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.915 0.388 . . . . 0.0 111.228 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 46.3 t0 63.51 43.83 5.66 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.233 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.82 15.01 59.44 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.571 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.6 m -99.93 146.73 26.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.898 0.38 . . . . 0.0 110.827 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.94 73.47 0.82 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.779 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.86 HD21 ' HG ' ' A' ' 67' ' ' LEU . 1.1 pp -79.74 106.11 11.53 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.209 0.528 . . . . 0.0 110.923 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.5 t -86.41 127.72 34.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.922 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -160.19 151.44 19.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.26 0.553 . . . . 0.0 111.327 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 63' ' ' LYS . . . -79.66 109.01 13.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.912 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -59.23 99.42 0.05 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.161 0.505 . . . . 0.0 111.142 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.468 ' O ' ' CH2' ' A' ' 56' ' ' TRP . . . -41.46 168.07 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.978 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.453 ' HG3' ' HA ' ' A' ' 61' ' ' SER . 2.8 tm-20 -71.77 65.51 0.51 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.96 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.529 ' HB3' ' CZ3' ' A' ' 56' ' ' TRP . . . -85.73 143.34 28.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.983 0.42 . . . . 0.0 111.602 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.507 HG23 HG23 ' A' ' 83' ' ' VAL . 0.5 OUTLIER -136.45 -49.04 0.65 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.239 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.936 ' O ' HG23 ' A' ' 85' ' ' VAL . 1.9 t -79.87 145.3 61.54 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.193 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.71 ' HD2' HG12 ' A' ' 83' ' ' VAL . 95.5 Cg_exo -44.29 82.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.196 1.931 . . . . 0.0 112.579 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.936 HG23 ' O ' ' A' ' 83' ' ' VAL . 44.3 t -98.58 125.46 51.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.644 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.9 103.36 15.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.708 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.504 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -64.99 106.48 1.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.029 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.6 t -84.39 123.34 38.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.527 ' OE1' HD22 ' A' ' 74' ' ' LEU . 56.9 tt0 -139.1 112.46 8.18 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.501 HG22 ' HB3' ' A' ' 51' ' ' ARG . 6.2 p -79.12 116.98 19.74 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.344 0.593 . . . . 0.0 111.75 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -131.45 123.11 27.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.183 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -69.81 111.12 5.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.563 -179.775 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.883 HD12 ' HD2' ' A' ' 50' ' ' TYR . 2.3 mt -93.11 141.19 28.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.952 0.406 . . . . 0.0 111.185 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.779 ' O ' HG11 ' A' ' 44' ' ' VAL . 3.6 p -116.59 146.37 42.72 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.578 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.707 ' H ' HG23 ' A' ' 47' ' ' THR . . . -50.07 150.14 2.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.55 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.547 ' C ' HG23 ' A' ' 44' ' ' VAL . . . 135.38 -115.31 1.35 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.403 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -166.2 144.07 5.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 110.997 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.95 ' CE1' HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -160.45 169.39 23.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.056 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.4 p -119.78 114.6 22.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.451 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.63 ' CZ ' HD11 ' A' ' 93' ' ' LEU . 47.5 m-85 -92.02 175.75 6.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.552 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.545 ' HA3' ' HA ' ' A' ' 39' ' ' ILE . . . 151.53 -153.36 24.9 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.252 -1.452 . . . . 0.0 114.172 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -153.13 124.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 114.999 -0.601 . . . . 0.0 109.699 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.491 ' HD3' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -122.38 152.25 40.38 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.403 0.621 . . . . 0.0 112.29 -178.371 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.88 HG11 ' CA ' ' A' ' 110' ' ' GLY . 0.1 OUTLIER -137.44 137.73 45.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.074 178.673 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . 0.556 ' C ' ' HB1' ' A' ' 34' ' ' ALA . . . -149.02 -171.06 17.36 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.905 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.0 p -53.43 -42.98 67.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.805 0.336 . . . . 0.0 110.891 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.7 m -73.13 -16.16 61.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.053 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.832 ' O ' HG12 ' A' ' 104' ' ' VAL . 3.7 p-10 -155.11 79.85 1.05 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.617 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TRP . . . . . 0.579 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . 20.5 p-90 -61.94 157.23 19.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.49 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.88 ' CA ' HG11 ' A' ' 104' ' ' VAL . . . -120.69 170.3 14.39 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.215 -0.993 . . . . 0.0 114.066 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.463 ' CD2' ' O ' ' A' ' 110' ' ' GLY . 0.6 OUTLIER 165.34 57.72 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.827 ' HE3' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -141.1 -170.82 3.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.742 -178.758 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 82.9 m-20 -116.77 131.36 56.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.814 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.93 HG21 HG21 ' A' ' 38' ' ' VAL . 68.6 t -103.43 85.63 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.064 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' HIS . . . . . 0.703 ' HA ' HG13 ' A' ' 28' ' ' VAL . 35.4 t-80 -57.93 -52.26 66.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.262 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.443 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 5.6 t -176.08 169.59 2.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.164 0.507 . . . . 0.0 111.964 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.814 HD12 ' CE3' ' A' ' 40' ' ' TRP . 1.1 tt -115.05 90.34 3.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.55 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.0 tttm -87.91 139.61 30.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.12 0.486 . . . . 0.0 111.78 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.58 HD23 ' HB3' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -132.76 127.85 35.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.897 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -115.84 150.99 36.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.218 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.481 ' CD1' ' CE1' ' A' ' 50' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.207 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.774 0.321 . . . . 0.0 111.322 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.432 ' NE1' ' CB ' ' A' ' 119' ' ' LEU . 2.4 p90 -130.06 146.97 51.76 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.914 0.388 . . . . 0.0 111.241 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.544 HG22 ' CB ' ' A' ' 116' ' ' SER . 0.2 OUTLIER -95.65 97.3 9.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.489 179.388 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.501 ' CZ ' HG11 ' A' ' 42' ' ' VAL . 4.1 m-85 -74.75 97.04 3.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.312 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 p -51.1 131.93 27.6 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.665 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.53 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . . . -71.0 -16.45 62.63 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.79 ' HB2' HD11 ' A' ' 24' ' ' LEU . . . -69.93 -27.77 65.03 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.604 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.74 -8.86 59.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.843 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.725 ' HB1' ' O ' ' A' ' 39' ' ' ILE . . . -89.6 -171.12 3.08 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.705 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.6 m -106.83 103.71 13.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.689 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.955 HD11 HD23 ' A' ' 24' ' ' LEU . 1.7 mp -80.88 94.63 2.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.255 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.515 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 63.8 m -91.97 128.3 37.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.95 146.27 2.83 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.133 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 36' ' ' SER . 80.6 Cg_endo -74.86 9.15 9.23 Favored 'Cis proline' 0 C--N 1.348 0.526 0 C-N-CA 123.84 -1.317 . . . . 0.0 113.583 0.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.707 ' HB2' ' CD2' ' A' ' 31' ' ' LEU . . . -59.47 143.46 49.87 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.342 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.43 120.06 10.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.397 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.955 HD23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -79.14 114.79 18.36 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.94 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.2 m -134.75 117.62 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.918 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.47 37.29 92.55 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.286 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.75 27.91 11.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.753 0.311 . . . . 0.0 110.988 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.733 HG13 ' HA ' ' A' ' 115' ' ' HIS . 25.4 t -134.8 105.4 6.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.152 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.523 ' O ' ' HB ' ' A' ' 114' ' ' VAL . . . -75.53 106.87 2.19 Favored Glycine 0 C--O 1.223 -0.58 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.605 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 0.8 OUTLIER -105.59 118.38 36.43 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.971 0.415 . . . . 0.0 111.486 -179.196 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.037 HD21 HG22 ' A' ' 38' ' ' VAL . 69.7 mt -80.98 153.73 27.31 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.113 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.459 ' HA ' ' CD1' ' A' ' 111' ' ' TYR . 21.2 mt-30 -142.7 86.93 1.96 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.822 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.469 ' CA ' ' CE2' ' A' ' 111' ' ' TYR . . . 85.78 156.08 26.63 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.881 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.538 ' HB1' ' C ' ' A' ' 105' ' ' GLY . . . -47.21 157.46 0.19 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.835 0.317 . . . . 0.0 110.436 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 104' ' ' VAL . . . 100.47 -20.79 46.92 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.601 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.834 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -81.98 152.13 26.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.585 0.231 . . . . 0.0 110.747 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.422 ' HB2' ' HD3' ' A' ' 103' ' ' ARG . . . -156.45 100.34 1.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.996 0.427 . . . . 0.0 112.051 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 1.061 HG21 HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -89.08 88.54 2.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.063 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.725 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 29.2 mm -90.28 127.26 42.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.297 0.57 . . . . 0.0 112.408 -177.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.849 ' CE3' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -100.68 128.49 46.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.642 179.464 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -106.04 111.77 24.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.303 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.501 HG11 ' CZ ' ' A' ' 11' ' ' TYR . 15.7 m -147.92 161.76 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.442 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -112.56 124.58 52.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.007 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.873 ' CG1' HD13 ' A' ' 93' ' ' LEU . 1.7 m -56.81 123.94 61.25 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.211 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -62.05 -66.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.57 2.18 . . . . 0.0 113.03 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.96 -171.95 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.127 0.489 . . . . 0.0 112.013 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.751 HG23 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -98.16 94.53 6.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.646 179.804 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -159.24 165.66 34.4 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.459 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 66.3 tt0 -77.4 108.65 10.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.777 0.322 . . . . 0.0 111.123 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.871 ' HD2' HD12 ' A' ' 93' ' ' LEU . 3.4 m-30 -104.19 119.9 39.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.014 0.435 . . . . 0.0 110.072 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.457 ' HB3' HG22 ' A' ' 90' ' ' THR . 4.8 ptt180 -84.42 126.76 33.54 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.712 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.81 HG21 ' HG3' ' A' ' 69' ' ' MET . 6.1 mm -78.58 118.75 26.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.448 -178.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.544 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 8.4 m-80 -120.06 110.18 16.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.119 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.699 HD21 ' HG ' ' A' ' 117' ' ' LEU . 0.7 OUTLIER -99.24 122.36 42.31 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.388 0.613 . . . . 0.0 111.445 -178.854 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.433 ' HB ' ' HB2' ' A' ' 115' ' ' HIS . 0.2 OUTLIER -92.85 116.07 28.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.377 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.463 ' CH2' ' HB3' ' A' ' 78' ' ' PHE . 11.5 p-90 -145.15 167.2 23.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.331 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.5 m -148.72 92.72 2.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.889 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 111' ' ' TYR . 0.2 OUTLIER -127.11 83.55 65.71 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.92 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.44 90.18 0.17 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.644 2.23 . . . . 0.0 112.213 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.33 -77.75 0.23 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.328 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 m 178.39 -63.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.804 0.335 . . . . 0.0 111.108 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.4 t -172.82 121.28 0.39 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.997 0.427 . . . . 0.0 111.429 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.466 ' HG3' ' CH2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -110.97 171.77 7.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.171 179.556 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 108' ' ' ASP . 57.4 t -117.09 86.8 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.222 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.817 HD22 ' HA3' ' A' ' 110' ' ' GLY . 4.4 m120 -110.8 168.12 9.72 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.3 m -123.43 110.33 14.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.096 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.974 HD11 ' CE ' ' A' ' 69' ' ' MET . 16.2 tp -79.55 127.17 31.82 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.837 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.428 ' CG2' ' HB3' ' A' ' 103' ' ' ARG . 13.0 t -99.68 103.92 15.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.433 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.974 ' CE ' HD11 ' A' ' 67' ' ' LEU . 8.3 mmt -137.92 140.84 40.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.86 0.362 . . . . 0.0 111.047 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.473 ' HB3' HD21 ' A' ' 93' ' ' LEU . 6.2 p-10 45.84 40.76 6.93 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.765 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.68 25.96 70.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.786 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.5 m -119.2 141.9 48.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.01 0.433 . . . . 0.0 111.075 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -100.31 74.02 1.71 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.495 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.763 HD11 HD23 ' A' ' 67' ' ' LEU . 1.4 pp -79.3 106.48 11.37 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.227 0.536 . . . . 0.0 110.978 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.0 t -82.82 131.91 35.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.089 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.459 ' CE1' ' HB2' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -160.28 151.18 18.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.628 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 63' ' ' LYS . . . -89.06 118.75 29.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.92 0.39 . . . . 0.0 111.177 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.463 ' HB3' ' CH2' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -58.54 93.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.944 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.41 140.15 28.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.764 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -37.51 101.59 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.444 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.45 ' HB3' ' CH2' ' A' ' 56' ' ' TRP . . . -128.18 165.88 19.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.225 0.536 . . . . 0.0 111.558 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.621 HG23 HG23 ' A' ' 83' ' ' VAL . 0.8 OUTLIER -160.46 -48.92 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.651 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.949 ' O ' HG23 ' A' ' 85' ' ' VAL . 6.9 t -80.13 141.54 54.27 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.217 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.479 ' HD2' ' CG1' ' A' ' 83' ' ' VAL . 43.5 Cg_exo -35.35 83.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.699 2.266 . . . . 0.0 112.922 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.949 HG23 ' O ' ' A' ' 83' ' ' VAL . 79.4 t -97.37 126.3 50.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.643 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.416 HG22 ' HB3' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -100.36 99.82 10.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.217 -179.677 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.619 ' OH ' HD13 ' A' ' 74' ' ' LEU . 1.0 OUTLIER -62.92 103.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.858 179.269 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 23.1 t -79.89 121.37 33.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 1.9 tt0 -137.11 112.66 9.37 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.457 HG22 ' HB3' ' A' ' 51' ' ' ARG . 12.1 p -79.09 118.07 20.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.404 0.621 . . . . 0.0 111.943 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -134.96 121.44 20.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.86 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -67.59 110.85 3.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.883 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.873 HD13 ' CG1' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -93.93 143.49 26.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.981 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.666 ' O ' HG21 ' A' ' 44' ' ' VAL . 59.6 m -113.74 163.26 15.26 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.939 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.751 ' H ' HG23 ' A' ' 47' ' ' THR . . . -72.87 148.75 44.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.012 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 127.01 -112.86 1.63 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.503 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -141.81 130.0 22.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.829 0.347 . . . . 0.0 110.981 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.419 ' ND1' HD22 ' A' ' 93' ' ' LEU . 10.6 m-70 -133.84 150.28 51.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.867 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 27.7 p -105.25 131.56 52.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.92 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.844 ' HZ ' HD11 ' A' ' 93' ' ' LEU . 49.9 m-85 -124.45 168.15 13.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.416 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 39' ' ' ILE . . . 152.35 -164.72 30.66 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 119.949 -1.12 . . . . 0.0 113.575 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.426 HG21 HG11 ' A' ' 114' ' ' VAL . 0.1 OUTLIER -148.23 123.2 2.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.562 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.428 ' HB3' ' CG2' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -122.22 143.44 49.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.36 0.6 . . . . 0.0 112.512 -178.24 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.712 HG22 HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -126.88 132.05 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.265 178.299 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.538 ' C ' ' HB1' ' A' ' 34' ' ' ALA . . . -149.35 -172.99 19.53 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.603 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.87 -40.78 81.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.876 0.369 . . . . 0.0 110.507 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.3 t -70.62 -29.16 65.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.481 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 64' ' ' VAL . 0.6 OUTLIER -147.35 86.53 1.62 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.321 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.511 ' CE3' ' N ' ' A' ' 110' ' ' GLY . 9.7 p-90 -86.42 157.17 19.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.933 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.817 ' HA3' HD22 ' A' ' 65' ' ' ASN . . . -155.01 -171.25 21.52 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.108 -1.044 . . . . 0.0 114.001 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.469 ' CE2' ' CA ' ' A' ' 33' ' ' GLY . 0.7 OUTLIER -176.61 79.2 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.793 ' CE ' HG22 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -146.61 -176.8 5.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.2 0.524 . . . . 0.0 111.744 -178.08 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 40.8 m-20 -107.74 131.32 54.56 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.095 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 1.061 HG21 HG21 ' A' ' 38' ' ' VAL . 3.3 t -104.14 85.6 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.028 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.733 ' HA ' HG13 ' A' ' 28' ' ' VAL . 2.0 m80 -54.13 -66.58 0.37 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.265 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.544 ' CB ' HG22 ' A' ' 10' ' ' THR . 0.3 OUTLIER -164.36 148.12 9.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.146 0.498 . . . . 0.0 111.526 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.849 HD12 ' CE3' ' A' ' 40' ' ' TRP . 0.4 OUTLIER -84.72 95.57 8.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.858 179.411 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 53' ' ' ASN . 1.0 OUTLIER -80.08 134.06 36.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.03 0.443 . . . . 0.0 111.704 -178.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.731 HD23 ' HB3' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -124.92 107.75 11.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.285 179.426 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -99.48 152.96 19.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 111.223 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.2 90.55 8.4 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.299 0.571 . . . . 0.0 110.624 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -62.11 -65.14 0.73 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.737 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.535 179.894 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 7.8 p . . . . . 0 C--O 1.231 0.108 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 10.9 p90 -156.59 151.64 26.24 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.08 0.467 . . . . 0.0 112.017 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.854 HG22 ' HB2' ' A' ' 116' ' ' SER . 0.2 OUTLIER -98.48 145.36 26.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.254 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.828 ' OH ' HD12 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -122.02 101.72 7.72 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.243 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.2 p -47.38 144.04 3.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.882 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.703 ' HB3' HD21 ' A' ' 24' ' ' LEU . . . -68.57 -9.2 48.03 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.571 ' HA ' ' HG ' ' A' ' 24' ' ' LEU . . . -69.9 -29.53 66.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.9 0.381 . . . . 0.0 110.615 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.69 -2.36 53.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.99 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.686 ' HB1' ' O ' ' A' ' 39' ' ' ILE . . . -96.86 -164.1 1.12 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.9 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.9 p -110.95 103.75 12.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.597 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.693 HD11 HD23 ' A' ' 24' ' ' LEU . 1.6 mp -87.53 91.48 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.53 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.518 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 27.4 m -90.72 134.72 34.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.653 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.28 145.21 5.56 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.159 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 36' ' ' SER . 86.5 Cg_endo -78.48 10.9 18.93 Favored 'Cis proline' 0 C--N 1.348 0.509 0 C-N-CA 123.64 -1.4 . . . . 0.0 113.447 0.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.647 ' HB2' ' CD2' ' A' ' 31' ' ' LEU . . . -59.53 143.66 49.52 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.43 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -147.67 118.88 7.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.051 0.453 . . . . 0.0 111.765 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.791 HD22 ' HA2' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -79.81 104.69 10.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.397 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 25' ' ' VAL . 27.6 m -116.12 124.4 72.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.865 0.364 . . . . 0.0 111.598 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.58 ' O ' HG23 ' A' ' 28' ' ' VAL . . . 58.79 46.62 93.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.391 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 60.0 20.59 9.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.837 0.351 . . . . 0.0 110.912 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 26' ' ' GLY . 38.5 t -130.08 131.41 65.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.728 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.791 ' HA2' HD22 ' A' ' 24' ' ' LEU . . . -80.25 146.87 28.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.782 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.55 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 32.6 mt-10 -147.29 102.37 3.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.819 0.342 . . . . 0.0 110.807 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.979 HD21 HG22 ' A' ' 38' ' ' VAL . 94.9 mt -79.68 154.74 28.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.456 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.508 ' HG3' ' CE1' ' A' ' 111' ' ' TYR . 0.0 OUTLIER -123.59 -156.32 0.7 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.815 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 32' ' ' GLN . . . -37.02 152.9 0.01 OUTLIER Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.281 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.926 ' HB2' ' HA ' ' A' ' 109' ' ' TRP . . . -39.22 158.14 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.744 0.307 . . . . 0.0 111.274 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.27 -22.81 30.23 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.661 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.858 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.7 OUTLIER -65.91 157.47 30.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.605 0.24 . . . . 0.0 110.664 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.88 96.21 1.46 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 1.061 HG21 HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -90.55 88.77 2.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.171 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.686 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 26.7 mm -91.89 131.73 38.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.147 0.499 . . . . 0.0 111.905 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.747 ' CE3' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -103.62 126.52 50.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.357 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -94.27 119.06 32.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.862 0.363 . . . . 0.0 111.172 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.5 m -156.01 155.72 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.993 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -117.55 119.51 35.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.199 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.715 ' CG1' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -45.05 123.66 5.14 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.362 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -66.23 -52.62 0.81 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.462 2.108 . . . . 0.0 112.935 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.97 -171.26 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.192 0.52 . . . . 0.0 112.071 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.6 92.7 6.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.936 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -158.79 175.21 35.84 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.282 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 75.5 tt0 -89.38 117.87 28.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.689 0.28 . . . . 0.0 111.056 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.954 ' CE1' HD13 ' A' ' 121' ' ' LEU . 4.9 m-30 -115.07 117.41 30.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.156 0.503 . . . . 0.0 109.856 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 4.8 ptp180 -79.79 124.26 28.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.696 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 17.4 mm -78.54 148.23 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.739 -178.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.445 ' HB3' HG22 ' A' ' 86' ' ' THR . 2.0 m-80 -148.33 109.78 4.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.044 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.975 HD12 HD21 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -99.53 119.76 38.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.292 0.568 . . . . 0.0 110.986 -179.625 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 0.2 OUTLIER -96.41 117.6 31.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.832 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.59 ' CH2' ' HB3' ' A' ' 81' ' ' ALA . 5.4 p-90 -142.73 165.2 28.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.035 0.445 . . . . 0.0 111.514 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 82' ' ' THR . 1.4 p -144.32 72.07 1.33 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.383 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.455 ' HB3' ' CZ3' ' A' ' 56' ' ' TRP . 31.1 t -115.99 91.78 32.64 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.109 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.68 105.89 1.37 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.791 2.327 . . . . 0.0 112.154 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.482 ' O ' ' CB ' ' A' ' 61' ' ' SER . 91.0 t80 -144.39 -86.89 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.128 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 1.2 m 155.51 64.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.884 0.373 . . . . 0.0 110.201 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.3 p 69.69 111.75 0.05 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.738 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.506 ' CB ' ' CH2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -123.61 169.36 11.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.513 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.526 HG12 ' OD1' ' A' ' 108' ' ' ASP . 26.0 t -110.64 102.95 14.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 120.75 0.31 . . . . 0.0 111.178 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.472 ' HB2' ' CD1' ' A' ' 78' ' ' PHE . 2.3 m-80 -128.02 149.97 50.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.165 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.469 ' OG1' ' HB2' ' A' ' 108' ' ' ASP . 0.2 OUTLIER -101.79 110.94 23.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.726 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.975 HD21 HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -77.28 123.67 26.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.798 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.544 HG21 ' HB3' ' A' ' 103' ' ' ARG . 34.9 t -100.09 96.55 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.37 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.873 ' SD ' HD21 ' A' ' 117' ' ' LEU . 3.8 mmt -138.28 137.39 37.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.858 0.361 . . . . 0.0 111.323 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.5 t70 56.54 35.58 26.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.949 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.92 15.54 60.42 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.269 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.1 m -106.39 148.32 28.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.969 0.414 . . . . 0.0 110.887 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.84 74.46 0.99 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.472 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.534 HD21 ' HB3' ' A' ' 67' ' ' LEU . 1.6 pp -79.28 112.5 16.57 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.221 0.534 . . . . 0.0 110.556 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.0 t -96.46 106.21 18.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.076 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.588 ' HE1' HD23 ' A' ' 67' ' ' LEU . 4.7 p90 -132.89 151.24 52.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.725 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 63' ' ' LYS . . . -79.69 101.58 8.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.946 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.558 ' HE1' HD23 ' A' ' 67' ' ' LEU . 2.5 m-85 -48.22 101.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.019 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.459 ' O ' ' CH2' ' A' ' 56' ' ' TRP . . . -56.93 140.94 46.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.245 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -38.0 108.94 0.09 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.207 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.59 ' HB3' ' CH2' ' A' ' 56' ' ' TRP . . . -133.34 124.5 27.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.888 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.41 ' O ' ' CB ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -122.18 -51.5 1.99 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.609 178.811 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.895 ' O ' HG23 ' A' ' 85' ' ' VAL . 1.9 m -79.74 163.23 59.52 Favored Pre-proline 0 N--CA 1.421 -1.887 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.496 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.409 ' N ' HG23 ' A' ' 83' ' ' VAL . 84.3 Cg_exo -45.47 86.5 0.02 OUTLIER 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.37 2.046 . . . . 0.0 112.686 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 83' ' ' VAL . 45.4 t -102.97 122.66 55.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.742 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.445 HG22 ' HB3' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -103.95 100.18 9.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.543 -179.484 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 89' ' ' GLN . 6.0 t80 -67.46 99.94 0.8 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 20.4 t -79.73 119.01 28.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 7.4 tp60 -131.09 112.16 12.63 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 2.2 p -79.75 118.45 21.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.116 0.484 . . . . 0.0 111.532 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.2 mtpp -136.11 118.76 16.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.425 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -67.53 110.86 3.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.484 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.743 HD11 ' CZ ' ' A' ' 100' ' ' PHE . 2.1 mt -89.51 148.11 23.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.377 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.524 ' O ' HG21 ' A' ' 44' ' ' VAL . 1.3 p -114.22 163.3 15.43 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.931 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.92 150.15 46.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.35 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 126.66 -124.33 5.02 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.557 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.87 139.32 47.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.717 0.294 . . . . 0.0 110.487 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.717 ' CD2' HD22 ' A' ' 93' ' ' LEU . 1.7 m-70 -136.37 169.31 17.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.952 0.406 . . . . 0.0 111.344 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.72 104.74 6.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.86 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.743 ' CZ ' HD11 ' A' ' 93' ' ' LEU . 39.8 m-85 -97.18 171.85 8.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.151 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 39' ' ' ILE . . . 151.32 -161.53 29.18 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.68 -1.248 . . . . 0.0 113.491 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.485 HG13 HD22 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -151.94 126.47 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.544 ' HB3' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -128.11 163.0 25.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.214 0.53 . . . . 0.0 112.23 -178.919 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.894 HG11 ' CA ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -139.46 142.94 31.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.516 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.453 ' C ' ' HB1' ' A' ' 34' ' ' ALA . . . -151.45 177.69 29.23 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.649 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.4 t -49.47 -36.3 22.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 110.856 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.24 -29.15 53.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.513 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.636 ' O ' HG12 ' A' ' 104' ' ' VAL . 6.8 m-20 -134.28 72.87 1.47 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.137 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.926 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . 7.4 p-90 -47.99 153.12 0.69 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.252 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.894 ' CA ' HG11 ' A' ' 104' ' ' VAL . . . -123.23 159.51 17.85 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.685 -0.769 . . . . 0.0 114.268 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.508 ' CE1' ' HG3' ' A' ' 32' ' ' GLN . 0.2 OUTLIER 163.6 58.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.719 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.745 ' CE ' HG22 ' A' ' 114' ' ' VAL . 0.3 OUTLIER -137.53 -171.68 3.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.734 -178.936 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 89.7 m-20 -119.06 131.1 55.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.307 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 1.061 HG21 HG21 ' A' ' 38' ' ' VAL . 6.1 t -103.98 86.6 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.519 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -52.23 -56.5 14.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.614 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.854 ' HB2' HG22 ' A' ' 10' ' ' THR . 0.1 OUTLIER 175.74 151.94 0.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.174 0.511 . . . . 0.0 111.506 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.873 HD21 ' SD ' ' A' ' 69' ' ' MET . 0.3 OUTLIER -90.01 123.09 33.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.463 179.098 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -123.33 138.64 54.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.958 0.408 . . . . 0.0 111.923 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.828 HD12 ' OH ' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -123.81 128.86 50.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.234 178.97 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 122' ' ' LEU . 1.2 tm-20 -112.84 107.45 16.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.474 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.954 HD13 ' CE1' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -52.73 90.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.77 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.667 HD13 ' H ' ' A' ' 123' ' ' GLY . 0.4 OUTLIER -46.03 163.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.287 -179.542 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.667 ' H ' HD13 ' A' ' 122' ' ' LEU . . . . . . . . 0 CA--C 1.519 0.333 0 C-N-CA 121.104 -0.569 . . . . 0.0 113.213 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 52.3 p . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.823 0.344 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.514 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -73.77 103.95 4.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.325 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.561 HG23 ' HB3' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -103.52 96.11 6.51 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.34 179.571 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.495 ' O ' ' NE1' ' A' ' 40' ' ' TRP . 5.4 m-85 -83.65 110.06 17.96 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.5 p -55.69 131.93 47.79 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.388 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.573 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . . . -57.34 -21.51 35.98 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.557 ' HA ' ' HG ' ' A' ' 24' ' ' LEU . . . -73.13 -23.01 60.42 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.82 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.4 p -83.79 -2.48 56.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.009 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.427 ' HB2' ' CD1' ' A' ' 40' ' ' TRP . . . -95.58 -163.27 1.03 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.941 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -113.57 103.84 11.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.383 . . . . 0.0 110.84 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.959 HD11 HD23 ' A' ' 24' ' ' LEU . 1.5 mp -82.51 102.48 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.535 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.508 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 26.5 m -96.56 125.37 40.99 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.143 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.52 146.39 1.76 Allowed Pre-proline 0 CA--C 1.529 0.171 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.189 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 36' ' ' SER . 95.4 Cg_endo -73.43 7.78 7.46 Favored 'Cis proline' 0 C--N 1.348 0.547 0 C-N-CA 124.045 -1.231 . . . . 0.0 113.558 0.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.961 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -59.24 143.47 49.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.882 0.373 . . . . 0.0 110.286 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.419 ' HA ' HG21 ' A' ' 18' ' ' ILE . 1.1 pt20 -148.06 119.3 7.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.271 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.959 HD23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -79.06 114.03 17.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.34 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.4 m -123.83 113.29 36.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.699 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 58.28 39.11 92.09 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.289 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.409 ' HA ' ' CD1' ' A' ' 24' ' ' LEU . 7.6 m120 70.1 36.16 1.98 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.786 0.327 . . . . 0.0 111.006 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.18 104.62 9.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.411 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.442 ' HA2' ' CD2' ' A' ' 24' ' ' LEU . . . -70.47 83.75 0.35 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.091 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 83.5 mt-10 -88.29 99.92 12.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.683 0.278 . . . . 0.0 111.612 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.961 HD23 ' HB2' ' A' ' 22' ' ' ALA . 15.5 mt -79.93 150.68 30.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.075 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.458 ' O ' ' CG ' ' A' ' 21' ' ' PRO . 1.8 mp0 -125.33 137.56 54.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.965 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 110' ' ' GLY . . . 40.64 -154.8 0.06 OUTLIER Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.762 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.75 ' HB2' ' HA ' ' A' ' 109' ' ' TRP . . . -90.26 173.69 8.0 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.183 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.65 -28.13 6.64 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.436 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.814 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -67.43 163.79 20.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.879 0.339 . . . . 0.0 110.865 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.479 ' HB2' ' HD3' ' A' ' 103' ' ' ARG . . . -169.28 103.7 0.36 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.876 HG22 HD21 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -86.6 88.59 2.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 176.831 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.441 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 27.7 mm -90.83 113.02 25.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -177.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.85 ' CE3' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -83.27 148.46 27.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.582 179.168 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.03 111.91 15.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.644 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.491 HG11 ' CD1' ' A' ' 11' ' ' TYR . 16.4 m -149.36 -174.98 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.958 0.409 . . . . 0.0 111.567 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -139.15 128.21 23.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.48 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.516 HG23 ' CG ' ' A' ' 98' ' ' HIS . 91.8 t -57.28 123.33 60.3 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.146 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.19 -48.64 1.19 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.777 2.318 . . . . 0.0 113.171 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.446 HG23 ' OH ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -144.4 176.63 2.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.157 0.503 . . . . 0.0 111.92 -179.28 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.13 97.59 11.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.27 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -157.43 178.56 33.72 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.639 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 65.1 tt0 -98.83 98.44 9.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.665 0.269 . . . . 0.0 111.227 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.949 ' CD2' HD21 ' A' ' 93' ' ' LEU . 1.4 m-30 -100.72 118.72 37.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 3.4 ptt180 -79.71 132.58 36.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.094 0.474 . . . . 0.0 110.584 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.853 HG21 ' HG2' ' A' ' 69' ' ' MET . 15.2 mm -78.16 131.0 35.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.875 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.647 HD21 HG22 ' A' ' 88' ' ' VAL . 0.9 OUTLIER -130.12 105.14 7.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.86 -1.063 . . . . 0.0 108.898 178.719 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.711 ' CD1' HD13 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -98.99 126.64 44.73 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.321 0.581 . . . . 0.0 110.781 -178.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.48 131.05 39.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.269 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.69 ' CZ3' ' HB3' ' A' ' 81' ' ' ALA . 11.6 p-90 -157.18 167.43 30.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.036 0.446 . . . . 0.0 111.605 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.1 m -152.19 84.74 1.26 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.284 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.5 t -118.4 80.01 15.91 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.291 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.05 91.27 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.452 2.101 . . . . 0.0 111.86 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.92 -76.4 0.31 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.775 0.321 . . . . 0.0 111.436 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.523 ' HA ' ' HB2' ' A' ' 80' ' ' GLU . 11.7 t 173.28 -32.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.905 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 61' ' ' SER . 4.0 p 162.61 143.37 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.166 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -137.22 171.55 14.31 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.665 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 t -121.6 87.76 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-O 120.671 0.272 . . . . 0.0 110.309 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.58 ' ND2' ' CD1' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -115.92 157.8 23.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.108 0.48 . . . . 0.0 111.624 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.2 m -107.38 110.67 22.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.227 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.849 HD11 ' CE ' ' A' ' 69' ' ' MET . 22.4 tp -78.79 121.99 25.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.517 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' A' ' 101' ' ' GLY . 38.9 t -96.5 101.6 12.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.977 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.853 ' HG2' HG21 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -127.48 129.81 48.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.249 -179.515 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.413 ' OD1' ' HG3' ' A' ' 91' ' ' LYS . 6.4 p-10 44.5 50.83 8.1 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.757 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.75 14.64 58.58 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.698 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.2 m -104.56 130.16 52.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.072 0.463 . . . . 0.0 110.932 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.83 72.27 2.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.699 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.637 HD11 HD23 ' A' ' 67' ' ' LEU . 1.1 pp -79.46 105.48 10.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.306 0.574 . . . . 0.0 110.784 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.0 t -88.67 117.61 27.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.22 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.448 ' CZ ' ' CE1' ' A' ' 78' ' ' PHE . 1.2 p90 -144.82 151.15 38.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.11 0.481 . . . . 0.0 111.157 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.75 108.86 17.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.156 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.58 ' CD1' ' ND2' ' A' ' 65' ' ' ASN . 3.8 m-85 -50.79 176.08 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.017 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.03 176.94 5.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.191 0.52 . . . . 0.0 112.182 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 61' ' ' SER . 33.7 tt0 -81.29 57.56 3.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.797 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.69 ' HB3' ' CZ3' ' A' ' 56' ' ' TRP . . . -84.92 162.54 19.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.137 0.494 . . . . 0.0 111.304 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.563 HG23 HG23 ' A' ' 83' ' ' VAL . 0.6 OUTLIER -151.17 -49.78 0.12 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.01 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.966 ' O ' HG23 ' A' ' 85' ' ' VAL . 4.2 t -79.79 141.23 55.25 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.463 ' HD2' ' CG1' ' A' ' 83' ' ' VAL . 52.0 Cg_exo -36.85 84.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.588 2.192 . . . . 0.0 112.998 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.966 HG23 ' O ' ' A' ' 83' ' ' VAL . 76.4 t -99.42 158.49 3.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.443 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.488 ' N ' HG12 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -125.21 139.99 53.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.055 0.455 . . . . 0.0 111.539 -179.508 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.548 ' CZ ' ' HB2' ' A' ' 89' ' ' GLN . 0.6 OUTLIER -102.21 107.44 18.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.672 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.647 HG22 HD21 ' A' ' 53' ' ' ASN . 22.3 t -82.68 126.37 40.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.292 0.568 . . . . 0.0 112.47 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.548 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 15.9 tt0 -145.36 113.63 6.6 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 14.9 p -78.59 116.77 19.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.706 0.765 . . . . 0.0 111.424 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.453 ' CD ' ' N ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -133.33 123.55 25.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.994 -179.221 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -93.55 110.81 22.39 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.858 0.361 . . . . 0.0 110.544 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.949 HD21 ' CD2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -109.66 149.64 29.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.175 0.512 . . . . 0.0 111.45 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.405 ' C ' HG11 ' A' ' 44' ' ' VAL . 35.0 m -97.31 156.41 16.45 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.574 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.27 135.76 57.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.253 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 141.72 -155.13 25.2 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.214 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -96.09 116.83 29.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.336 . . . . 0.0 110.745 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.516 ' CG ' HG23 ' A' ' 44' ' ' VAL . 9.0 m170 -119.04 169.06 10.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.551 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.3 p -121.67 118.25 28.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.975 0.417 . . . . 0.0 111.483 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.867 ' CE1' HD11 ' A' ' 119' ' ' LEU . 55.0 m-85 -116.44 165.02 13.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.723 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 68' ' ' VAL . . . 154.0 -163.11 30.82 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 119.798 -1.191 . . . . 0.0 113.575 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -151.59 123.67 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.479 ' HD3' ' HB2' ' A' ' 37' ' ' ALA . 1.0 OUTLIER -124.53 153.73 41.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.519 0.675 . . . . 0.0 112.751 -177.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.751 HG11 ' HA3' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -134.27 129.12 53.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.364 178.619 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 109' ' ' TRP . . . -129.24 163.84 22.38 Favored Glycine 0 C--O 1.228 -0.279 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.952 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.4 t -49.29 -28.44 4.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.85 0.357 . . . . 0.0 110.946 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.8 t -79.45 -29.26 41.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.782 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.522 ' O ' ' CD1' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -101.8 -67.53 0.86 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.914 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.75 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 79.01 133.72 0.06 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.751 ' HA3' HG11 ' A' ' 104' ' ' VAL . . . -140.83 -169.78 11.88 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.18 -1.009 . . . . 0.0 114.319 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.547 ' HB2' ' HZ3' ' A' ' 109' ' ' TRP . 0.5 OUTLIER 168.8 75.55 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.457 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.3 -177.26 5.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.174 0.511 . . . . 0.0 112.066 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 1.6 m-80 -113.08 137.72 51.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.33 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.619 HG21 HG21 ' A' ' 38' ' ' VAL . 45.1 t -114.96 87.78 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.02 0.438 . . . . 0.0 110.582 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -57.31 -47.69 80.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.298 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.524 ' OG ' HG22 ' A' ' 10' ' ' THR . 39.4 t -176.6 160.53 2.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.259 0.552 . . . . 0.0 111.866 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.85 HD12 ' CE3' ' A' ' 40' ' ' TRP . 0.9 OUTLIER -104.07 87.76 2.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.323 179.189 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.561 ' HB3' HG23 ' A' ' 10' ' ' THR . 0.3 OUTLIER -87.79 129.02 35.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.943 0.401 . . . . 0.0 111.801 -178.719 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.867 HD11 ' CE1' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -115.98 107.21 14.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.134 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 50' ' ' TYR . 5.1 mt-10 -83.21 153.34 24.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.881 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.729 HD13 ' CE1' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -92.14 27.49 2.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.934 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.468 HD12 ' CG ' ' A' ' 49' ' ' GLU . 3.6 mt 48.85 89.83 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.931 0.396 . . . . 0.0 111.1 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.222 -179.717 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.468 ' HA ' ' CE3' ' A' ' 9' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.128 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.611 ' HE3' ' O ' ' A' ' 119' ' ' LEU . 0.1 OUTLIER -137.09 103.82 5.25 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.686 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.65 95.78 9.79 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.68 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.944 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 7.5 m-30 -77.09 94.86 4.1 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.0 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.3 p -64.25 133.43 52.76 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.644 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.592 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . . . -67.24 -28.74 68.3 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.563 ' HB2' HD11 ' A' ' 24' ' ' LEU . . . -69.85 -22.89 63.23 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.702 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.3 p -82.99 -4.54 58.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.033 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.88 -163.17 1.02 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.725 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.8 p -114.31 103.81 11.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.905 0.384 . . . . 0.0 110.873 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.905 HD11 HD23 ' A' ' 24' ' ' LEU . 1.7 mp -83.89 103.62 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.608 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.538 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 80.8 m -101.37 125.06 47.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.923 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.406 ' HA ' ' C ' ' A' ' 21' ' ' PRO . . . -45.39 145.93 1.81 Allowed Pre-proline 0 N--CA 1.462 0.144 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.915 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 36' ' ' SER . 63.2 Cg_endo -69.67 2.72 4.61 Favored 'Cis proline' 0 C--N 1.348 0.551 0 C-N-CA 124.293 -1.128 . . . . 0.0 113.817 0.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.903 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -59.23 141.32 54.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.923 0.392 . . . . 0.0 110.359 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.42 ' HA ' HG21 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -146.5 120.36 9.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.212 -179.314 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.905 HD23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -79.18 110.89 14.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.253 -179.836 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.1 m -124.25 116.43 47.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.499 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.03 38.71 93.35 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.211 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.402 ' HA ' HD11 ' A' ' 24' ' ' LEU . 0.8 OUTLIER 67.43 37.28 3.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.87 0.367 . . . . 0.0 110.912 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.8 t -135.3 104.2 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.513 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.482 ' O ' HG23 ' A' ' 114' ' ' VAL . . . -68.77 86.23 0.21 Allowed Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.153 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 53.3 mt-10 -84.59 99.44 10.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.777 0.322 . . . . 0.0 111.633 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.062 HD21 HG22 ' A' ' 38' ' ' VAL . 23.5 mt -80.0 149.62 30.7 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.488 ' HG3' ' CZ ' ' A' ' 111' ' ' TYR . 0.9 OUTLIER -129.21 132.5 47.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.876 0.37 . . . . 0.0 111.436 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 110' ' ' GLY . . . 43.32 -152.05 0.37 Allowed Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.557 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.536 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . . . -90.2 159.83 16.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.623 0.249 . . . . 0.0 110.594 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.44 -24.41 32.1 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.883 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.785 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -71.52 155.31 40.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 0.0 111.191 -179.474 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . . . -162.75 113.66 1.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.075 0.464 . . . . 0.0 112.168 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 1.062 HG22 HD21 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -103.16 87.91 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.44 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.5 mm -89.95 118.81 35.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.328 0.585 . . . . 0.0 112.114 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.877 ' CE3' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -86.57 145.64 26.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.698 179.636 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -121.34 111.85 17.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.458 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.937 HG21 ' CE2' ' A' ' 11' ' ' TYR . 26.5 m -145.05 -177.05 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.964 0.411 . . . . 0.0 111.66 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -136.85 123.5 21.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.614 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.606 HG21 ' O ' ' A' ' 94' ' ' SER . 45.3 t -53.61 123.89 39.43 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.265 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -65.52 -47.86 3.77 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.562 2.175 . . . . 0.0 112.755 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.579 HG23 ' OH ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -148.33 -175.56 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.035 0.445 . . . . 0.0 111.678 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.18 99.14 11.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.352 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.46 -178.7 39.3 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.83 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.645 ' HG2' HD12 ' A' ' 122' ' ' LEU . 67.2 tt0 -90.85 117.52 29.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.059 0.429 . . . . 0.0 110.707 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.586 ' CD1' ' HB2' ' A' ' 93' ' ' LEU . 0.6 OUTLIER -110.87 115.86 30.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.923 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.408 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 4.9 ptm180 -79.62 128.85 33.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.049 0.452 . . . . 0.0 110.517 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.534 ' CG2' ' CE ' ' A' ' 69' ' ' MET . 12.1 mm -78.76 133.36 30.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.8 -178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 1.2 m120 -133.04 109.08 9.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.177 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.695 HD21 ' HG ' ' A' ' 117' ' ' LEU . 1.3 mt -99.95 123.49 44.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.281 0.562 . . . . 0.0 111.466 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.85 118.04 31.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.262 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.601 ' CZ3' ' HB3' ' A' ' 81' ' ' ALA . 3.4 p-90 -139.66 167.02 23.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.056 0.455 . . . . 0.0 111.412 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.62 72.88 0.99 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.184 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 23.2 t -114.43 93.92 33.88 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.034 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.19 86.97 1.47 Allowed 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.987 2.458 . . . . 0.0 111.878 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -126.31 -82.8 0.62 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.456 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 62' ' ' SER . 1.5 p 178.85 -32.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.172 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 61' ' ' SER . 4.0 t 157.88 130.1 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.428 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 2.2 mttp -129.56 171.07 12.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.679 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 38.3 t -124.82 83.61 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 CA-C-O 120.559 0.219 . . . . 0.0 110.832 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -104.92 169.09 8.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.002 0.429 . . . . 0.0 111.529 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.0 m -117.68 110.65 18.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.851 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.742 ' HG ' HD21 ' A' ' 74' ' ' LEU . 11.8 tp -79.05 125.37 29.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.671 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.5 t -101.01 97.45 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.174 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.898 ' SD ' HD21 ' A' ' 117' ' ' LEU . 6.4 mmt -132.79 131.53 41.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.926 0.393 . . . . 0.0 111.482 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.1 t70 61.46 38.99 15.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.821 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.81 15.69 60.39 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.273 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.7 m -107.05 150.44 26.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.079 0.466 . . . . 0.0 111.014 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.56 74.72 0.91 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.312 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.742 HD21 ' HG ' ' A' ' 67' ' ' LEU . 1.5 pp -79.25 105.85 10.86 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.188 0.518 . . . . 0.0 110.943 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.9 t -82.61 134.33 35.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.59 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.446 ' CZ ' ' CE1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -160.35 151.23 18.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.207 0.527 . . . . 0.0 111.761 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . . . -88.19 102.11 14.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.071 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.544 ' CE2' ' CD2' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -59.15 145.91 40.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.107 0.48 . . . . 0.0 110.808 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.1 -178.73 7.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.797 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.462 ' HB3' ' CA ' ' A' ' 61' ' ' SER . 1.1 pt-20 -89.13 38.48 0.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.562 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.601 ' HB3' ' CZ3' ' A' ' 56' ' ' TRP . . . -51.14 172.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.176 0.512 . . . . 0.0 112.013 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.527 HG23 HG23 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -160.5 -48.77 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.877 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.952 ' O ' HG23 ' A' ' 85' ' ' VAL . 2.3 t -82.97 143.78 46.56 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.074 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.626 ' HD2' HG12 ' A' ' 83' ' ' VAL . 71.6 Cg_exo -41.56 84.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.269 1.979 . . . . 0.0 112.992 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.952 HG23 ' O ' ' A' ' 83' ' ' VAL . 46.3 t -101.79 141.47 18.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.566 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.666 HG21 ' HD3' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -108.33 127.51 53.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.931 0.396 . . . . 0.0 111.547 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 89' ' ' GLN . 0.6 OUTLIER -93.33 110.25 21.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.993 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.2 t -80.04 122.75 35.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 21.0 tp60 -136.45 113.33 10.36 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.8 p -78.43 116.73 19.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.456 0.646 . . . . 0.0 111.544 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.3 111.66 9.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.24 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -64.77 110.82 2.52 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 120.963 0.411 . . . . 0.0 110.817 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.707 HD11 ' CE2' ' A' ' 100' ' ' PHE . 4.8 mt -88.78 141.88 28.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.443 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.606 ' O ' HG21 ' A' ' 44' ' ' VAL . 66.3 m -115.24 152.38 32.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.933 0.397 . . . . 0.0 111.323 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.67 138.43 55.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.211 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 125.56 -159.77 20.06 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.561 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.62 116.98 29.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 0.0 110.866 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -118.71 169.13 10.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.804 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 53.9 p -122.57 124.8 44.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.054 0.454 . . . . 0.0 111.588 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.707 ' CE2' HD11 ' A' ' 93' ' ' LEU . 25.6 m-85 -120.54 167.65 12.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.59 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 68' ' ' VAL . . . 151.49 -163.22 29.86 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 119.384 -1.389 . . . . 0.0 114.253 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.439 HG13 HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -149.55 154.67 9.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.821 -0.689 . . . . 0.0 109.15 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.554 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -160.3 162.78 33.65 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.136 -0.625 . . . . 0.0 112.311 -179.563 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.617 HG11 ' N ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -139.02 142.05 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.466 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.452 ' C ' ' HB1' ' A' ' 34' ' ' ALA . . . -154.45 173.93 32.88 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.808 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.2 m -54.12 -24.82 19.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.787 0.327 . . . . 0.0 111.005 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.01 5.22 26.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.372 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.481 ' O ' ' CD1' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -152.88 -70.28 0.15 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.782 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.526 ' CE3' ' N ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER 77.82 133.54 0.06 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.521 179.666 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.617 ' N ' HG11 ' A' ' 104' ' ' VAL . . . -146.07 -169.14 13.83 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.472 -0.871 . . . . 0.0 113.703 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.488 ' CZ ' ' HG3' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -179.37 76.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.574 ' HE1' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -148.78 175.14 11.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.166 0.508 . . . . 0.0 112.149 -177.599 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.563 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 61.2 m-80 -108.16 131.77 54.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.828 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.89 HG21 HG21 ' A' ' 38' ' ' VAL . 42.9 t -100.0 85.87 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.101 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.91 -47.86 76.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.94 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.5 p -177.59 167.28 2.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.239 0.542 . . . . 0.0 111.228 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.944 ' O ' ' HB2' ' A' ' 11' ' ' TYR . 1.1 tt -111.61 77.98 1.08 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.666 ' HD3' HG21 ' A' ' 86' ' ' THR . 0.2 OUTLIER -78.79 118.53 20.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.208 0.528 . . . . 0.0 111.38 -177.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.611 ' O ' ' HE3' ' A' ' 9' ' ' TRP . 0.2 OUTLIER -101.92 143.83 31.31 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.795 179.473 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.431 ' OE2' ' N ' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -129.36 166.46 19.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.513 -179.341 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.552 HD22 ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -98.51 26.45 5.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.928 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.645 HD12 ' HG2' ' A' ' 49' ' ' GLU . 1.4 mt 60.34 -165.99 0.2 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.669 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.453 179.978 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.529 0.167 0 CA-C-O 120.706 0.288 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.427 ' N ' ' CE3' ' A' ' 9' ' ' TRP . 1.5 p90 -155.84 151.05 26.69 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.17 0.51 . . . . 0.0 111.43 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.852 HG22 ' OG ' ' A' ' 116' ' ' SER . 0.6 OUTLIER -83.93 140.24 32.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.74 -179.1 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.442 ' O ' ' CZ2' ' A' ' 40' ' ' TRP . 1.7 m-30 -106.1 103.26 12.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.539 178.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 p -52.25 134.74 33.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.788 0.328 . . . . 0.0 110.839 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.577 ' HB3' HD21 ' A' ' 24' ' ' LEU . . . -68.71 -18.1 64.18 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.563 ' HA ' ' HG ' ' A' ' 24' ' ' LEU . . . -69.76 -23.75 63.42 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.785 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.76 0.5 54.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.903 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.51 -163.57 1.04 Allowed 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.785 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.9 t -110.44 103.73 12.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.82 0.343 . . . . 0.0 110.972 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.633 HD11 HD23 ' A' ' 24' ' ' LEU . 1.6 mp -88.03 91.62 3.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.654 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.509 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 6.6 m -89.83 132.34 35.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.689 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.55 147.05 3.19 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.287 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 36' ' ' SER . 89.9 Cg_endo -75.98 10.01 11.72 Favored 'Cis proline' 0 C--N 1.347 0.475 0 C-N-CA 123.723 -1.365 . . . . 0.0 113.34 0.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.674 ' HB2' ' CD2' ' A' ' 31' ' ' LEU . . . -59.43 140.34 56.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.937 0.399 . . . . 0.0 110.884 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.442 ' HG3' ' C ' ' A' ' 22' ' ' ALA . 1.2 mp0 -142.9 116.73 9.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.324 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.85 HD22 ' HA2' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -80.03 111.35 16.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.343 179.161 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.46 87.99 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.85 0.357 . . . . 0.0 111.173 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.82 -54.98 2.15 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.006 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -155.33 -36.02 0.09 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.705 0.288 . . . . 0.0 110.757 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.703 HG13 ' HA ' ' A' ' 115' ' ' HIS . 4.1 t -81.29 126.22 39.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.906 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.85 ' HA2' HD22 ' A' ' 24' ' ' LEU . . . -79.48 157.07 41.87 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.693 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 38.5 mt-10 -149.28 101.14 3.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.806 0.336 . . . . 0.0 111.145 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.002 HD21 HG22 ' A' ' 38' ' ' VAL . 95.4 mt -80.76 158.38 25.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.612 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.46 ' CG ' ' CE1' ' A' ' 111' ' ' TYR . 0.5 OUTLIER -127.64 -155.87 0.72 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.873 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.66 164.04 0.02 OUTLIER Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.269 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.579 ' HB2' ' HA ' ' A' ' 109' ' ' TRP . . . -40.57 163.19 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.906 0.353 . . . . 0.0 111.193 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.83 -27.16 21.51 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.688 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.878 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -67.78 150.47 48.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.819 0.342 . . . . 0.0 110.727 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.491 ' HB2' ' HD3' ' A' ' 103' ' ' ARG . . . -158.28 96.53 1.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.979 0.418 . . . . 0.0 111.902 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 1.002 HG22 HD21 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -86.16 88.74 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.018 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.545 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 31.6 mm -93.37 114.56 30.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.225 0.536 . . . . 0.0 112.297 -178.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.814 ' CE3' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -82.72 146.74 28.85 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.207 179.055 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -110.71 113.86 26.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.829 0.347 . . . . 0.0 111.146 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.0 m -149.53 155.41 8.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.962 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -119.22 117.29 28.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.974 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.95 HG13 ' CE1' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -35.0 110.09 0.39 Allowed Pre-proline 0 N--CA 1.47 0.569 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.716 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 44' ' ' VAL . 17.3 Cg_endo -57.75 -43.8 46.64 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.351 2.034 . . . . 0.0 112.626 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.532 ' C ' ' HH ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -156.94 -172.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.106 0.479 . . . . 0.0 111.75 -179.518 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.707 HG23 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -99.3 98.61 9.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.147 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.95 -145.23 4.25 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.434 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 62.5 tt0 -126.73 108.24 10.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.764 0.316 . . . . 0.0 110.905 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.883 ' HD2' HD12 ' A' ' 93' ' ' LEU . 1.3 m-30 -108.89 122.65 47.65 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.501 ' HB3' HG22 ' A' ' 90' ' ' THR . 3.7 ptt180 -84.19 131.47 34.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.303 0.573 . . . . 0.0 111.341 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.895 HG21 ' HG3' ' A' ' 69' ' ' MET . 11.4 mm -78.83 133.31 30.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.843 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 1.6 m120 -134.51 105.02 6.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.016 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.71 ' CD1' HD13 ' A' ' 67' ' ' LEU . 0.6 OUTLIER -99.35 118.71 36.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.223 0.535 . . . . 0.0 111.309 -179.374 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 0.2 OUTLIER -91.93 123.87 35.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.594 179.154 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TRP . . . . . 0.529 ' CZ3' ' HB3' ' A' ' 81' ' ' ALA . 1.5 p-90 -146.11 167.28 23.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.989 0.424 . . . . 0.0 111.49 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 p -155.25 83.45 1.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.677 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.7 t -117.67 82.94 16.79 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.75 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.409 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 27.5 Cg_exo -61.91 100.28 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.827 2.351 . . . . 0.0 112.309 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.409 ' CD1' ' O ' ' A' ' 59' ' ' PRO . 89.8 m-85 -156.07 -83.37 0.06 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.706 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.453 ' HA ' ' HG3' ' A' ' 80' ' ' GLU . 2.3 m -173.81 -45.15 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.894 0.378 . . . . 0.0 111.662 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 78' ' ' PHE . 0.2 OUTLIER 169.57 109.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.631 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.594 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -93.22 170.14 9.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.294 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.488 ' O ' ' O ' ' A' ' 109' ' ' TRP . 36.2 t -115.84 79.06 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -112.86 155.75 24.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.1 0.476 . . . . 0.0 112.043 -178.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.0 m -114.41 111.04 20.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.075 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.86 ' HG ' HD21 ' A' ' 74' ' ' LEU . 8.2 tp -74.17 133.92 42.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.934 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.516 ' N ' HD12 ' A' ' 67' ' ' LEU . 38.5 t -108.67 106.94 21.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.64 -178.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.895 ' HG3' HG21 ' A' ' 52' ' ' ILE . 3.7 mmt -137.34 122.09 18.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.915 0.388 . . . . 0.0 111.228 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 46.3 t0 63.51 43.83 5.66 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.233 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.82 15.01 59.44 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.571 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.6 m -99.93 146.73 26.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.898 0.38 . . . . 0.0 110.827 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.94 73.47 0.82 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.779 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.86 HD21 ' HG ' ' A' ' 67' ' ' LEU . 1.1 pp -79.74 106.11 11.53 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.209 0.528 . . . . 0.0 110.923 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.5 t -86.41 127.72 34.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.922 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -160.19 151.44 19.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.26 0.553 . . . . 0.0 111.327 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 63' ' ' LYS . . . -79.66 109.01 13.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.912 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -59.23 99.42 0.05 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.161 0.505 . . . . 0.0 111.142 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.468 ' O ' ' CH2' ' A' ' 56' ' ' TRP . . . -41.46 168.07 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.978 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.453 ' HG3' ' HA ' ' A' ' 61' ' ' SER . 2.8 tm-20 -71.77 65.51 0.51 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.96 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.529 ' HB3' ' CZ3' ' A' ' 56' ' ' TRP . . . -85.73 143.34 28.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.983 0.42 . . . . 0.0 111.602 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.507 HG23 HG23 ' A' ' 83' ' ' VAL . 0.5 OUTLIER -136.45 -49.04 0.65 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.239 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.936 ' O ' HG23 ' A' ' 85' ' ' VAL . 1.9 t -79.87 145.3 61.54 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.193 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.71 ' HD2' HG12 ' A' ' 83' ' ' VAL . 95.5 Cg_exo -44.29 82.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.196 1.931 . . . . 0.0 112.579 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.936 HG23 ' O ' ' A' ' 83' ' ' VAL . 44.3 t -98.58 125.46 51.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.644 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.9 103.36 15.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.708 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.504 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -64.99 106.48 1.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.029 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.6 t -84.39 123.34 38.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.527 ' OE1' HD22 ' A' ' 74' ' ' LEU . 56.9 tt0 -139.1 112.46 8.18 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.501 HG22 ' HB3' ' A' ' 51' ' ' ARG . 6.2 p -79.12 116.98 19.74 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.344 0.593 . . . . 0.0 111.75 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -131.45 123.11 27.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.183 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -69.81 111.12 5.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.563 -179.775 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.883 HD12 ' HD2' ' A' ' 50' ' ' TYR . 2.3 mt -93.11 141.19 28.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.952 0.406 . . . . 0.0 111.185 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.779 ' O ' HG11 ' A' ' 44' ' ' VAL . 3.6 p -116.59 146.37 42.72 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.578 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.707 ' H ' HG23 ' A' ' 47' ' ' THR . . . -50.07 150.14 2.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.55 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.547 ' C ' HG23 ' A' ' 44' ' ' VAL . . . 135.38 -115.31 1.35 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.403 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -166.2 144.07 5.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 110.997 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.95 ' CE1' HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -160.45 169.39 23.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.056 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.4 p -119.78 114.6 22.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.451 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.63 ' CZ ' HD11 ' A' ' 93' ' ' LEU . 47.5 m-85 -92.02 175.75 6.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.552 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.545 ' HA3' ' HA ' ' A' ' 39' ' ' ILE . . . 151.53 -153.36 24.9 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.252 -1.452 . . . . 0.0 114.172 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -153.13 124.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 114.999 -0.601 . . . . 0.0 109.699 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.491 ' HD3' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -122.38 152.25 40.38 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.403 0.621 . . . . 0.0 112.29 -178.371 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.88 HG11 ' CA ' ' A' ' 110' ' ' GLY . 0.1 OUTLIER -137.44 137.73 45.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.074 178.673 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.556 ' C ' ' HB1' ' A' ' 34' ' ' ALA . . . -149.02 -171.06 17.36 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.905 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.0 p -53.43 -42.98 67.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.805 0.336 . . . . 0.0 110.891 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.7 m -73.13 -16.16 61.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.053 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.832 ' O ' HG12 ' A' ' 104' ' ' VAL . 3.7 p-10 -155.11 79.85 1.05 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.617 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.579 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . 20.5 p-90 -61.94 157.23 19.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.49 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.88 ' CA ' HG11 ' A' ' 104' ' ' VAL . . . -120.69 170.3 14.39 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.215 -0.993 . . . . 0.0 114.066 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.463 ' CD2' ' O ' ' A' ' 110' ' ' GLY . 0.6 OUTLIER 165.34 57.72 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.827 ' HE3' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -141.1 -170.82 3.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.742 -178.758 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 82.9 m-20 -116.77 131.36 56.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.814 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.93 HG21 HG21 ' A' ' 38' ' ' VAL . 68.6 t -103.43 85.63 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.064 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' HIS . . . . . 0.703 ' HA ' HG13 ' A' ' 28' ' ' VAL . 35.4 t-80 -57.93 -52.26 66.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.262 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.852 ' OG ' HG22 ' A' ' 10' ' ' THR . 5.6 t -176.08 169.59 2.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.164 0.507 . . . . 0.0 111.964 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.814 HD12 ' CE3' ' A' ' 40' ' ' TRP . 1.1 tt -115.05 90.34 3.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.55 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.0 tttm -87.91 139.61 30.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.12 0.486 . . . . 0.0 111.78 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.58 HD23 ' HB3' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -132.76 127.85 35.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.897 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -115.84 150.99 36.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.218 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.481 ' CD1' ' CE1' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -89.59 38.13 0.9 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.207 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.56 HD12 ' HG2' ' A' ' 49' ' ' GLU . 1.2 mt 47.53 28.48 1.19 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.325 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.46 179.968 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 p . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.627 0.251 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.53 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . . . -71.0 -16.45 62.63 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.79 ' HB2' HD11 ' A' ' 24' ' ' LEU . . . -69.93 -27.77 65.03 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.604 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.74 -8.86 59.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.843 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.725 ' HB1' ' O ' ' A' ' 39' ' ' ILE . . . -89.6 -171.12 3.08 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.705 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.6 m -106.83 103.71 13.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.689 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.955 HD11 HD23 ' A' ' 24' ' ' LEU . 1.7 mp -80.88 94.63 2.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.255 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.515 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 63.8 m -91.97 128.3 37.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.95 146.27 2.83 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.133 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 36' ' ' SER . 80.6 Cg_endo -74.86 9.15 9.23 Favored 'Cis proline' 0 C--N 1.348 0.526 0 C-N-CA 123.84 -1.317 . . . . 0.0 113.583 0.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.707 ' HB2' ' CD2' ' A' ' 31' ' ' LEU . . . -59.47 143.46 49.87 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.342 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.43 120.06 10.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.397 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.955 HD23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -79.14 114.79 18.36 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.94 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.2 m -134.75 117.62 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.918 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.47 37.29 92.55 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.286 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.75 27.91 11.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.753 0.311 . . . . 0.0 110.988 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.733 HG13 ' HA ' ' A' ' 115' ' ' HIS . 25.4 t -134.8 105.4 6.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.152 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.523 ' O ' ' HB ' ' A' ' 114' ' ' VAL . . . -75.53 106.87 2.19 Favored Glycine 0 C--O 1.223 -0.58 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.605 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 0.8 OUTLIER -105.59 118.38 36.43 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.971 0.415 . . . . 0.0 111.486 -179.196 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.037 HD21 HG22 ' A' ' 38' ' ' VAL . 69.7 mt -80.98 153.73 27.31 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.113 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.459 ' HA ' ' CD1' ' A' ' 111' ' ' TYR . 21.2 mt-30 -142.7 86.93 1.96 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.822 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.469 ' CA ' ' CE2' ' A' ' 111' ' ' TYR . . . 85.78 156.08 26.63 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.881 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.538 ' HB1' ' C ' ' A' ' 105' ' ' GLY . . . -47.21 157.46 0.19 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.835 0.317 . . . . 0.0 110.436 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 104' ' ' VAL . . . 100.47 -20.79 46.92 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.601 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.834 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -81.98 152.13 26.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.585 0.231 . . . . 0.0 110.747 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.422 ' HB2' ' HD3' ' A' ' 103' ' ' ARG . . . -156.45 100.34 1.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.996 0.427 . . . . 0.0 112.051 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 1.061 HG21 HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -89.08 88.54 2.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.725 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 29.2 mm -90.28 127.26 42.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.297 0.57 . . . . 0.0 112.408 -177.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.849 ' CE3' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -100.68 128.49 46.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.642 179.464 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -106.04 111.77 24.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.303 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 15.7 m -147.92 161.76 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.442 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -112.56 124.58 52.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.007 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.873 ' CG1' HD13 ' A' ' 93' ' ' LEU . 1.7 m -56.81 123.94 61.25 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.211 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -62.05 -66.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.57 2.18 . . . . 0.0 113.03 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.96 -171.95 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.127 0.489 . . . . 0.0 112.013 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.751 HG23 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -98.16 94.53 6.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.646 179.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -159.24 165.66 34.4 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.459 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 66.3 tt0 -77.4 108.65 10.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.777 0.322 . . . . 0.0 111.123 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.871 ' HD2' HD12 ' A' ' 93' ' ' LEU . 3.4 m-30 -104.19 119.9 39.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.014 0.435 . . . . 0.0 110.072 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.457 ' HB3' HG22 ' A' ' 90' ' ' THR . 4.8 ptt180 -84.42 126.76 33.54 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.712 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.81 HG21 ' HG3' ' A' ' 69' ' ' MET . 6.1 mm -78.58 118.75 26.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.448 -178.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.544 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 8.4 m-80 -120.06 110.18 16.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.119 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.699 HD21 ' HG ' ' A' ' 117' ' ' LEU . 0.7 OUTLIER -99.24 122.36 42.31 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.388 0.613 . . . . 0.0 111.445 -178.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.433 ' HB ' ' HB2' ' A' ' 115' ' ' HIS . 0.2 OUTLIER -92.85 116.07 28.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.377 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.463 ' CH2' ' HB3' ' A' ' 78' ' ' PHE . 11.5 p-90 -145.15 167.2 23.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.331 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.5 m -148.72 92.72 2.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.889 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 111' ' ' TYR . 0.2 OUTLIER -127.11 83.55 65.71 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.92 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.44 90.18 0.17 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.644 2.23 . . . . 0.0 112.213 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.33 -77.75 0.23 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.328 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 m 178.39 -63.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.804 0.335 . . . . 0.0 111.108 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.4 t -172.82 121.28 0.39 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.997 0.427 . . . . 0.0 111.429 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.466 ' HG3' ' CH2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -110.97 171.77 7.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.171 179.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 108' ' ' ASP . 57.4 t -117.09 86.8 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.222 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.483 ' OD1' ' HA3' ' A' ' 110' ' ' GLY . 1.7 m-80 -110.8 168.12 9.72 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.3 m -123.43 110.33 14.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.096 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.974 HD11 ' CE ' ' A' ' 69' ' ' MET . 16.2 tp -79.55 127.17 31.82 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.837 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.428 ' CG2' ' HB3' ' A' ' 103' ' ' ARG . 13.0 t -99.68 103.92 15.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.433 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.974 ' CE ' HD11 ' A' ' 67' ' ' LEU . 8.3 mmt -137.92 140.84 40.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.86 0.362 . . . . 0.0 111.047 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.473 ' HB3' HD21 ' A' ' 93' ' ' LEU . 6.2 p-10 45.84 40.76 6.93 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.765 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.68 25.96 70.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.786 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.5 m -119.2 141.9 48.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.01 0.433 . . . . 0.0 111.075 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -100.31 74.02 1.71 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.495 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.763 HD11 HD23 ' A' ' 67' ' ' LEU . 1.4 pp -79.3 106.48 11.37 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.227 0.536 . . . . 0.0 110.978 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.0 t -82.82 131.91 35.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.089 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.459 ' CE1' ' HB2' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -160.28 151.18 18.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.628 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 63' ' ' LYS . . . -89.06 118.75 29.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.92 0.39 . . . . 0.0 111.177 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.463 ' HB3' ' CH2' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -58.54 93.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.944 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.41 140.15 28.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.764 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -37.51 101.59 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.444 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.45 ' HB3' ' CH2' ' A' ' 56' ' ' TRP . . . -128.18 165.88 19.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.225 0.536 . . . . 0.0 111.558 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.621 HG23 HG23 ' A' ' 83' ' ' VAL . 0.8 OUTLIER -160.46 -48.92 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.651 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.949 ' O ' HG23 ' A' ' 85' ' ' VAL . 6.9 t -80.13 141.54 54.27 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.217 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.479 ' HD2' ' CG1' ' A' ' 83' ' ' VAL . 43.5 Cg_exo -35.35 83.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.699 2.266 . . . . 0.0 112.922 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.949 HG23 ' O ' ' A' ' 83' ' ' VAL . 79.4 t -97.37 126.3 50.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.643 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.416 HG22 ' HB3' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -100.36 99.82 10.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.217 -179.677 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.619 ' OH ' HD13 ' A' ' 74' ' ' LEU . 1.0 OUTLIER -62.92 103.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.858 179.269 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 23.1 t -79.89 121.37 33.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 1.9 tt0 -137.11 112.66 9.37 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.457 HG22 ' HB3' ' A' ' 51' ' ' ARG . 12.1 p -79.09 118.07 20.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.404 0.621 . . . . 0.0 111.943 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -134.96 121.44 20.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.86 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -67.59 110.85 3.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.883 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.873 HD13 ' CG1' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -93.93 143.49 26.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.981 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.666 ' O ' HG21 ' A' ' 44' ' ' VAL . 59.6 m -113.74 163.26 15.26 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.939 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.751 ' H ' HG23 ' A' ' 47' ' ' THR . . . -72.87 148.75 44.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.012 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 127.01 -112.86 1.63 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.503 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -141.81 130.0 22.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.829 0.347 . . . . 0.0 110.981 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.419 ' ND1' HD22 ' A' ' 93' ' ' LEU . 10.6 m-70 -133.84 150.28 51.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.867 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 27.7 p -105.25 131.56 52.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.92 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.844 ' HZ ' HD11 ' A' ' 93' ' ' LEU . 49.9 m-85 -124.45 168.15 13.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.416 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 39' ' ' ILE . . . 152.35 -164.72 30.66 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 119.949 -1.12 . . . . 0.0 113.575 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.426 HG21 HG11 ' A' ' 114' ' ' VAL . 0.1 OUTLIER -148.23 123.2 2.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.428 ' HB3' ' CG2' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -122.22 143.44 49.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.36 0.6 . . . . 0.0 112.512 -178.24 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.712 HG22 HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -126.88 132.05 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.265 178.299 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.538 ' C ' ' HB1' ' A' ' 34' ' ' ALA . . . -149.35 -172.99 19.53 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.603 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.87 -40.78 81.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.876 0.369 . . . . 0.0 110.507 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.3 t -70.62 -29.16 65.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.481 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 64' ' ' VAL . 0.6 OUTLIER -147.35 86.53 1.62 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.321 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.511 ' CE3' ' N ' ' A' ' 110' ' ' GLY . 9.7 p-90 -86.42 157.17 19.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.933 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.511 ' N ' ' CE3' ' A' ' 109' ' ' TRP . . . -155.01 -171.25 21.52 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.108 -1.044 . . . . 0.0 114.001 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.469 ' CE2' ' CA ' ' A' ' 33' ' ' GLY . 0.7 OUTLIER -176.61 79.2 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.793 ' CE ' HG22 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -146.61 -176.8 5.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.2 0.524 . . . . 0.0 111.744 -178.08 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 40.8 m-20 -107.74 131.32 54.56 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.095 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 1.061 HG21 HG21 ' A' ' 38' ' ' VAL . 3.3 t -104.14 85.6 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.028 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.733 ' HA ' HG13 ' A' ' 28' ' ' VAL . 2.0 m80 -54.13 -66.58 0.37 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.265 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.428 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 0.3 OUTLIER -164.36 148.12 9.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.146 0.498 . . . . 0.0 111.526 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.849 HD12 ' CE3' ' A' ' 40' ' ' TRP . 0.4 OUTLIER -84.72 95.57 8.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.858 179.411 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 53' ' ' ASN . 1.0 OUTLIER -80.08 134.06 36.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.03 0.443 . . . . 0.0 111.704 -178.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.731 HD23 ' HB3' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -124.92 107.75 11.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.285 179.426 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -99.48 152.96 19.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 111.223 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.516 -0.327 0 CA-C-O 121.299 0.571 . . . . 0.0 110.624 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.2 p . . . . . 0 N--CA 1.455 -0.191 0 CA-C-O 120.791 0.329 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.703 ' HB3' HD21 ' A' ' 24' ' ' LEU . . . -68.57 -9.2 48.03 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.571 ' HA ' ' HG ' ' A' ' 24' ' ' LEU . . . -69.9 -29.53 66.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.9 0.381 . . . . 0.0 110.615 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.69 -2.36 53.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.99 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.686 ' HB1' ' O ' ' A' ' 39' ' ' ILE . . . -96.86 -164.1 1.12 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.9 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.9 p -110.95 103.75 12.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.597 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.693 HD11 HD23 ' A' ' 24' ' ' LEU . 1.6 mp -87.53 91.48 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.53 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.518 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 27.4 m -90.72 134.72 34.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.653 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.28 145.21 5.56 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.159 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 36' ' ' SER . 86.5 Cg_endo -78.48 10.9 18.93 Favored 'Cis proline' 0 C--N 1.348 0.509 0 C-N-CA 123.64 -1.4 . . . . 0.0 113.447 0.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.647 ' HB2' ' CD2' ' A' ' 31' ' ' LEU . . . -59.53 143.66 49.52 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.43 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -147.67 118.88 7.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.051 0.453 . . . . 0.0 111.765 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.791 HD22 ' HA2' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -79.81 104.69 10.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.397 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 25' ' ' VAL . 27.6 m -116.12 124.4 72.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.865 0.364 . . . . 0.0 111.598 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.58 ' O ' HG23 ' A' ' 28' ' ' VAL . . . 58.79 46.62 93.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.391 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.0 20.59 9.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.837 0.351 . . . . 0.0 110.912 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 26' ' ' GLY . 38.5 t -130.08 131.41 65.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.728 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.791 ' HA2' HD22 ' A' ' 24' ' ' LEU . . . -80.25 146.87 28.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.782 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.55 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 32.6 mt-10 -147.29 102.37 3.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.819 0.342 . . . . 0.0 110.807 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.979 HD21 HG22 ' A' ' 38' ' ' VAL . 94.9 mt -79.68 154.74 28.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.456 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.508 ' HG3' ' CE1' ' A' ' 111' ' ' TYR . 0.0 OUTLIER -123.59 -156.32 0.7 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 32' ' ' GLN . . . -37.02 152.9 0.01 OUTLIER Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.281 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.926 ' HB2' ' HA ' ' A' ' 109' ' ' TRP . . . -39.22 158.14 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.744 0.307 . . . . 0.0 111.274 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.27 -22.81 30.23 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.661 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.858 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.7 OUTLIER -65.91 157.47 30.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.605 0.24 . . . . 0.0 110.664 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.88 96.21 1.46 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 1.061 HG21 HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -90.55 88.77 2.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.171 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.686 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 26.7 mm -91.89 131.73 38.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.147 0.499 . . . . 0.0 111.905 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.747 ' CE3' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -103.62 126.52 50.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.357 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -94.27 119.06 32.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.862 0.363 . . . . 0.0 111.172 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.5 m -156.01 155.72 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.993 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -117.55 119.51 35.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.199 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.715 ' CG1' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -45.05 123.66 5.14 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.362 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -66.23 -52.62 0.81 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.462 2.108 . . . . 0.0 112.935 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.97 -171.26 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.192 0.52 . . . . 0.0 112.071 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.6 92.7 6.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.936 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -158.79 175.21 35.84 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.282 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 75.5 tt0 -89.38 117.87 28.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.689 0.28 . . . . 0.0 111.056 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.954 ' CE1' HD13 ' A' ' 121' ' ' LEU . 4.9 m-30 -115.07 117.41 30.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.156 0.503 . . . . 0.0 109.856 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 4.8 ptp180 -79.79 124.26 28.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.696 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 17.4 mm -78.54 148.23 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.739 -178.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.445 ' HB3' HG22 ' A' ' 86' ' ' THR . 2.0 m-80 -148.33 109.78 4.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.044 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.975 HD12 HD21 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -99.53 119.76 38.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.292 0.568 . . . . 0.0 110.986 -179.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 0.2 OUTLIER -96.41 117.6 31.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.832 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.59 ' CH2' ' HB3' ' A' ' 81' ' ' ALA . 5.4 p-90 -142.73 165.2 28.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.035 0.445 . . . . 0.0 111.514 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 82' ' ' THR . 1.4 p -144.32 72.07 1.33 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.383 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.455 ' HB3' ' CZ3' ' A' ' 56' ' ' TRP . 31.1 t -115.99 91.78 32.64 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.109 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.68 105.89 1.37 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.791 2.327 . . . . 0.0 112.154 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.482 ' O ' ' CB ' ' A' ' 61' ' ' SER . 91.0 t80 -144.39 -86.89 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.128 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 1.2 m 155.51 64.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.884 0.373 . . . . 0.0 110.201 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.3 p 69.69 111.75 0.05 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.738 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.506 ' CB ' ' CH2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -123.61 169.36 11.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.513 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.526 HG12 ' OD1' ' A' ' 108' ' ' ASP . 26.0 t -110.64 102.95 14.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 120.75 0.31 . . . . 0.0 111.178 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.472 ' HB2' ' CD1' ' A' ' 78' ' ' PHE . 2.3 m-80 -128.02 149.97 50.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.165 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.469 ' OG1' ' HB2' ' A' ' 108' ' ' ASP . 0.2 OUTLIER -101.79 110.94 23.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.726 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.975 HD21 HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -77.28 123.67 26.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.798 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.544 HG21 ' HB3' ' A' ' 103' ' ' ARG . 34.9 t -100.09 96.55 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.37 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.873 ' SD ' HD21 ' A' ' 117' ' ' LEU . 3.8 mmt -138.28 137.39 37.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.858 0.361 . . . . 0.0 111.323 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.5 t70 56.54 35.58 26.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.949 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.92 15.54 60.42 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.269 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.1 m -106.39 148.32 28.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.969 0.414 . . . . 0.0 110.887 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.84 74.46 0.99 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.472 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.534 HD21 ' HB3' ' A' ' 67' ' ' LEU . 1.6 pp -79.28 112.5 16.57 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.221 0.534 . . . . 0.0 110.556 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.0 t -96.46 106.21 18.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.076 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.588 ' HE1' HD23 ' A' ' 67' ' ' LEU . 4.7 p90 -132.89 151.24 52.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.725 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 63' ' ' LYS . . . -79.69 101.58 8.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.946 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.558 ' HE1' HD23 ' A' ' 67' ' ' LEU . 2.5 m-85 -48.22 101.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.019 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.459 ' O ' ' CH2' ' A' ' 56' ' ' TRP . . . -56.93 140.94 46.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.245 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -38.0 108.94 0.09 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.207 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.59 ' HB3' ' CH2' ' A' ' 56' ' ' TRP . . . -133.34 124.5 27.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.888 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.41 ' O ' ' CB ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -122.18 -51.5 1.99 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.609 178.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.895 ' O ' HG23 ' A' ' 85' ' ' VAL . 1.9 m -79.74 163.23 59.52 Favored Pre-proline 0 N--CA 1.421 -1.887 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.496 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.409 ' N ' HG23 ' A' ' 83' ' ' VAL . 84.3 Cg_exo -45.47 86.5 0.02 OUTLIER 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.37 2.046 . . . . 0.0 112.686 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 83' ' ' VAL . 45.4 t -102.97 122.66 55.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.742 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.445 HG22 ' HB3' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -103.95 100.18 9.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.543 -179.484 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 89' ' ' GLN . 6.0 t80 -67.46 99.94 0.8 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 20.4 t -79.73 119.01 28.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 7.4 tp60 -131.09 112.16 12.63 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 2.2 p -79.75 118.45 21.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.116 0.484 . . . . 0.0 111.532 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.2 mtpp -136.11 118.76 16.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.425 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -67.53 110.86 3.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.484 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.743 HD11 ' CZ ' ' A' ' 100' ' ' PHE . 2.1 mt -89.51 148.11 23.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.377 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.524 ' O ' HG21 ' A' ' 44' ' ' VAL . 1.3 p -114.22 163.3 15.43 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.931 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.92 150.15 46.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.35 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 126.66 -124.33 5.02 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.557 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.87 139.32 47.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.717 0.294 . . . . 0.0 110.487 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.717 ' CD2' HD22 ' A' ' 93' ' ' LEU . 1.7 m-70 -136.37 169.31 17.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.952 0.406 . . . . 0.0 111.344 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.72 104.74 6.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.86 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.743 ' CZ ' HD11 ' A' ' 93' ' ' LEU . 39.8 m-85 -97.18 171.85 8.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.151 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 39' ' ' ILE . . . 151.32 -161.53 29.18 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.68 -1.248 . . . . 0.0 113.491 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.485 HG13 HD22 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -151.94 126.47 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.544 ' HB3' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -128.11 163.0 25.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.214 0.53 . . . . 0.0 112.23 -178.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.894 HG11 ' CA ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -139.46 142.94 31.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.516 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.453 ' C ' ' HB1' ' A' ' 34' ' ' ALA . . . -151.45 177.69 29.23 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.649 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.4 t -49.47 -36.3 22.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 110.856 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.24 -29.15 53.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.513 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.636 ' O ' HG12 ' A' ' 104' ' ' VAL . 6.8 m-20 -134.28 72.87 1.47 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.137 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.926 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . 7.4 p-90 -47.99 153.12 0.69 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.252 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.894 ' CA ' HG11 ' A' ' 104' ' ' VAL . . . -123.23 159.51 17.85 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.685 -0.769 . . . . 0.0 114.268 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.508 ' CE1' ' HG3' ' A' ' 32' ' ' GLN . 0.2 OUTLIER 163.6 58.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.719 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.745 ' CE ' HG22 ' A' ' 114' ' ' VAL . 0.3 OUTLIER -137.53 -171.68 3.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.734 -178.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 89.7 m-20 -119.06 131.1 55.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.307 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 1.061 HG21 HG21 ' A' ' 38' ' ' VAL . 6.1 t -103.98 86.6 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.519 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -52.23 -56.5 14.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.614 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.455 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 0.1 OUTLIER 175.74 151.94 0.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.174 0.511 . . . . 0.0 111.506 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.873 HD21 ' SD ' ' A' ' 69' ' ' MET . 0.3 OUTLIER -90.01 123.09 33.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.463 179.098 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -123.33 138.64 54.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.958 0.408 . . . . 0.0 111.923 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.541 HD23 ' HB3' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -123.81 128.86 50.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.234 178.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -112.84 107.45 16.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.474 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.954 HD13 ' CE1' ' A' ' 50' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.77 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.5 p . . . . . 0 CA--C 1.531 0.217 0 CA-C-O 120.702 0.287 . . . . 0.0 110.388 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.573 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . . . -57.34 -21.51 35.98 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.557 ' HA ' ' HG ' ' A' ' 24' ' ' LEU . . . -73.13 -23.01 60.42 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.82 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.4 p -83.79 -2.48 56.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.009 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.427 ' HB2' ' CD1' ' A' ' 40' ' ' TRP . . . -95.58 -163.27 1.03 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.941 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -113.57 103.84 11.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.383 . . . . 0.0 110.84 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.959 HD11 HD23 ' A' ' 24' ' ' LEU . 1.5 mp -82.51 102.48 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.535 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.508 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 26.5 m -96.56 125.37 40.99 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.143 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.52 146.39 1.76 Allowed Pre-proline 0 CA--C 1.529 0.171 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.189 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 36' ' ' SER . 95.4 Cg_endo -73.43 7.78 7.46 Favored 'Cis proline' 0 C--N 1.348 0.547 0 C-N-CA 124.045 -1.231 . . . . 0.0 113.558 0.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.961 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -59.24 143.47 49.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.882 0.373 . . . . 0.0 110.286 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.419 ' HA ' HG21 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -148.06 119.3 7.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.271 -179.154 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.959 HD23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -79.06 114.03 17.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.34 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.4 m -123.83 113.29 36.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.699 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 58.28 39.11 92.09 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.289 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.409 ' HA ' ' CD1' ' A' ' 24' ' ' LEU . 7.6 m120 70.1 36.16 1.98 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.786 0.327 . . . . 0.0 111.006 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.18 104.62 9.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.411 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.442 ' HA2' ' CD2' ' A' ' 24' ' ' LEU . . . -70.47 83.75 0.35 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.091 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 83.5 mt-10 -88.29 99.92 12.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.683 0.278 . . . . 0.0 111.612 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.961 HD23 ' HB2' ' A' ' 22' ' ' ALA . 15.5 mt -79.93 150.68 30.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.075 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.458 ' O ' ' CG ' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -125.33 137.56 54.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.965 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 110' ' ' GLY . . . 40.64 -154.8 0.06 OUTLIER Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.762 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.75 ' HB2' ' HA ' ' A' ' 109' ' ' TRP . . . -90.26 173.69 8.0 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.183 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.65 -28.13 6.64 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.436 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.814 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -67.43 163.79 20.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.879 0.339 . . . . 0.0 110.865 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.479 ' HB2' ' HD3' ' A' ' 103' ' ' ARG . . . -169.28 103.7 0.36 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.876 HG22 HD21 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -86.6 88.59 2.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 176.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.441 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 27.7 mm -90.83 113.02 25.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -177.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.85 ' CE3' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -83.27 148.46 27.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.582 179.168 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.03 111.91 15.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.644 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.4 m -149.36 -174.98 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.958 0.409 . . . . 0.0 111.567 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -139.15 128.21 23.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.48 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.516 HG23 ' CG ' ' A' ' 98' ' ' HIS . 91.8 t -57.28 123.33 60.3 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.146 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.19 -48.64 1.19 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.777 2.318 . . . . 0.0 113.171 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.446 HG23 ' OH ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -144.4 176.63 2.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.157 0.503 . . . . 0.0 111.92 -179.28 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.13 97.59 11.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.27 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -157.43 178.56 33.72 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.639 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 65.1 tt0 -98.83 98.44 9.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.665 0.269 . . . . 0.0 111.227 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.949 ' CD2' HD21 ' A' ' 93' ' ' LEU . 1.4 m-30 -100.72 118.72 37.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 3.4 ptt180 -79.71 132.58 36.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.094 0.474 . . . . 0.0 110.584 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.853 HG21 ' HG2' ' A' ' 69' ' ' MET . 15.2 mm -78.16 131.0 35.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.875 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.647 HD21 HG22 ' A' ' 88' ' ' VAL . 0.9 OUTLIER -130.12 105.14 7.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.86 -1.063 . . . . 0.0 108.898 178.719 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.711 ' CD1' HD13 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -98.99 126.64 44.73 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.321 0.581 . . . . 0.0 110.781 -178.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.48 131.05 39.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.269 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.69 ' CZ3' ' HB3' ' A' ' 81' ' ' ALA . 11.6 p-90 -157.18 167.43 30.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.036 0.446 . . . . 0.0 111.605 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.1 m -152.19 84.74 1.26 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.284 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.5 t -118.4 80.01 15.91 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.291 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.05 91.27 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.452 2.101 . . . . 0.0 111.86 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.92 -76.4 0.31 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.775 0.321 . . . . 0.0 111.436 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.523 ' HA ' ' HB2' ' A' ' 80' ' ' GLU . 11.7 t 173.28 -32.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.905 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 61' ' ' SER . 4.0 p 162.61 143.37 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.166 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -137.22 171.55 14.31 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.665 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 t -121.6 87.76 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-O 120.671 0.272 . . . . 0.0 110.309 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.469 ' ND2' ' HA2' ' A' ' 110' ' ' GLY . 0.3 OUTLIER -115.92 157.8 23.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.108 0.48 . . . . 0.0 111.624 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.2 m -107.38 110.67 22.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.227 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.849 HD11 ' CE ' ' A' ' 69' ' ' MET . 22.4 tp -78.79 121.99 25.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.517 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' A' ' 101' ' ' GLY . 38.9 t -96.5 101.6 12.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.977 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.853 ' HG2' HG21 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -127.48 129.81 48.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.249 -179.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.413 ' OD1' ' HG3' ' A' ' 91' ' ' LYS . 6.4 p-10 44.5 50.83 8.1 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.757 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.75 14.64 58.58 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.698 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.2 m -104.56 130.16 52.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.072 0.463 . . . . 0.0 110.932 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.83 72.27 2.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.699 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.637 HD11 HD23 ' A' ' 67' ' ' LEU . 1.1 pp -79.46 105.48 10.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.306 0.574 . . . . 0.0 110.784 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.0 t -88.67 117.61 27.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.22 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.448 ' CZ ' ' CE1' ' A' ' 78' ' ' PHE . 1.2 p90 -144.82 151.15 38.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.11 0.481 . . . . 0.0 111.157 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.75 108.86 17.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.156 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.452 ' N ' ' O ' ' A' ' 63' ' ' LYS . 3.8 m-85 -50.79 176.08 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.017 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.03 176.94 5.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.191 0.52 . . . . 0.0 112.182 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 61' ' ' SER . 33.7 tt0 -81.29 57.56 3.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.797 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.69 ' HB3' ' CZ3' ' A' ' 56' ' ' TRP . . . -84.92 162.54 19.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.137 0.494 . . . . 0.0 111.304 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.563 HG23 HG23 ' A' ' 83' ' ' VAL . 0.6 OUTLIER -151.17 -49.78 0.12 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.01 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.966 ' O ' HG23 ' A' ' 85' ' ' VAL . 4.2 t -79.79 141.23 55.25 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.463 ' HD2' ' CG1' ' A' ' 83' ' ' VAL . 52.0 Cg_exo -36.85 84.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.588 2.192 . . . . 0.0 112.998 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.966 HG23 ' O ' ' A' ' 83' ' ' VAL . 76.4 t -99.42 158.49 3.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.443 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.488 ' N ' HG12 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -125.21 139.99 53.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.055 0.455 . . . . 0.0 111.539 -179.508 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.548 ' CZ ' ' HB2' ' A' ' 89' ' ' GLN . 0.6 OUTLIER -102.21 107.44 18.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.672 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.647 HG22 HD21 ' A' ' 53' ' ' ASN . 22.3 t -82.68 126.37 40.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.292 0.568 . . . . 0.0 112.47 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.548 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 15.9 tt0 -145.36 113.63 6.6 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 14.9 p -78.59 116.77 19.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.706 0.765 . . . . 0.0 111.424 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.453 ' CD ' ' N ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -133.33 123.55 25.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.994 -179.221 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -93.55 110.81 22.39 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.858 0.361 . . . . 0.0 110.544 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.949 HD21 ' CD2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -109.66 149.64 29.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.175 0.512 . . . . 0.0 111.45 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.405 ' C ' HG11 ' A' ' 44' ' ' VAL . 35.0 m -97.31 156.41 16.45 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.574 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.27 135.76 57.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.253 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 141.72 -155.13 25.2 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.214 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -96.09 116.83 29.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.336 . . . . 0.0 110.745 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.516 ' CG ' HG23 ' A' ' 44' ' ' VAL . 9.0 m170 -119.04 169.06 10.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.551 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.3 p -121.67 118.25 28.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.975 0.417 . . . . 0.0 111.483 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.867 ' CE1' HD11 ' A' ' 119' ' ' LEU . 55.0 m-85 -116.44 165.02 13.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.723 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 68' ' ' VAL . . . 154.0 -163.11 30.82 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 119.798 -1.191 . . . . 0.0 113.575 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -151.59 123.67 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.479 ' HD3' ' HB2' ' A' ' 37' ' ' ALA . 1.0 OUTLIER -124.53 153.73 41.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.519 0.675 . . . . 0.0 112.751 -177.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.751 HG11 ' HA3' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -134.27 129.12 53.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.364 178.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 109' ' ' TRP . . . -129.24 163.84 22.38 Favored Glycine 0 C--O 1.228 -0.279 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.952 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.4 t -49.29 -28.44 4.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.85 0.357 . . . . 0.0 110.946 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.8 t -79.45 -29.26 41.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.782 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.522 ' O ' ' CD1' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -101.8 -67.53 0.86 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.914 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.75 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 79.01 133.72 0.06 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.751 ' HA3' HG11 ' A' ' 104' ' ' VAL . . . -140.83 -169.78 11.88 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.18 -1.009 . . . . 0.0 114.319 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.547 ' HB2' ' HZ3' ' A' ' 109' ' ' TRP . 0.5 OUTLIER 168.8 75.55 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.457 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.3 -177.26 5.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.174 0.511 . . . . 0.0 112.066 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 1.6 m-80 -113.08 137.72 51.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.33 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.619 HG21 HG21 ' A' ' 38' ' ' VAL . 45.1 t -114.96 87.78 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.02 0.438 . . . . 0.0 110.582 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -57.31 -47.69 80.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.298 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.441 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 39.4 t -176.6 160.53 2.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.259 0.552 . . . . 0.0 111.866 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.85 HD12 ' CE3' ' A' ' 40' ' ' TRP . 0.9 OUTLIER -104.07 87.76 2.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.323 179.189 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -87.79 129.02 35.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.943 0.401 . . . . 0.0 111.801 -178.719 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.867 HD11 ' CE1' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -115.98 107.21 14.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.134 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 50' ' ' TYR . 5.1 mt-10 -83.21 153.34 24.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.881 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.729 HD13 ' CE1' ' A' ' 50' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.934 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.3 p . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.524 0.202 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.592 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . . . -67.24 -28.74 68.3 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.563 ' HB2' HD11 ' A' ' 24' ' ' LEU . . . -69.85 -22.89 63.23 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.702 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.3 p -82.99 -4.54 58.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.033 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.88 -163.17 1.02 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.725 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.8 p -114.31 103.81 11.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.905 0.384 . . . . 0.0 110.873 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.905 HD11 HD23 ' A' ' 24' ' ' LEU . 1.7 mp -83.89 103.62 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.608 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.538 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 80.8 m -101.37 125.06 47.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.923 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.406 ' HA ' ' C ' ' A' ' 21' ' ' PRO . . . -45.39 145.93 1.81 Allowed Pre-proline 0 N--CA 1.462 0.144 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.915 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 36' ' ' SER . 63.2 Cg_endo -69.67 2.72 4.61 Favored 'Cis proline' 0 C--N 1.348 0.551 0 C-N-CA 124.293 -1.128 . . . . 0.0 113.817 0.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.903 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -59.23 141.32 54.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.923 0.392 . . . . 0.0 110.359 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.42 ' HA ' HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -146.5 120.36 9.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.212 -179.314 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.905 HD23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -79.18 110.89 14.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.253 -179.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.1 m -124.25 116.43 47.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.499 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.03 38.71 93.35 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.211 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.402 ' HA ' HD11 ' A' ' 24' ' ' LEU . 0.8 OUTLIER 67.43 37.28 3.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.87 0.367 . . . . 0.0 110.912 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.8 t -135.3 104.2 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.513 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.482 ' O ' HG23 ' A' ' 114' ' ' VAL . . . -68.77 86.23 0.21 Allowed Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.153 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 53.3 mt-10 -84.59 99.44 10.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.777 0.322 . . . . 0.0 111.633 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.062 HD21 HG22 ' A' ' 38' ' ' VAL . 23.5 mt -80.0 149.62 30.7 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.488 ' HG3' ' CZ ' ' A' ' 111' ' ' TYR . 0.0 OUTLIER -129.21 132.5 47.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.876 0.37 . . . . 0.0 111.436 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 110' ' ' GLY . . . 43.32 -152.05 0.37 Allowed Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.557 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.536 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . . . -90.2 159.83 16.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.623 0.249 . . . . 0.0 110.594 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.44 -24.41 32.1 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.883 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.785 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -71.52 155.31 40.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 0.0 111.191 -179.474 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . . . -162.75 113.66 1.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.075 0.464 . . . . 0.0 112.168 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 1.062 HG22 HD21 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -103.16 87.91 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.44 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.5 mm -89.95 118.81 35.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.328 0.585 . . . . 0.0 112.114 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.877 ' CE3' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -86.57 145.64 26.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.698 179.636 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -121.34 111.85 17.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.458 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.5 m -145.05 -177.05 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.964 0.411 . . . . 0.0 111.66 -179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -136.85 123.5 21.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.614 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.606 HG21 ' O ' ' A' ' 94' ' ' SER . 45.3 t -53.61 123.89 39.43 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.265 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -65.52 -47.86 3.77 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.562 2.175 . . . . 0.0 112.755 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.579 HG23 ' OH ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -148.33 -175.56 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.035 0.445 . . . . 0.0 111.678 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.18 99.14 11.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.352 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.46 -178.7 39.3 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.83 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 67.2 tt0 -90.85 117.52 29.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.059 0.429 . . . . 0.0 110.707 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.586 ' CD1' ' HB2' ' A' ' 93' ' ' LEU . 0.6 OUTLIER -110.87 115.86 30.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.923 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.9 ptm180 -79.62 128.85 33.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.049 0.452 . . . . 0.0 110.517 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.534 ' CG2' ' CE ' ' A' ' 69' ' ' MET . 12.1 mm -78.76 133.36 30.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.8 -178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.57 HD21 HG22 ' A' ' 88' ' ' VAL . 0.8 OUTLIER -133.04 109.08 9.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.177 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.695 HD21 ' HG ' ' A' ' 117' ' ' LEU . 1.3 mt -99.95 123.49 44.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.281 0.562 . . . . 0.0 111.466 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.85 118.04 31.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.262 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.601 ' CZ3' ' HB3' ' A' ' 81' ' ' ALA . 3.4 p-90 -139.66 167.02 23.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.056 0.455 . . . . 0.0 111.412 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.62 72.88 0.99 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.184 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 23.2 t -114.43 93.92 33.88 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.034 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.19 86.97 1.47 Allowed 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.987 2.458 . . . . 0.0 111.878 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -126.31 -82.8 0.62 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.456 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 62' ' ' SER . 1.5 p 178.85 -32.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.172 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 61' ' ' SER . 4.0 t 157.88 130.1 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.428 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 2.2 mttp -129.56 171.07 12.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.679 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 38.3 t -124.82 83.61 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 CA-C-O 120.559 0.219 . . . . 0.0 110.832 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.446 ' ND2' ' CA ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -104.92 169.09 8.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.002 0.429 . . . . 0.0 111.529 -179.42 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.0 m -117.68 110.65 18.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.851 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.742 ' HG ' HD21 ' A' ' 74' ' ' LEU . 11.8 tp -79.05 125.37 29.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.671 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.5 t -101.01 97.45 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.174 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.898 ' SD ' HD21 ' A' ' 117' ' ' LEU . 6.4 mmt -132.79 131.53 41.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.926 0.393 . . . . 0.0 111.482 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.1 t70 61.46 38.99 15.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.821 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.81 15.69 60.39 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.273 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.7 m -107.05 150.44 26.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.079 0.466 . . . . 0.0 111.014 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.56 74.72 0.91 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.312 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.742 HD21 ' HG ' ' A' ' 67' ' ' LEU . 1.5 pp -79.25 105.85 10.86 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.188 0.518 . . . . 0.0 110.943 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.9 t -82.61 134.33 35.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.59 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.446 ' CZ ' ' CE1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -160.35 151.23 18.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.207 0.527 . . . . 0.0 111.761 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . . . -88.19 102.11 14.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.071 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.544 ' CE2' ' CD2' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -59.15 145.91 40.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.107 0.48 . . . . 0.0 110.808 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.1 -178.73 7.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.797 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.462 ' HB3' ' CA ' ' A' ' 61' ' ' SER . 1.1 pt-20 -89.13 38.48 0.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.562 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.601 ' HB3' ' CZ3' ' A' ' 56' ' ' TRP . . . -51.14 172.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.176 0.512 . . . . 0.0 112.013 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.527 HG23 HG23 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -160.5 -48.77 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.877 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.952 ' O ' HG23 ' A' ' 85' ' ' VAL . 2.3 t -82.97 143.78 46.56 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.074 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.626 ' HD2' HG12 ' A' ' 83' ' ' VAL . 71.6 Cg_exo -41.56 84.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.269 1.979 . . . . 0.0 112.992 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.952 HG23 ' O ' ' A' ' 83' ' ' VAL . 46.3 t -101.79 141.47 18.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.566 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.666 HG21 ' HD3' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -108.33 127.51 53.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.931 0.396 . . . . 0.0 111.547 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 89' ' ' GLN . 0.6 OUTLIER -93.33 110.25 21.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.993 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.57 HG22 HD21 ' A' ' 53' ' ' ASN . 25.2 t -80.04 122.75 35.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 21.0 tp60 -136.45 113.33 10.36 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.8 p -78.43 116.73 19.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.456 0.646 . . . . 0.0 111.544 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.3 111.66 9.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.24 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -64.77 110.82 2.52 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 120.963 0.411 . . . . 0.0 110.817 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.707 HD11 ' CE2' ' A' ' 100' ' ' PHE . 4.8 mt -88.78 141.88 28.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.443 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.606 ' O ' HG21 ' A' ' 44' ' ' VAL . 66.3 m -115.24 152.38 32.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.933 0.397 . . . . 0.0 111.323 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.67 138.43 55.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.211 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 125.56 -159.77 20.06 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.561 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.62 116.98 29.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 0.0 110.866 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -118.71 169.13 10.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.804 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 53.9 p -122.57 124.8 44.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.054 0.454 . . . . 0.0 111.588 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.707 ' CE2' HD11 ' A' ' 93' ' ' LEU . 25.6 m-85 -120.54 167.65 12.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.59 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 68' ' ' VAL . . . 151.49 -163.22 29.86 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 119.384 -1.389 . . . . 0.0 114.253 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.439 HG13 HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -149.55 154.67 9.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.821 -0.689 . . . . 0.0 109.15 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.554 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -160.3 162.78 33.65 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.136 -0.625 . . . . 0.0 112.311 -179.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.617 HG11 ' N ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -139.02 142.05 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.466 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.452 ' C ' ' HB1' ' A' ' 34' ' ' ALA . . . -154.45 173.93 32.88 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.808 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.2 m -54.12 -24.82 19.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.787 0.327 . . . . 0.0 111.005 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.01 5.22 26.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.372 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.481 ' O ' ' CD1' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -152.88 -70.28 0.15 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.782 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.526 ' CE3' ' N ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER 77.82 133.54 0.06 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.521 179.666 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.617 ' N ' HG11 ' A' ' 104' ' ' VAL . . . -146.07 -169.14 13.83 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.472 -0.871 . . . . 0.0 113.703 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.488 ' CZ ' ' HG3' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -179.37 76.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.574 ' HE1' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -148.78 175.14 11.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.166 0.508 . . . . 0.0 112.149 -177.599 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.563 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 61.2 m-80 -108.16 131.77 54.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.828 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.89 HG21 HG21 ' A' ' 38' ' ' VAL . 42.9 t -100.0 85.87 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.101 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.91 -47.86 76.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.94 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.5 p -177.59 167.28 2.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.239 0.542 . . . . 0.0 111.228 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.898 HD21 ' SD ' ' A' ' 69' ' ' MET . 1.1 tt -111.61 77.98 1.08 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.666 ' HD3' HG21 ' A' ' 86' ' ' THR . 0.2 OUTLIER -78.79 118.53 20.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.208 0.528 . . . . 0.0 111.38 -177.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.547 HD23 ' HB3' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -101.92 143.83 31.31 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.795 179.473 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.431 ' OE2' ' N ' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -129.36 166.46 19.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.513 -179.341 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.552 HD22 ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.928 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 p . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.788 0.328 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.577 ' HB3' HD21 ' A' ' 24' ' ' LEU . . . -68.71 -18.1 64.18 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.563 ' HA ' ' HG ' ' A' ' 24' ' ' LEU . . . -69.76 -23.75 63.42 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.785 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.76 0.5 54.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.903 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.51 -163.57 1.04 Allowed 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.785 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.9 t -110.44 103.73 12.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.82 0.343 . . . . 0.0 110.972 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.633 HD11 HD23 ' A' ' 24' ' ' LEU . 1.6 mp -88.03 91.62 3.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.654 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.509 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 6.6 m -89.83 132.34 35.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.689 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.55 147.05 3.19 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.287 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 36' ' ' SER . 89.9 Cg_endo -75.98 10.01 11.72 Favored 'Cis proline' 0 C--N 1.347 0.475 0 C-N-CA 123.723 -1.365 . . . . 0.0 113.34 0.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.674 ' HB2' ' CD2' ' A' ' 31' ' ' LEU . . . -59.43 140.34 56.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.937 0.399 . . . . 0.0 110.884 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.442 ' HG3' ' C ' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -142.9 116.73 9.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.324 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.85 HD22 ' HA2' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -80.03 111.35 16.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.343 179.161 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.46 87.99 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.85 0.357 . . . . 0.0 111.173 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.82 -54.98 2.15 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.006 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -155.33 -36.02 0.09 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.705 0.288 . . . . 0.0 110.757 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.703 HG13 ' HA ' ' A' ' 115' ' ' HIS . 4.1 t -81.29 126.22 39.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.906 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.85 ' HA2' HD22 ' A' ' 24' ' ' LEU . . . -79.48 157.07 41.87 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.693 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 38.5 mt-10 -149.28 101.14 3.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.806 0.336 . . . . 0.0 111.145 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.002 HD21 HG22 ' A' ' 38' ' ' VAL . 95.4 mt -80.76 158.38 25.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.612 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.46 ' CG ' ' CE1' ' A' ' 111' ' ' TYR . 0.0 OUTLIER -127.64 -155.87 0.72 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.66 164.04 0.02 OUTLIER Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.269 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.579 ' HB2' ' HA ' ' A' ' 109' ' ' TRP . . . -40.57 163.19 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.906 0.353 . . . . 0.0 111.193 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.83 -27.16 21.51 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.688 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.878 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -67.78 150.47 48.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.819 0.342 . . . . 0.0 110.727 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.491 ' HB2' ' HD3' ' A' ' 103' ' ' ARG . . . -158.28 96.53 1.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.979 0.418 . . . . 0.0 111.902 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 1.002 HG22 HD21 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -86.16 88.74 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.018 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.545 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 31.6 mm -93.37 114.56 30.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.225 0.536 . . . . 0.0 112.297 -178.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.814 ' CE3' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -82.72 146.74 28.85 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.207 179.055 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -110.71 113.86 26.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.829 0.347 . . . . 0.0 111.146 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.0 m -149.53 155.41 8.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.962 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -119.22 117.29 28.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.974 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.95 HG13 ' CE1' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -35.0 110.09 0.39 Allowed Pre-proline 0 N--CA 1.47 0.569 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.716 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 44' ' ' VAL . 17.3 Cg_endo -57.75 -43.8 46.64 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.351 2.034 . . . . 0.0 112.626 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.532 ' C ' ' HH ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -156.94 -172.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.106 0.479 . . . . 0.0 111.75 -179.518 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.707 HG23 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -99.3 98.61 9.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.147 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.95 -145.23 4.25 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.434 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 62.5 tt0 -126.73 108.24 10.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.764 0.316 . . . . 0.0 110.905 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.883 ' HD2' HD12 ' A' ' 93' ' ' LEU . 1.3 m-30 -108.89 122.65 47.65 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.501 ' HB3' HG22 ' A' ' 90' ' ' THR . 3.7 ptt180 -84.19 131.47 34.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.303 0.573 . . . . 0.0 111.341 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.895 HG21 ' HG3' ' A' ' 69' ' ' MET . 11.4 mm -78.83 133.31 30.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.843 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 1.6 m120 -134.51 105.02 6.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.016 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.71 ' CD1' HD13 ' A' ' 67' ' ' LEU . 0.6 OUTLIER -99.35 118.71 36.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.223 0.535 . . . . 0.0 111.309 -179.374 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 0.2 OUTLIER -91.93 123.87 35.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.594 179.154 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TRP . . . . . 0.529 ' CZ3' ' HB3' ' A' ' 81' ' ' ALA . 1.5 p-90 -146.11 167.28 23.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.989 0.424 . . . . 0.0 111.49 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 p -155.25 83.45 1.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.677 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.7 t -117.67 82.94 16.79 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.75 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.409 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 27.5 Cg_exo -61.91 100.28 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.827 2.351 . . . . 0.0 112.309 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.409 ' CD1' ' O ' ' A' ' 59' ' ' PRO . 89.8 m-85 -156.07 -83.37 0.06 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.706 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.453 ' HA ' ' HG3' ' A' ' 80' ' ' GLU . 2.3 m -173.81 -45.15 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.894 0.378 . . . . 0.0 111.662 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 78' ' ' PHE . 0.2 OUTLIER 169.57 109.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.631 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.594 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -93.22 170.14 9.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.294 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.488 ' O ' ' O ' ' A' ' 109' ' ' TRP . 36.2 t -115.84 79.06 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.444 HD22 ' N ' ' A' ' 65' ' ' ASN . 1.5 m-80 -112.86 155.75 24.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.1 0.476 . . . . 0.0 112.043 -178.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.0 m -114.41 111.04 20.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.075 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.86 ' HG ' HD21 ' A' ' 74' ' ' LEU . 8.2 tp -74.17 133.92 42.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.934 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.516 ' N ' HD12 ' A' ' 67' ' ' LEU . 38.5 t -108.67 106.94 21.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.64 -178.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.895 ' HG3' HG21 ' A' ' 52' ' ' ILE . 3.7 mmt -137.34 122.09 18.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.915 0.388 . . . . 0.0 111.228 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 46.3 t0 63.51 43.83 5.66 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.233 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.82 15.01 59.44 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.571 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.6 m -99.93 146.73 26.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.898 0.38 . . . . 0.0 110.827 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.94 73.47 0.82 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.779 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.86 HD21 ' HG ' ' A' ' 67' ' ' LEU . 1.1 pp -79.74 106.11 11.53 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.209 0.528 . . . . 0.0 110.923 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.5 t -86.41 127.72 34.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.922 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -160.19 151.44 19.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.26 0.553 . . . . 0.0 111.327 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 63' ' ' LYS . . . -79.66 109.01 13.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.912 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -59.23 99.42 0.05 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.161 0.505 . . . . 0.0 111.142 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.468 ' O ' ' CH2' ' A' ' 56' ' ' TRP . . . -41.46 168.07 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.978 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.453 ' HG3' ' HA ' ' A' ' 61' ' ' SER . 2.8 tm-20 -71.77 65.51 0.51 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.96 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.529 ' HB3' ' CZ3' ' A' ' 56' ' ' TRP . . . -85.73 143.34 28.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.983 0.42 . . . . 0.0 111.602 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.507 HG23 HG23 ' A' ' 83' ' ' VAL . 0.5 OUTLIER -136.45 -49.04 0.65 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.239 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.936 ' O ' HG23 ' A' ' 85' ' ' VAL . 1.9 t -79.87 145.3 61.54 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.193 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.71 ' HD2' HG12 ' A' ' 83' ' ' VAL . 95.5 Cg_exo -44.29 82.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.196 1.931 . . . . 0.0 112.579 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.936 HG23 ' O ' ' A' ' 83' ' ' VAL . 44.3 t -98.58 125.46 51.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.644 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.9 103.36 15.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.708 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.504 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -64.99 106.48 1.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.029 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.6 t -84.39 123.34 38.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.527 ' OE1' HD22 ' A' ' 74' ' ' LEU . 56.9 tt0 -139.1 112.46 8.18 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.501 HG22 ' HB3' ' A' ' 51' ' ' ARG . 6.2 p -79.12 116.98 19.74 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.344 0.593 . . . . 0.0 111.75 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -131.45 123.11 27.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.183 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -69.81 111.12 5.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.563 -179.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.883 HD12 ' HD2' ' A' ' 50' ' ' TYR . 2.3 mt -93.11 141.19 28.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.952 0.406 . . . . 0.0 111.185 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.779 ' O ' HG11 ' A' ' 44' ' ' VAL . 3.6 p -116.59 146.37 42.72 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.578 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.707 ' H ' HG23 ' A' ' 47' ' ' THR . . . -50.07 150.14 2.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.55 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.547 ' C ' HG23 ' A' ' 44' ' ' VAL . . . 135.38 -115.31 1.35 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.403 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -166.2 144.07 5.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 110.997 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.95 ' CE1' HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -160.45 169.39 23.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.056 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.4 p -119.78 114.6 22.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.451 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.63 ' CZ ' HD11 ' A' ' 93' ' ' LEU . 47.5 m-85 -92.02 175.75 6.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.552 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.545 ' HA3' ' HA ' ' A' ' 39' ' ' ILE . . . 151.53 -153.36 24.9 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.252 -1.452 . . . . 0.0 114.172 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -153.13 124.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 114.999 -0.601 . . . . 0.0 109.699 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.491 ' HD3' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -122.38 152.25 40.38 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.403 0.621 . . . . 0.0 112.29 -178.371 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.88 HG11 ' CA ' ' A' ' 110' ' ' GLY . 0.1 OUTLIER -137.44 137.73 45.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.074 178.673 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . 0.556 ' C ' ' HB1' ' A' ' 34' ' ' ALA . . . -149.02 -171.06 17.36 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.905 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.0 p -53.43 -42.98 67.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.805 0.336 . . . . 0.0 110.891 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.7 m -73.13 -16.16 61.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.053 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.832 ' O ' HG12 ' A' ' 104' ' ' VAL . 3.7 p-10 -155.11 79.85 1.05 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.617 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TRP . . . . . 0.579 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . 20.5 p-90 -61.94 157.23 19.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.49 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.88 ' CA ' HG11 ' A' ' 104' ' ' VAL . . . -120.69 170.3 14.39 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.215 -0.993 . . . . 0.0 114.066 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.463 ' CD2' ' O ' ' A' ' 110' ' ' GLY . 0.6 OUTLIER 165.34 57.72 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.827 ' HE3' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -141.1 -170.82 3.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.742 -178.758 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 82.9 m-20 -116.77 131.36 56.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.814 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.93 HG21 HG21 ' A' ' 38' ' ' VAL . 68.6 t -103.43 85.63 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.064 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' HIS . . . . . 0.703 ' HA ' HG13 ' A' ' 28' ' ' VAL . 35.4 t-80 -57.93 -52.26 66.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.262 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.443 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 5.6 t -176.08 169.59 2.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.164 0.507 . . . . 0.0 111.964 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.814 HD12 ' CE3' ' A' ' 40' ' ' TRP . 1.1 tt -115.05 90.34 3.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.55 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.0 tttm -87.91 139.61 30.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.12 0.486 . . . . 0.0 111.78 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.58 HD23 ' HB3' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -132.76 127.85 35.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.897 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -115.84 150.99 36.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.218 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.481 ' CD1' ' CE1' ' A' ' 50' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.207 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.774 0.321 . . . . 0.0 111.322 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.432 ' NE1' ' CB ' ' A' ' 119' ' ' LEU . 2.4 p90 -130.06 146.97 51.76 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.914 0.388 . . . . 0.0 111.241 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.544 HG22 ' CB ' ' A' ' 116' ' ' SER . 0.2 OUTLIER -95.65 97.3 9.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.489 179.388 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.501 ' CZ ' HG11 ' A' ' 42' ' ' VAL . 4.1 m-85 -74.75 97.04 3.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.312 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 p -51.1 131.93 27.6 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.665 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.53 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . . . -71.0 -16.45 62.63 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.79 ' HB2' HD11 ' A' ' 24' ' ' LEU . . . -69.93 -27.77 65.03 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.604 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.74 -8.86 59.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.843 178.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.725 ' HB1' ' O ' ' A' ' 39' ' ' ILE . . . -89.6 -171.12 3.08 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.705 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.6 m -106.83 103.71 13.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.689 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.955 HD11 HD23 ' A' ' 24' ' ' LEU . 1.7 mp -80.88 94.63 2.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.255 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.515 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 63.8 m -91.97 128.3 37.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.873 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -46.95 146.27 2.83 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.133 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 36' ' ' SER . 80.6 Cg_endo -74.86 9.15 9.23 Favored 'Cis proline' 0 C--N 1.348 0.526 0 C-N-CA 123.84 -1.317 . . . . 0.0 113.583 0.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.707 ' HB2' ' CD2' ' A' ' 31' ' ' LEU . . . -59.47 143.46 49.87 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.342 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.43 120.06 10.44 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.397 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.955 HD23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -79.14 114.79 18.36 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.94 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.2 m -134.75 117.62 23.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.918 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.47 37.29 92.55 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.286 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.75 27.91 11.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.753 0.311 . . . . 0.0 110.988 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.733 HG13 ' HA ' ' A' ' 115' ' ' HIS . 25.4 t -134.8 105.4 6.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.152 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.523 ' O ' ' HB ' ' A' ' 114' ' ' VAL . . . -75.53 106.87 2.19 Favored Glycine 0 C--O 1.223 -0.58 0 C-N-CA 120.54 -0.838 . . . . 0.0 111.605 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 0.8 OUTLIER -105.59 118.38 36.43 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.971 0.415 . . . . 0.0 111.486 -179.196 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.037 HD21 HG22 ' A' ' 38' ' ' VAL . 69.7 mt -80.98 153.73 27.31 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.113 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.459 ' HA ' ' CD1' ' A' ' 111' ' ' TYR . 21.2 mt-30 -142.7 86.93 1.96 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.822 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.469 ' CA ' ' CE2' ' A' ' 111' ' ' TYR . . . 85.78 156.08 26.63 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.881 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.538 ' HB1' ' C ' ' A' ' 105' ' ' GLY . . . -47.21 157.46 0.19 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.835 0.317 . . . . 0.0 110.436 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 104' ' ' VAL . . . 100.47 -20.79 46.92 Favored Glycine 0 CA--C 1.52 0.362 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.601 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.834 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -81.98 152.13 26.86 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.585 0.231 . . . . 0.0 110.747 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.422 ' HB2' ' HD3' ' A' ' 103' ' ' ARG . . . -156.45 100.34 1.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.996 0.427 . . . . 0.0 112.051 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 1.061 HG21 HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -89.08 88.54 2.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.725 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 29.2 mm -90.28 127.26 42.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.297 0.57 . . . . 0.0 112.408 -177.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.849 ' CE3' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -100.68 128.49 46.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.642 179.464 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -106.04 111.77 24.54 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.303 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.501 HG11 ' CZ ' ' A' ' 11' ' ' TYR . 15.7 m -147.92 161.76 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.442 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 p-10 -112.56 124.58 52.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.007 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.873 ' CG1' HD13 ' A' ' 93' ' ' LEU . 1.7 m -56.81 123.94 61.25 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.211 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -62.05 -66.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.57 2.18 . . . . 0.0 113.03 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.96 -171.95 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.127 0.489 . . . . 0.0 112.013 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.751 HG23 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -98.16 94.53 6.86 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.646 179.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -159.24 165.66 34.4 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.459 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 66.3 tt0 -77.4 108.65 10.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.777 0.322 . . . . 0.0 111.123 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.871 ' HD2' HD12 ' A' ' 93' ' ' LEU . 3.4 m-30 -104.19 119.9 39.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.014 0.435 . . . . 0.0 110.072 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.457 ' HB3' HG22 ' A' ' 90' ' ' THR . 4.8 ptt180 -84.42 126.76 33.54 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.712 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.81 HG21 ' HG3' ' A' ' 69' ' ' MET . 6.1 mm -78.58 118.75 26.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.448 -178.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.544 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 8.4 m-80 -120.06 110.18 16.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.119 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.699 HD21 ' HG ' ' A' ' 117' ' ' LEU . 0.7 OUTLIER -99.24 122.36 42.31 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.388 0.613 . . . . 0.0 111.445 -178.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.433 ' HB ' ' HB2' ' A' ' 115' ' ' HIS . 0.2 OUTLIER -92.85 116.07 28.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.377 179.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.463 ' CH2' ' HB3' ' A' ' 78' ' ' PHE . 11.5 p-90 -145.15 167.2 23.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.331 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.5 m -148.72 92.72 2.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.889 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 111' ' ' TYR . 0.2 OUTLIER -127.11 83.55 65.71 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.92 179.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.44 90.18 0.17 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.644 2.23 . . . . 0.0 112.213 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -143.33 -77.75 0.23 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.328 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.1 m 178.39 -63.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.804 0.335 . . . . 0.0 111.108 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.4 t -172.82 121.28 0.39 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.997 0.427 . . . . 0.0 111.429 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.466 ' HG3' ' CH2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -110.97 171.77 7.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.171 179.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.431 ' O ' ' C ' ' A' ' 108' ' ' ASP . 57.4 t -117.09 86.8 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.222 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.483 ' OD1' ' HA3' ' A' ' 110' ' ' GLY . 1.7 m-80 -110.8 168.12 9.72 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.3 m -123.43 110.33 14.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.096 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.974 HD11 ' CE ' ' A' ' 69' ' ' MET . 16.2 tp -79.55 127.17 31.82 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.837 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.428 ' CG2' ' HB3' ' A' ' 103' ' ' ARG . 13.0 t -99.68 103.92 15.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.433 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.974 ' CE ' HD11 ' A' ' 67' ' ' LEU . 8.3 mmt -137.92 140.84 40.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.86 0.362 . . . . 0.0 111.047 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.473 ' HB3' HD21 ' A' ' 93' ' ' LEU . 6.2 p-10 45.84 40.76 6.93 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.765 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.68 25.96 70.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.786 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.5 m -119.2 141.9 48.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.01 0.433 . . . . 0.0 111.075 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -100.31 74.02 1.71 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.495 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.763 HD11 HD23 ' A' ' 67' ' ' LEU . 1.4 pp -79.3 106.48 11.37 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.227 0.536 . . . . 0.0 110.978 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.0 t -82.82 131.91 35.18 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.089 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.459 ' CE1' ' HB2' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -160.28 151.18 18.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.628 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 63' ' ' LYS . . . -89.06 118.75 29.0 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.92 0.39 . . . . 0.0 111.177 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.463 ' HB3' ' CH2' ' A' ' 56' ' ' TRP . 1.0 OUTLIER -58.54 93.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.944 -179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -53.41 140.15 28.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.764 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -37.51 101.59 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.444 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.45 ' HB3' ' CH2' ' A' ' 56' ' ' TRP . . . -128.18 165.88 19.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.225 0.536 . . . . 0.0 111.558 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.621 HG23 HG23 ' A' ' 83' ' ' VAL . 0.8 OUTLIER -160.46 -48.92 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.651 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.949 ' O ' HG23 ' A' ' 85' ' ' VAL . 6.9 t -80.13 141.54 54.27 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.217 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.479 ' HD2' ' CG1' ' A' ' 83' ' ' VAL . 43.5 Cg_exo -35.35 83.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.699 2.266 . . . . 0.0 112.922 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.949 HG23 ' O ' ' A' ' 83' ' ' VAL . 79.4 t -97.37 126.3 50.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.643 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.416 HG22 ' HB3' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -100.36 99.82 10.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.217 -179.677 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.619 ' OH ' HD13 ' A' ' 74' ' ' LEU . 1.0 OUTLIER -62.92 103.14 0.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 109.858 179.269 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 23.1 t -79.89 121.37 33.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 1.9 tt0 -137.11 112.66 9.37 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.457 HG22 ' HB3' ' A' ' 51' ' ' ARG . 12.1 p -79.09 118.07 20.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.404 0.621 . . . . 0.0 111.943 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -134.96 121.44 20.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.86 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -67.59 110.85 3.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.883 -179.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.873 HD13 ' CG1' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -93.93 143.49 26.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.981 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.666 ' O ' HG21 ' A' ' 44' ' ' VAL . 59.6 m -113.74 163.26 15.26 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.939 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.751 ' H ' HG23 ' A' ' 47' ' ' THR . . . -72.87 148.75 44.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.012 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 127.01 -112.86 1.63 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.503 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -141.81 130.0 22.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.829 0.347 . . . . 0.0 110.981 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.419 ' ND1' HD22 ' A' ' 93' ' ' LEU . 10.6 m-70 -133.84 150.28 51.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.867 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 27.7 p -105.25 131.56 52.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.92 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.844 ' HZ ' HD11 ' A' ' 93' ' ' LEU . 49.9 m-85 -124.45 168.15 13.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.416 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.49 ' HA3' ' HA ' ' A' ' 39' ' ' ILE . . . 152.35 -164.72 30.66 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 119.949 -1.12 . . . . 0.0 113.575 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.426 HG21 HG11 ' A' ' 114' ' ' VAL . 0.1 OUTLIER -148.23 123.2 2.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.428 ' HB3' ' CG2' ' A' ' 68' ' ' VAL . 0.7 OUTLIER -122.22 143.44 49.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.36 0.6 . . . . 0.0 112.512 -178.24 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.712 HG22 HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -126.88 132.05 70.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.265 178.299 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.538 ' C ' ' HB1' ' A' ' 34' ' ' ALA . . . -149.35 -172.99 19.53 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.603 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -57.87 -40.78 81.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.876 0.369 . . . . 0.0 110.507 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 5.3 t -70.62 -29.16 65.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.481 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 64' ' ' VAL . 0.6 OUTLIER -147.35 86.53 1.62 Allowed 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.321 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.511 ' CE3' ' N ' ' A' ' 110' ' ' GLY . 9.7 p-90 -86.42 157.17 19.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.933 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.511 ' N ' ' CE3' ' A' ' 109' ' ' TRP . . . -155.01 -171.25 21.52 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.108 -1.044 . . . . 0.0 114.001 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.469 ' CE2' ' CA ' ' A' ' 33' ' ' GLY . 0.7 OUTLIER -176.61 79.2 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.793 ' CE ' HG22 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -146.61 -176.8 5.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.2 0.524 . . . . 0.0 111.744 -178.08 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 40.8 m-20 -107.74 131.32 54.56 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.095 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 1.061 HG21 HG21 ' A' ' 38' ' ' VAL . 3.3 t -104.14 85.6 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.028 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.733 ' HA ' HG13 ' A' ' 28' ' ' VAL . 2.0 m80 -54.13 -66.58 0.37 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.265 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.544 ' CB ' HG22 ' A' ' 10' ' ' THR . 0.3 OUTLIER -164.36 148.12 9.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.146 0.498 . . . . 0.0 111.526 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.849 HD12 ' CE3' ' A' ' 40' ' ' TRP . 0.4 OUTLIER -84.72 95.57 8.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.858 179.411 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 53' ' ' ASN . 1.0 OUTLIER -80.08 134.06 36.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.03 0.443 . . . . 0.0 111.704 -178.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.731 HD23 ' HB3' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -124.92 107.75 11.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.285 179.426 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -99.48 152.96 19.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.865 0.364 . . . . 0.0 111.223 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.2 90.55 8.4 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.299 0.571 . . . . 0.0 110.624 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -62.11 -65.14 0.73 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.737 179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.535 179.894 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 7.8 p . . . . . 0 C--O 1.231 0.108 0 N-CA-C 110.378 -0.23 . . . . 0.0 110.378 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 10.9 p90 -156.59 151.64 26.24 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.08 0.467 . . . . 0.0 112.017 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.854 HG22 ' HB2' ' A' ' 116' ' ' SER . 0.2 OUTLIER -98.48 145.36 26.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.254 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.828 ' OH ' HD12 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -122.02 101.72 7.72 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.243 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.2 p -47.38 144.04 3.14 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.882 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.703 ' HB3' HD21 ' A' ' 24' ' ' LEU . . . -68.57 -9.2 48.03 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -178.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.571 ' HA ' ' HG ' ' A' ' 24' ' ' LEU . . . -69.9 -29.53 66.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.9 0.381 . . . . 0.0 110.615 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.69 -2.36 53.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.99 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.686 ' HB1' ' O ' ' A' ' 39' ' ' ILE . . . -96.86 -164.1 1.12 Allowed 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.9 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.9 p -110.95 103.75 12.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.597 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.693 HD11 HD23 ' A' ' 24' ' ' LEU . 1.6 mp -87.53 91.48 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.53 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.518 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 27.4 m -90.72 134.72 34.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.653 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.28 145.21 5.56 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.159 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 36' ' ' SER . 86.5 Cg_endo -78.48 10.9 18.93 Favored 'Cis proline' 0 C--N 1.348 0.509 0 C-N-CA 123.64 -1.4 . . . . 0.0 113.447 0.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.647 ' HB2' ' CD2' ' A' ' 31' ' ' LEU . . . -59.53 143.66 49.52 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.43 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -147.67 118.88 7.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.051 0.453 . . . . 0.0 111.765 -179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.791 HD22 ' HA2' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -79.81 104.69 10.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.397 179.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 25' ' ' VAL . 27.6 m -116.12 124.4 72.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.865 0.364 . . . . 0.0 111.598 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.58 ' O ' HG23 ' A' ' 28' ' ' VAL . . . 58.79 46.62 93.23 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.391 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 60.0 20.59 9.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.837 0.351 . . . . 0.0 110.912 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 26' ' ' GLY . 38.5 t -130.08 131.41 65.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.728 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.791 ' HA2' HD22 ' A' ' 24' ' ' LEU . . . -80.25 146.87 28.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.782 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.55 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 32.6 mt-10 -147.29 102.37 3.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.819 0.342 . . . . 0.0 110.807 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.979 HD21 HG22 ' A' ' 38' ' ' VAL . 94.9 mt -79.68 154.74 28.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.456 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.508 ' HG3' ' CE1' ' A' ' 111' ' ' TYR . 0.0 OUTLIER -123.59 -156.32 0.7 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.815 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 32' ' ' GLN . . . -37.02 152.9 0.01 OUTLIER Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.281 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.926 ' HB2' ' HA ' ' A' ' 109' ' ' TRP . . . -39.22 158.14 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 120.744 0.307 . . . . 0.0 111.274 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 106.27 -22.81 30.23 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.661 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.858 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.7 OUTLIER -65.91 157.47 30.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.605 0.24 . . . . 0.0 110.664 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -157.88 96.21 1.46 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 1.061 HG21 HG21 ' A' ' 114' ' ' VAL . 0.0 OUTLIER -90.55 88.77 2.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.171 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.686 ' O ' ' HB1' ' A' ' 16' ' ' ALA . 26.7 mm -91.89 131.73 38.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.147 0.499 . . . . 0.0 111.905 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.747 ' CE3' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -103.62 126.52 50.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.357 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -94.27 119.06 32.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.862 0.363 . . . . 0.0 111.172 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.5 m -156.01 155.72 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.993 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -117.55 119.51 35.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.199 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.715 ' CG1' HD13 ' A' ' 93' ' ' LEU . 0.0 OUTLIER -45.05 123.66 5.14 Favored Pre-proline 0 N--CA 1.464 0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.362 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -66.23 -52.62 0.81 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.462 2.108 . . . . 0.0 112.935 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.97 -171.26 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.192 0.52 . . . . 0.0 112.071 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.6 92.7 6.75 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.936 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -158.79 175.21 35.84 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.282 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 75.5 tt0 -89.38 117.87 28.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.689 0.28 . . . . 0.0 111.056 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.954 ' CE1' HD13 ' A' ' 121' ' ' LEU . 4.9 m-30 -115.07 117.41 30.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.156 0.503 . . . . 0.0 109.856 179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 4.8 ptp180 -79.79 124.26 28.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.696 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 17.4 mm -78.54 148.23 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.739 -178.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.445 ' HB3' HG22 ' A' ' 86' ' ' THR . 2.0 m-80 -148.33 109.78 4.41 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.044 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.975 HD12 HD21 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -99.53 119.76 38.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.292 0.568 . . . . 0.0 110.986 -179.625 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 0.2 OUTLIER -96.41 117.6 31.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.832 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.59 ' CH2' ' HB3' ' A' ' 81' ' ' ALA . 5.4 p-90 -142.73 165.2 28.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.035 0.445 . . . . 0.0 111.514 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.41 ' CB ' ' O ' ' A' ' 82' ' ' THR . 1.4 p -144.32 72.07 1.33 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.383 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.455 ' HB3' ' CZ3' ' A' ' 56' ' ' TRP . 31.1 t -115.99 91.78 32.64 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.109 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.68 105.89 1.37 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.791 2.327 . . . . 0.0 112.154 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.482 ' O ' ' CB ' ' A' ' 61' ' ' SER . 91.0 t80 -144.39 -86.89 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.128 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.482 ' CB ' ' O ' ' A' ' 60' ' ' TYR . 1.2 m 155.51 64.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 120.884 0.373 . . . . 0.0 110.201 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.3 p 69.69 111.75 0.05 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.738 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.506 ' CB ' ' CH2' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -123.61 169.36 11.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.513 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.526 HG12 ' OD1' ' A' ' 108' ' ' ASP . 26.0 t -110.64 102.95 14.71 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 120.75 0.31 . . . . 0.0 111.178 -179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.472 ' HB2' ' CD1' ' A' ' 78' ' ' PHE . 2.3 m-80 -128.02 149.97 50.13 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.165 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.469 ' OG1' ' HB2' ' A' ' 108' ' ' ASP . 0.2 OUTLIER -101.79 110.94 23.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.726 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.975 HD21 HD12 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -77.28 123.67 26.79 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.798 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.544 HG21 ' HB3' ' A' ' 103' ' ' ARG . 34.9 t -100.09 96.55 4.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.37 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.873 ' SD ' HD21 ' A' ' 117' ' ' LEU . 3.8 mmt -138.28 137.39 37.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.858 0.361 . . . . 0.0 111.323 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 28.5 t70 56.54 35.58 26.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.949 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.92 15.54 60.42 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.269 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.1 m -106.39 148.32 28.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.969 0.414 . . . . 0.0 110.887 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.84 74.46 0.99 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.472 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.534 HD21 ' HB3' ' A' ' 67' ' ' LEU . 1.6 pp -79.28 112.5 16.57 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.221 0.534 . . . . 0.0 110.556 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 16.0 t -96.46 106.21 18.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.076 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.588 ' HE1' HD23 ' A' ' 67' ' ' LEU . 4.7 p90 -132.89 151.24 52.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.725 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 63' ' ' LYS . . . -79.69 101.58 8.47 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.946 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.558 ' HE1' HD23 ' A' ' 67' ' ' LEU . 2.5 m-85 -48.22 101.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.019 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.459 ' O ' ' CH2' ' A' ' 56' ' ' TRP . . . -56.93 140.94 46.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.245 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -38.0 108.94 0.09 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.207 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.59 ' HB3' ' CH2' ' A' ' 56' ' ' TRP . . . -133.34 124.5 27.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.888 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.41 ' O ' ' CB ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -122.18 -51.5 1.99 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.609 178.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.895 ' O ' HG23 ' A' ' 85' ' ' VAL . 1.9 m -79.74 163.23 59.52 Favored Pre-proline 0 N--CA 1.421 -1.887 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.496 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.409 ' N ' HG23 ' A' ' 83' ' ' VAL . 84.3 Cg_exo -45.47 86.5 0.02 OUTLIER 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.37 2.046 . . . . 0.0 112.686 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.895 HG23 ' O ' ' A' ' 83' ' ' VAL . 45.4 t -102.97 122.66 55.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.742 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.445 HG22 ' HB3' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -103.95 100.18 9.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.543 -179.484 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 89' ' ' GLN . 6.0 t80 -67.46 99.94 0.8 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 52' ' ' ILE . 20.4 t -79.73 119.01 28.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -178.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 7.4 tp60 -131.09 112.16 12.63 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 2.2 p -79.75 118.45 21.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.116 0.484 . . . . 0.0 111.532 -178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.2 mtpp -136.11 118.76 16.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.425 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.3 OUTLIER -67.53 110.86 3.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.484 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.743 HD11 ' CZ ' ' A' ' 100' ' ' PHE . 2.1 mt -89.51 148.11 23.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.377 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.524 ' O ' HG21 ' A' ' 44' ' ' VAL . 1.3 p -114.22 163.3 15.43 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.931 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.92 150.15 46.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.35 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 126.66 -124.33 5.02 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.557 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -132.87 139.32 47.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.717 0.294 . . . . 0.0 110.487 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.717 ' CD2' HD22 ' A' ' 93' ' ' LEU . 1.7 m-70 -136.37 169.31 17.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.952 0.406 . . . . 0.0 111.344 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.72 104.74 6.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.86 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.743 ' CZ ' HD11 ' A' ' 93' ' ' LEU . 39.8 m-85 -97.18 171.85 8.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.151 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 39' ' ' ILE . . . 151.32 -161.53 29.18 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 119.68 -1.248 . . . . 0.0 113.491 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.485 HG13 HD22 ' A' ' 67' ' ' LEU . 0.2 OUTLIER -151.94 126.47 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.544 ' HB3' HG21 ' A' ' 68' ' ' VAL . 0.0 OUTLIER -128.11 163.0 25.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.214 0.53 . . . . 0.0 112.23 -178.919 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.894 HG11 ' CA ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -139.46 142.94 31.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.516 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.453 ' C ' ' HB1' ' A' ' 34' ' ' ALA . . . -151.45 177.69 29.23 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.649 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 3.4 t -49.47 -36.3 22.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.837 0.351 . . . . 0.0 110.856 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.24 -29.15 53.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.513 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.636 ' O ' HG12 ' A' ' 104' ' ' VAL . 6.8 m-20 -134.28 72.87 1.47 Allowed 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.137 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.926 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . 7.4 p-90 -47.99 153.12 0.69 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.252 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.894 ' CA ' HG11 ' A' ' 104' ' ' VAL . . . -123.23 159.51 17.85 Favored Glycine 0 C--N 1.337 0.591 0 C-N-CA 120.685 -0.769 . . . . 0.0 114.268 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.508 ' CE1' ' HG3' ' A' ' 32' ' ' GLN . 0.2 OUTLIER 163.6 58.14 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.719 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.745 ' CE ' HG22 ' A' ' 114' ' ' VAL . 0.3 OUTLIER -137.53 -171.68 3.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.734 -178.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.55 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 89.7 m-20 -119.06 131.1 55.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.307 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 1.061 HG21 HG21 ' A' ' 38' ' ' VAL . 6.1 t -103.98 86.6 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.519 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -52.23 -56.5 14.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.614 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.854 ' HB2' HG22 ' A' ' 10' ' ' THR . 0.1 OUTLIER 175.74 151.94 0.14 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.174 0.511 . . . . 0.0 111.506 179.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.873 HD21 ' SD ' ' A' ' 69' ' ' MET . 0.3 OUTLIER -90.01 123.09 33.61 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.463 179.098 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.3 ttpp -123.33 138.64 54.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.958 0.408 . . . . 0.0 111.923 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.828 HD12 ' OH ' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -123.81 128.86 50.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.234 178.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.413 ' O ' ' N ' ' A' ' 122' ' ' LEU . 1.2 tm-20 -112.84 107.45 16.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.474 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.954 HD13 ' CE1' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -52.73 90.04 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.77 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.667 HD13 ' H ' ' A' ' 123' ' ' GLY . 0.4 OUTLIER -46.03 163.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.287 -179.542 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.667 ' H ' HD13 ' A' ' 122' ' ' LEU . . . . . . . . 0 CA--C 1.519 0.333 0 C-N-CA 121.104 -0.569 . . . . 0.0 113.213 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 52.3 p . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.823 0.344 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.514 ' O ' ' HA ' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -73.77 103.95 4.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.325 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.561 HG23 ' HB3' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -103.52 96.11 6.51 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.34 179.571 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.495 ' O ' ' NE1' ' A' ' 40' ' ' TRP . 5.4 m-85 -83.65 110.06 17.96 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.5 p -55.69 131.93 47.79 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.666 -0.413 . . . . 0.0 110.388 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.573 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . . . -57.34 -21.51 35.98 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.557 ' HA ' ' HG ' ' A' ' 24' ' ' LEU . . . -73.13 -23.01 60.42 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.55 -0.46 . . . . 0.0 110.82 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.4 p -83.79 -2.48 56.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.009 178.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.427 ' HB2' ' CD1' ' A' ' 40' ' ' TRP . . . -95.58 -163.27 1.03 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.941 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -113.57 103.84 11.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.903 0.383 . . . . 0.0 110.84 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.959 HD11 HD23 ' A' ' 24' ' ' LEU . 1.5 mp -82.51 102.48 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.535 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.508 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 26.5 m -96.56 125.37 40.99 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.143 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.52 146.39 1.76 Allowed Pre-proline 0 CA--C 1.529 0.171 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.189 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 36' ' ' SER . 95.4 Cg_endo -73.43 7.78 7.46 Favored 'Cis proline' 0 C--N 1.348 0.547 0 C-N-CA 124.045 -1.231 . . . . 0.0 113.558 0.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.961 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -59.24 143.47 49.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.882 0.373 . . . . 0.0 110.286 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.419 ' HA ' HG21 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -148.06 119.3 7.79 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.271 -179.154 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.959 HD23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -79.06 114.03 17.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.34 -179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.4 m -123.83 113.29 36.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.699 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 58.28 39.11 92.09 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.289 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.409 ' HA ' ' CD1' ' A' ' 24' ' ' LEU . 7.6 m120 70.1 36.16 1.98 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.786 0.327 . . . . 0.0 111.006 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.18 104.62 9.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.411 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.442 ' HA2' ' CD2' ' A' ' 24' ' ' LEU . . . -70.47 83.75 0.35 Allowed Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.091 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 83.5 mt-10 -88.29 99.92 12.6 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.683 0.278 . . . . 0.0 111.612 -179.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.961 HD23 ' HB2' ' A' ' 22' ' ' ALA . 15.5 mt -79.93 150.68 30.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.075 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.458 ' O ' ' CG ' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -125.33 137.56 54.05 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.965 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 110' ' ' GLY . . . 40.64 -154.8 0.06 OUTLIER Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.762 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.75 ' HB2' ' HA ' ' A' ' 109' ' ' TRP . . . -90.26 173.69 8.0 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.183 178.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 88.65 -28.13 6.64 Favored Glycine 0 CA--C 1.521 0.444 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.436 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.814 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -67.43 163.79 20.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.879 0.339 . . . . 0.0 110.865 -179.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.479 ' HB2' ' HD3' ' A' ' 103' ' ' ARG . . . -169.28 103.7 0.36 Allowed 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.876 HG22 HD21 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -86.6 88.59 2.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 176.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.441 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 27.7 mm -90.83 113.02 25.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -177.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.85 ' CE3' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -83.27 148.46 27.37 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.582 179.168 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.03 111.91 15.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.644 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.491 HG11 ' CD1' ' A' ' 11' ' ' TYR . 16.4 m -149.36 -174.98 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.958 0.409 . . . . 0.0 111.567 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -139.15 128.21 23.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.48 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.516 HG23 ' CG ' ' A' ' 98' ' ' HIS . 91.8 t -57.28 123.33 60.3 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.146 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -68.19 -48.64 1.19 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.777 2.318 . . . . 0.0 113.171 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.446 HG23 ' OH ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -144.4 176.63 2.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.157 0.503 . . . . 0.0 111.92 -179.28 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.13 97.59 11.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.27 179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -157.43 178.56 33.72 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.46 -0.876 . . . . 0.0 112.639 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 65.1 tt0 -98.83 98.44 9.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.665 0.269 . . . . 0.0 111.227 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.949 ' CD2' HD21 ' A' ' 93' ' ' LEU . 1.4 m-30 -100.72 118.72 37.4 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.459 ' HA ' ' HA ' ' A' ' 90' ' ' THR . 3.4 ptt180 -79.71 132.58 36.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.094 0.474 . . . . 0.0 110.584 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.853 HG21 ' HG2' ' A' ' 69' ' ' MET . 15.2 mm -78.16 131.0 35.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.875 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.647 HD21 HG22 ' A' ' 88' ' ' VAL . 0.9 OUTLIER -130.12 105.14 7.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.86 -1.063 . . . . 0.0 108.898 178.719 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.711 ' CD1' HD13 ' A' ' 67' ' ' LEU . 0.5 OUTLIER -98.99 126.64 44.73 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-O 121.321 0.581 . . . . 0.0 110.781 -178.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -93.48 131.05 39.07 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.269 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.69 ' CZ3' ' HB3' ' A' ' 81' ' ' ALA . 11.6 p-90 -157.18 167.43 30.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.036 0.446 . . . . 0.0 111.605 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.1 m -152.19 84.74 1.26 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.284 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.5 t -118.4 80.01 15.91 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.291 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.05 91.27 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.452 2.101 . . . . 0.0 111.86 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.92 -76.4 0.31 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.775 0.321 . . . . 0.0 111.436 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.523 ' HA ' ' HB2' ' A' ' 80' ' ' GLU . 11.7 t 173.28 -32.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.905 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 61' ' ' SER . 4.0 p 162.61 143.37 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.166 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.452 ' O ' ' N ' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -137.22 171.55 14.31 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.665 -179.47 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.0 t -121.6 87.76 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-O 120.671 0.272 . . . . 0.0 110.309 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.469 ' ND2' ' HA2' ' A' ' 110' ' ' GLY . 0.3 OUTLIER -115.92 157.8 23.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.108 0.48 . . . . 0.0 111.624 -178.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.2 m -107.38 110.67 22.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.227 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.849 HD11 ' CE ' ' A' ' 69' ' ' MET . 22.4 tp -78.79 121.99 25.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.517 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' A' ' 101' ' ' GLY . 38.9 t -96.5 101.6 12.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.977 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.853 ' HG2' HG21 ' A' ' 52' ' ' ILE . 0.0 OUTLIER -127.48 129.81 48.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.249 -179.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.413 ' OD1' ' HG3' ' A' ' 91' ' ' LYS . 6.4 p-10 44.5 50.83 8.1 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.757 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.75 14.64 58.58 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.698 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.2 m -104.56 130.16 52.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.072 0.463 . . . . 0.0 110.932 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.83 72.27 2.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.699 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.637 HD11 HD23 ' A' ' 67' ' ' LEU . 1.1 pp -79.46 105.48 10.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.306 0.574 . . . . 0.0 110.784 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.0 t -88.67 117.61 27.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.22 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.448 ' CZ ' ' CE1' ' A' ' 78' ' ' PHE . 1.2 p90 -144.82 151.15 38.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.11 0.481 . . . . 0.0 111.157 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.75 108.86 17.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.156 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.452 ' N ' ' O ' ' A' ' 63' ' ' LYS . 3.8 m-85 -50.79 176.08 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.017 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.03 176.94 5.19 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.191 0.52 . . . . 0.0 112.182 -179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 61' ' ' SER . 33.7 tt0 -81.29 57.56 3.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.797 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.69 ' HB3' ' CZ3' ' A' ' 56' ' ' TRP . . . -84.92 162.54 19.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.137 0.494 . . . . 0.0 111.304 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.563 HG23 HG23 ' A' ' 83' ' ' VAL . 0.6 OUTLIER -151.17 -49.78 0.12 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.01 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.966 ' O ' HG23 ' A' ' 85' ' ' VAL . 4.2 t -79.79 141.23 55.25 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.463 ' HD2' ' CG1' ' A' ' 83' ' ' VAL . 52.0 Cg_exo -36.85 84.45 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.588 2.192 . . . . 0.0 112.998 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.966 HG23 ' O ' ' A' ' 83' ' ' VAL . 76.4 t -99.42 158.49 3.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.443 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.488 ' N ' HG12 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -125.21 139.99 53.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.055 0.455 . . . . 0.0 111.539 -179.508 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.548 ' CZ ' ' HB2' ' A' ' 89' ' ' GLN . 0.6 OUTLIER -102.21 107.44 18.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.672 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.647 HG22 HD21 ' A' ' 53' ' ' ASN . 22.3 t -82.68 126.37 40.03 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.292 0.568 . . . . 0.0 112.47 -178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.548 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 15.9 tt0 -145.36 113.63 6.6 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 51' ' ' ARG . 14.9 p -78.59 116.77 19.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.706 0.765 . . . . 0.0 111.424 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.453 ' CD ' ' N ' ' A' ' 92' ' ' THR . 0.0 OUTLIER -133.33 123.55 25.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.994 -179.221 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -93.55 110.81 22.39 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 120.858 0.361 . . . . 0.0 110.544 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.949 HD21 ' CD2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -109.66 149.64 29.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.175 0.512 . . . . 0.0 111.45 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.405 ' C ' HG11 ' A' ' 44' ' ' VAL . 35.0 m -97.31 156.41 16.45 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.574 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.27 135.76 57.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.253 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 141.72 -155.13 25.2 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.214 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -96.09 116.83 29.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.807 0.336 . . . . 0.0 110.745 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.516 ' CG ' HG23 ' A' ' 44' ' ' VAL . 9.0 m170 -119.04 169.06 10.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.551 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 17.3 p -121.67 118.25 28.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.975 0.417 . . . . 0.0 111.483 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.867 ' CE1' HD11 ' A' ' 119' ' ' LEU . 55.0 m-85 -116.44 165.02 13.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.723 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 68' ' ' VAL . . . 154.0 -163.11 30.82 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 119.798 -1.191 . . . . 0.0 113.575 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -151.59 123.67 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.479 ' HD3' ' HB2' ' A' ' 37' ' ' ALA . 1.0 OUTLIER -124.53 153.73 41.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.519 0.675 . . . . 0.0 112.751 -177.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.751 HG11 ' HA3' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -134.27 129.12 53.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 114.721 -1.127 . . . . 0.0 109.364 178.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 109' ' ' TRP . . . -129.24 163.84 22.38 Favored Glycine 0 C--O 1.228 -0.279 0 C-N-CA 120.327 -0.94 . . . . 0.0 112.952 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 10.4 t -49.29 -28.44 4.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.85 0.357 . . . . 0.0 110.946 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.8 t -79.45 -29.26 41.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.782 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.522 ' O ' ' CD1' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -101.8 -67.53 0.86 Allowed 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.914 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.75 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . 0.0 OUTLIER 79.01 133.72 0.06 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.751 ' HA3' HG11 ' A' ' 104' ' ' VAL . . . -140.83 -169.78 11.88 Favored Glycine 0 C--N 1.336 0.561 0 C-N-CA 120.18 -1.009 . . . . 0.0 114.319 -179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.547 ' HB2' ' HZ3' ' A' ' 109' ' ' TRP . 0.5 OUTLIER 168.8 75.55 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.457 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.3 -177.26 5.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.174 0.511 . . . . 0.0 112.066 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 1.6 m-80 -113.08 137.72 51.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.33 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.619 HG21 HG21 ' A' ' 38' ' ' VAL . 45.1 t -114.96 87.78 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.02 0.438 . . . . 0.0 110.582 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -57.31 -47.69 80.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.298 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.524 ' OG ' HG22 ' A' ' 10' ' ' THR . 39.4 t -176.6 160.53 2.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.259 0.552 . . . . 0.0 111.866 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.85 HD12 ' CE3' ' A' ' 40' ' ' TRP . 0.9 OUTLIER -104.07 87.76 2.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.323 179.189 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.561 ' HB3' HG23 ' A' ' 10' ' ' THR . 0.3 OUTLIER -87.79 129.02 35.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.943 0.401 . . . . 0.0 111.801 -178.719 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.867 HD11 ' CE1' ' A' ' 100' ' ' PHE . 0.0 OUTLIER -115.98 107.21 14.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.134 179.334 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 50' ' ' TYR . 5.1 mt-10 -83.21 153.34 24.79 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.881 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.729 HD13 ' CE1' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -92.14 27.49 2.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.934 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.468 HD12 ' CG ' ' A' ' 49' ' ' GLU . 3.6 mt 48.85 89.83 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.931 0.396 . . . . 0.0 111.1 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.222 -179.717 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.468 ' HA ' ' CE3' ' A' ' 9' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.128 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.611 ' HE3' ' O ' ' A' ' 119' ' ' LEU . 0.1 OUTLIER -137.09 103.82 5.25 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.4 -0.52 . . . . 0.0 110.686 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.65 95.78 9.79 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.68 179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.944 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 7.5 m-30 -77.09 94.86 4.1 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.0 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.3 p -64.25 133.43 52.76 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.644 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.592 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . . . -67.24 -28.74 68.3 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.563 ' HB2' HD11 ' A' ' 24' ' ' LEU . . . -69.85 -22.89 63.23 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.702 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 52.3 p -82.99 -4.54 58.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.033 178.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.88 -163.17 1.02 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.725 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.8 p -114.31 103.81 11.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.905 0.384 . . . . 0.0 110.873 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.905 HD11 HD23 ' A' ' 24' ' ' LEU . 1.7 mp -83.89 103.62 11.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.608 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.538 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 80.8 m -101.37 125.06 47.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.923 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.406 ' HA ' ' C ' ' A' ' 21' ' ' PRO . . . -45.39 145.93 1.81 Allowed Pre-proline 0 N--CA 1.462 0.144 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.915 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 36' ' ' SER . 63.2 Cg_endo -69.67 2.72 4.61 Favored 'Cis proline' 0 C--N 1.348 0.551 0 C-N-CA 124.293 -1.128 . . . . 0.0 113.817 0.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.903 ' HB2' HD23 ' A' ' 31' ' ' LEU . . . -59.23 141.32 54.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.923 0.392 . . . . 0.0 110.359 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.42 ' HA ' HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -146.5 120.36 9.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.212 -179.314 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.905 HD23 HD11 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -79.18 110.89 14.86 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.253 -179.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.1 m -124.25 116.43 47.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.499 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 59.03 38.71 93.35 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.211 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.402 ' HA ' HD11 ' A' ' 24' ' ' LEU . 0.8 OUTLIER 67.43 37.28 3.54 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.87 0.367 . . . . 0.0 110.912 -179.82 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.8 t -135.3 104.2 4.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.513 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.482 ' O ' HG23 ' A' ' 114' ' ' VAL . . . -68.77 86.23 0.21 Allowed Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.153 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 53.3 mt-10 -84.59 99.44 10.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.777 0.322 . . . . 0.0 111.633 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.062 HD21 HG22 ' A' ' 38' ' ' VAL . 23.5 mt -80.0 149.62 30.7 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.488 ' HG3' ' CZ ' ' A' ' 111' ' ' TYR . 0.0 OUTLIER -129.21 132.5 47.27 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.876 0.37 . . . . 0.0 111.436 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 110' ' ' GLY . . . 43.32 -152.05 0.37 Allowed Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.557 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.536 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . . . -90.2 159.83 16.52 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.623 0.249 . . . . 0.0 110.594 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.44 -24.41 32.1 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.883 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.785 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -71.52 155.31 40.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.806 0.336 . . . . 0.0 111.191 -179.474 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 103' ' ' ARG . . . -162.75 113.66 1.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.075 0.464 . . . . 0.0 112.168 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 1.062 HG22 HD21 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -103.16 87.91 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.44 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 25.5 mm -89.95 118.81 35.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.328 0.585 . . . . 0.0 112.114 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.877 ' CE3' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -86.57 145.64 26.67 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.698 179.636 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -121.34 111.85 17.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.458 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.937 HG21 ' CE2' ' A' ' 11' ' ' TYR . 26.5 m -145.05 -177.05 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.964 0.411 . . . . 0.0 111.66 -179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -136.85 123.5 21.06 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.614 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.606 HG21 ' O ' ' A' ' 94' ' ' SER . 45.3 t -53.61 123.89 39.43 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.265 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -65.52 -47.86 3.77 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.562 2.175 . . . . 0.0 112.755 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.579 HG23 ' OH ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -148.33 -175.56 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.035 0.445 . . . . 0.0 111.678 -179.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.18 99.14 11.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.352 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.46 -178.7 39.3 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.068 -0.587 . . . . 0.0 111.83 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.645 ' HG2' HD12 ' A' ' 122' ' ' LEU . 67.2 tt0 -90.85 117.52 29.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.059 0.429 . . . . 0.0 110.707 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.586 ' CD1' ' HB2' ' A' ' 93' ' ' LEU . 0.6 OUTLIER -110.87 115.86 30.24 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.923 179.739 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.408 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 4.9 ptm180 -79.62 128.85 33.9 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.049 0.452 . . . . 0.0 110.517 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.534 ' CG2' ' CE ' ' A' ' 69' ' ' MET . 12.1 mm -78.76 133.36 30.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.8 -178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.57 HD21 HG22 ' A' ' 88' ' ' VAL . 0.8 OUTLIER -133.04 109.08 9.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.177 179.576 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.695 HD21 ' HG ' ' A' ' 117' ' ' LEU . 1.3 mt -99.95 123.49 44.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.281 0.562 . . . . 0.0 111.466 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.85 118.04 31.74 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.262 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.601 ' CZ3' ' HB3' ' A' ' 81' ' ' ALA . 3.4 p-90 -139.66 167.02 23.05 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.056 0.455 . . . . 0.0 111.412 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -152.62 72.88 0.99 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.184 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 112' ' ' MET . 23.2 t -114.43 93.92 33.88 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.034 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.19 86.97 1.47 Allowed 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.987 2.458 . . . . 0.0 111.878 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -126.31 -82.8 0.62 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.456 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 62' ' ' SER . 1.5 p 178.85 -32.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.172 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.467 ' CB ' ' O ' ' A' ' 61' ' ' SER . 4.0 t 157.88 130.1 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.428 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 77' ' ' ALA . 2.2 mttp -129.56 171.07 12.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.679 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 77' ' ' ALA . 38.3 t -124.82 83.61 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.182 0 CA-C-O 120.559 0.219 . . . . 0.0 110.832 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.446 ' ND2' ' CA ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -104.92 169.09 8.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.002 0.429 . . . . 0.0 111.529 -179.42 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 97.0 m -117.68 110.65 18.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.851 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.742 ' HG ' HD21 ' A' ' 74' ' ' LEU . 11.8 tp -79.05 125.37 29.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.671 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 101' ' ' GLY . 1.5 t -101.01 97.45 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.174 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.898 ' SD ' HD21 ' A' ' 117' ' ' LEU . 6.4 mmt -132.79 131.53 41.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.926 0.393 . . . . 0.0 111.482 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.1 t70 61.46 38.99 15.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.821 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.81 15.69 60.39 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.273 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.7 m -107.05 150.44 26.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.079 0.466 . . . . 0.0 111.014 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.56 74.72 0.91 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.312 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.742 HD21 ' HG ' ' A' ' 67' ' ' LEU . 1.5 pp -79.25 105.85 10.86 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.188 0.518 . . . . 0.0 110.943 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 11.9 t -82.61 134.33 35.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.59 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.446 ' CZ ' ' CE1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -160.35 151.23 18.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.207 0.527 . . . . 0.0 111.761 -179.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.435 ' HA ' ' HA ' ' A' ' 64' ' ' VAL . . . -88.19 102.11 14.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.071 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.544 ' CE2' ' CD2' ' A' ' 56' ' ' TRP . 0.1 OUTLIER -59.15 145.91 40.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.107 0.48 . . . . 0.0 110.808 -179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.1 -178.73 7.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.797 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.462 ' HB3' ' CA ' ' A' ' 61' ' ' SER . 1.1 pt-20 -89.13 38.48 0.89 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.562 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.601 ' HB3' ' CZ3' ' A' ' 56' ' ' TRP . . . -51.14 172.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.176 0.512 . . . . 0.0 112.013 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.527 HG23 HG23 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -160.5 -48.77 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.877 179.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.952 ' O ' HG23 ' A' ' 85' ' ' VAL . 2.3 t -82.97 143.78 46.56 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.074 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.626 ' HD2' HG12 ' A' ' 83' ' ' VAL . 71.6 Cg_exo -41.56 84.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.269 1.979 . . . . 0.0 112.992 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.952 HG23 ' O ' ' A' ' 83' ' ' VAL . 46.3 t -101.79 141.47 18.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.566 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.666 HG21 ' HD3' ' A' ' 118' ' ' LYS . 0.2 OUTLIER -108.33 127.51 53.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.931 0.396 . . . . 0.0 111.547 -179.569 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 89' ' ' GLN . 0.6 OUTLIER -93.33 110.25 21.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.993 179.43 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.57 HG22 HD21 ' A' ' 53' ' ' ASN . 25.2 t -80.04 122.75 35.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 87' ' ' TYR . 21.0 tp60 -136.45 113.33 10.36 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.8 p -78.43 116.73 19.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.456 0.646 . . . . 0.0 111.544 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.3 111.66 9.16 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.24 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -64.77 110.82 2.52 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 120.963 0.411 . . . . 0.0 110.817 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.707 HD11 ' CE2' ' A' ' 100' ' ' PHE . 4.8 mt -88.78 141.88 28.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.443 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.606 ' O ' HG21 ' A' ' 44' ' ' VAL . 66.3 m -115.24 152.38 32.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.933 0.397 . . . . 0.0 111.323 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.67 138.43 55.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.211 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 125.56 -159.77 20.06 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.561 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.62 116.98 29.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.808 0.337 . . . . 0.0 110.866 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -118.71 169.13 10.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.804 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 53.9 p -122.57 124.8 44.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.054 0.454 . . . . 0.0 111.588 -179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.707 ' CE2' HD11 ' A' ' 93' ' ' LEU . 25.6 m-85 -120.54 167.65 12.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.59 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 68' ' ' VAL . . . 151.49 -163.22 29.86 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 119.384 -1.389 . . . . 0.0 114.253 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.439 HG13 HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -149.55 154.67 9.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.821 -0.689 . . . . 0.0 109.15 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.554 ' HA ' ' HA ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -160.3 162.78 33.65 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.136 -0.625 . . . . 0.0 112.311 -179.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.617 HG11 ' N ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER -139.02 142.05 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.466 179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.452 ' C ' ' HB1' ' A' ' 34' ' ' ALA . . . -154.45 173.93 32.88 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.468 -0.872 . . . . 0.0 112.808 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.2 m -54.12 -24.82 19.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.787 0.327 . . . . 0.0 111.005 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.01 5.22 26.55 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.372 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.481 ' O ' ' CD1' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -152.88 -70.28 0.15 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.682 -0.235 . . . . 0.0 110.782 179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.526 ' CE3' ' N ' ' A' ' 110' ' ' GLY . 0.0 OUTLIER 77.82 133.54 0.06 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.521 179.666 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.617 ' N ' HG11 ' A' ' 104' ' ' VAL . . . -146.07 -169.14 13.83 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.472 -0.871 . . . . 0.0 113.703 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.488 ' CZ ' ' HG3' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -179.37 76.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.574 ' HE1' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -148.78 175.14 11.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.166 0.508 . . . . 0.0 112.149 -177.599 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.563 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 61.2 m-80 -108.16 131.77 54.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.828 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.89 HG21 HG21 ' A' ' 38' ' ' VAL . 42.9 t -100.0 85.87 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.101 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -55.91 -47.86 76.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.94 -179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.5 p -177.59 167.28 2.22 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.239 0.542 . . . . 0.0 111.228 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.944 ' O ' ' HB2' ' A' ' 11' ' ' TYR . 1.1 tt -111.61 77.98 1.08 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.666 ' HD3' HG21 ' A' ' 86' ' ' THR . 0.2 OUTLIER -78.79 118.53 20.93 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.208 0.528 . . . . 0.0 111.38 -177.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.611 ' O ' ' HE3' ' A' ' 9' ' ' TRP . 0.2 OUTLIER -101.92 143.83 31.31 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.795 179.473 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.431 ' OE2' ' N ' ' A' ' 120' ' ' GLU . 0.8 OUTLIER -129.36 166.46 19.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.513 -179.341 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.552 HD22 ' CE2' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -98.51 26.45 5.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.928 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.645 HD12 ' HG2' ' A' ' 49' ' ' GLU . 1.4 mt 60.34 -165.99 0.2 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.669 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.453 179.978 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.529 0.167 0 CA-C-O 120.706 0.288 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.427 ' N ' ' CE3' ' A' ' 9' ' ' TRP . 1.5 p90 -155.84 151.05 26.69 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.17 0.51 . . . . 0.0 111.43 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.852 HG22 ' OG ' ' A' ' 116' ' ' SER . 0.6 OUTLIER -83.93 140.24 32.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.74 -179.1 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.442 ' O ' ' CZ2' ' A' ' 40' ' ' TRP . 1.7 m-30 -106.1 103.26 12.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.539 178.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.7 p -52.25 134.74 33.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.788 0.328 . . . . 0.0 110.839 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.577 ' HB3' HD21 ' A' ' 24' ' ' LEU . . . -68.71 -18.1 64.18 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -178.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.563 ' HA ' ' HG ' ' A' ' 24' ' ' LEU . . . -69.76 -23.75 63.42 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.785 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.76 0.5 54.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.903 178.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.51 -163.57 1.04 Allowed 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.785 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.9 t -110.44 103.73 12.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.82 0.343 . . . . 0.0 110.972 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.633 HD11 HD23 ' A' ' 24' ' ' LEU . 1.6 mp -88.03 91.62 3.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.654 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.509 ' O ' ' HB3' ' A' ' 22' ' ' ALA . 6.6 m -89.83 132.34 35.31 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.689 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.55 147.05 3.19 Favored Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.287 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 36' ' ' SER . 89.9 Cg_endo -75.98 10.01 11.72 Favored 'Cis proline' 0 C--N 1.347 0.475 0 C-N-CA 123.723 -1.365 . . . . 0.0 113.34 0.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.674 ' HB2' ' CD2' ' A' ' 31' ' ' LEU . . . -59.43 140.34 56.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.937 0.399 . . . . 0.0 110.884 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.442 ' HG3' ' C ' ' A' ' 22' ' ' ALA . 0.0 OUTLIER -142.9 116.73 9.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.324 -179.609 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.85 HD22 ' HA2' ' A' ' 29' ' ' GLY . 0.2 OUTLIER -80.03 111.35 16.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.343 179.161 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.46 87.99 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.85 0.357 . . . . 0.0 111.173 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 73.82 -54.98 2.15 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.006 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -155.33 -36.02 0.09 Allowed 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 120.705 0.288 . . . . 0.0 110.757 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.703 HG13 ' HA ' ' A' ' 115' ' ' HIS . 4.1 t -81.29 126.22 39.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.906 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.85 ' HA2' HD22 ' A' ' 24' ' ' LEU . . . -79.48 157.07 41.87 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.693 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 113' ' ' ASN . 38.5 mt-10 -149.28 101.14 3.1 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.806 0.336 . . . . 0.0 111.145 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.002 HD21 HG22 ' A' ' 38' ' ' VAL . 95.4 mt -80.76 158.38 25.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.612 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.46 ' CG ' ' CE1' ' A' ' 111' ' ' TYR . 0.0 OUTLIER -127.64 -155.87 0.72 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.66 164.04 0.02 OUTLIER Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.269 179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.579 ' HB2' ' HA ' ' A' ' 109' ' ' TRP . . . -40.57 163.19 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.906 0.353 . . . . 0.0 111.193 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.83 -27.16 21.51 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.688 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.878 ' HB2' HD22 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -67.78 150.47 48.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.819 0.342 . . . . 0.0 110.727 -179.799 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.491 ' HB2' ' HD3' ' A' ' 103' ' ' ARG . . . -158.28 96.53 1.44 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.979 0.418 . . . . 0.0 111.902 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 1.002 HG22 HD21 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -86.16 88.74 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.018 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.545 ' HA ' ' HA3' ' A' ' 101' ' ' GLY . 31.6 mm -93.37 114.56 30.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.225 0.536 . . . . 0.0 112.297 -178.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.814 ' CE3' HD12 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -82.72 146.74 28.85 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.207 179.055 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -110.71 113.86 26.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.829 0.347 . . . . 0.0 111.146 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.0 m -149.53 155.41 8.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.962 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 13.3 p-10 -119.22 117.29 28.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.974 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.95 HG13 ' CE1' ' A' ' 98' ' ' HIS . 0.0 OUTLIER -35.0 110.09 0.39 Allowed Pre-proline 0 N--CA 1.47 0.569 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.716 -179.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 44' ' ' VAL . 17.3 Cg_endo -57.75 -43.8 46.64 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.351 2.034 . . . . 0.0 112.626 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.532 ' C ' ' HH ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -156.94 -172.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.106 0.479 . . . . 0.0 111.75 -179.518 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.707 HG23 ' H ' ' A' ' 95' ' ' ALA . 0.1 OUTLIER -99.3 98.61 9.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.147 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -161.95 -145.23 4.25 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.434 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 92' ' ' THR . 62.5 tt0 -126.73 108.24 10.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.764 0.316 . . . . 0.0 110.905 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.883 ' HD2' HD12 ' A' ' 93' ' ' LEU . 1.3 m-30 -108.89 122.65 47.65 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.501 ' HB3' HG22 ' A' ' 90' ' ' THR . 3.7 ptt180 -84.19 131.47 34.76 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.303 0.573 . . . . 0.0 111.341 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.895 HG21 ' HG3' ' A' ' 69' ' ' MET . 11.4 mm -78.83 133.31 30.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.843 -179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 87' ' ' TYR . 1.6 m120 -134.51 105.02 6.34 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.016 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.71 ' CD1' HD13 ' A' ' 67' ' ' LEU . 0.6 OUTLIER -99.35 118.71 36.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.223 0.535 . . . . 0.0 111.309 -179.374 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' A' ' 115' ' ' HIS . 0.2 OUTLIER -91.93 123.87 35.62 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.594 179.154 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TRP . . . . . 0.529 ' CZ3' ' HB3' ' A' ' 81' ' ' ALA . 1.5 p-90 -146.11 167.28 23.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.989 0.424 . . . . 0.0 111.49 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.5 p -155.25 83.45 1.06 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.677 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.7 t -117.67 82.94 16.79 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.75 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.409 ' O ' ' CD1' ' A' ' 60' ' ' TYR . 27.5 Cg_exo -61.91 100.28 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.827 2.351 . . . . 0.0 112.309 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.409 ' CD1' ' O ' ' A' ' 59' ' ' PRO . 89.8 m-85 -156.07 -83.37 0.06 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.706 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.453 ' HA ' ' HG3' ' A' ' 80' ' ' GLU . 2.3 m -173.81 -45.15 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.894 0.378 . . . . 0.0 111.662 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 78' ' ' PHE . 0.2 OUTLIER 169.57 109.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.631 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.594 ' N ' ' HD2' ' A' ' 63' ' ' LYS . 0.2 OUTLIER -93.22 170.14 9.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.294 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.488 ' O ' ' O ' ' A' ' 109' ' ' TRP . 36.2 t -115.84 79.06 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.444 HD22 ' N ' ' A' ' 65' ' ' ASN . 1.5 m-80 -112.86 155.75 24.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.1 0.476 . . . . 0.0 112.043 -178.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 23.0 m -114.41 111.04 20.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.075 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.86 ' HG ' HD21 ' A' ' 74' ' ' LEU . 8.2 tp -74.17 133.92 42.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.934 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.516 ' N ' HD12 ' A' ' 67' ' ' LEU . 38.5 t -108.67 106.94 21.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.64 -178.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.895 ' HG3' HG21 ' A' ' 52' ' ' ILE . 3.7 mmt -137.34 122.09 18.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.915 0.388 . . . . 0.0 111.228 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 46.3 t0 63.51 43.83 5.66 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.233 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 64.82 15.01 59.44 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.571 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.6 m -99.93 146.73 26.34 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.898 0.38 . . . . 0.0 110.827 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.94 73.47 0.82 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.779 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.86 HD21 ' HG ' ' A' ' 67' ' ' LEU . 1.1 pp -79.74 106.11 11.53 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.209 0.528 . . . . 0.0 110.923 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 12.5 t -86.41 127.72 34.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.922 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -160.19 151.44 19.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.26 0.553 . . . . 0.0 111.327 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 63' ' ' LYS . . . -79.66 109.01 13.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.912 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.401 ' O ' ' HA ' ' A' ' 62' ' ' SER . 0.1 OUTLIER -59.23 99.42 0.05 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.161 0.505 . . . . 0.0 111.142 -179.58 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.468 ' O ' ' CH2' ' A' ' 56' ' ' TRP . . . -41.46 168.07 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.978 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.453 ' HG3' ' HA ' ' A' ' 61' ' ' SER . 2.8 tm-20 -71.77 65.51 0.51 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.96 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.529 ' HB3' ' CZ3' ' A' ' 56' ' ' TRP . . . -85.73 143.34 28.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.983 0.42 . . . . 0.0 111.602 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.507 HG23 HG23 ' A' ' 83' ' ' VAL . 0.5 OUTLIER -136.45 -49.04 0.65 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.239 179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.936 ' O ' HG23 ' A' ' 85' ' ' VAL . 1.9 t -79.87 145.3 61.54 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.193 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.71 ' HD2' HG12 ' A' ' 83' ' ' VAL . 95.5 Cg_exo -44.29 82.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.196 1.931 . . . . 0.0 112.579 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.936 HG23 ' O ' ' A' ' 83' ' ' VAL . 44.3 t -98.58 125.46 51.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.644 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.9 103.36 15.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.708 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.504 ' O ' ' CD1' ' A' ' 87' ' ' TYR . 0.5 OUTLIER -64.99 106.48 1.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.029 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.6 t -84.39 123.34 38.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.527 ' OE1' HD22 ' A' ' 74' ' ' LEU . 56.9 tt0 -139.1 112.46 8.18 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.501 HG22 ' HB3' ' A' ' 51' ' ' ARG . 6.2 p -79.12 116.98 19.74 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.344 0.593 . . . . 0.0 111.75 -178.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -131.45 123.11 27.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.183 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 0.2 OUTLIER -69.81 111.12 5.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.563 -179.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.883 HD12 ' HD2' ' A' ' 50' ' ' TYR . 2.3 mt -93.11 141.19 28.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.952 0.406 . . . . 0.0 111.185 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.779 ' O ' HG11 ' A' ' 44' ' ' VAL . 3.6 p -116.59 146.37 42.72 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.578 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.707 ' H ' HG23 ' A' ' 47' ' ' THR . . . -50.07 150.14 2.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.55 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.547 ' C ' HG23 ' A' ' 44' ' ' VAL . . . 135.38 -115.31 1.35 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.403 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -166.2 144.07 5.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.921 0.391 . . . . 0.0 110.997 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.95 ' CE1' HG13 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -160.45 169.39 23.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.056 179.855 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.4 p -119.78 114.6 22.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.451 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.63 ' CZ ' HD11 ' A' ' 93' ' ' LEU . 47.5 m-85 -92.02 175.75 6.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.552 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.545 ' HA3' ' HA ' ' A' ' 39' ' ' ILE . . . 151.53 -153.36 24.9 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 119.252 -1.452 . . . . 0.0 114.172 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.412 ' O ' ' N ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER -153.13 124.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 114.999 -0.601 . . . . 0.0 109.699 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.491 ' HD3' ' HB2' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -122.38 152.25 40.38 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.403 0.621 . . . . 0.0 112.29 -178.371 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.88 HG11 ' CA ' ' A' ' 110' ' ' GLY . 0.1 OUTLIER -137.44 137.73 45.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 114.957 -1.02 . . . . 0.0 110.074 178.673 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.556 ' C ' ' HB1' ' A' ' 34' ' ' ALA . . . -149.02 -171.06 17.36 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.905 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 52.0 p -53.43 -42.98 67.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.805 0.336 . . . . 0.0 110.891 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 2.7 m -73.13 -16.16 61.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.053 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.832 ' O ' HG12 ' A' ' 104' ' ' VAL . 3.7 p-10 -155.11 79.85 1.05 Allowed 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.617 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.579 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . 20.5 p-90 -61.94 157.23 19.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.49 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.88 ' CA ' HG11 ' A' ' 104' ' ' VAL . . . -120.69 170.3 14.39 Favored Glycine 0 C--N 1.335 0.523 0 C-N-CA 120.215 -0.993 . . . . 0.0 114.066 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.463 ' CD2' ' O ' ' A' ' 110' ' ' GLY . 0.6 OUTLIER 165.34 57.72 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.827 ' HE3' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -141.1 -170.82 3.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.742 -178.758 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 30' ' ' GLU . 82.9 m-20 -116.77 131.36 56.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.814 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.93 HG21 HG21 ' A' ' 38' ' ' VAL . 68.6 t -103.43 85.63 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.064 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' HIS . . . . . 0.703 ' HA ' HG13 ' A' ' 28' ' ' VAL . 35.4 t-80 -57.93 -52.26 66.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.262 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.852 ' OG ' HG22 ' A' ' 10' ' ' THR . 5.6 t -176.08 169.59 2.81 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.164 0.507 . . . . 0.0 111.964 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.814 HD12 ' CE3' ' A' ' 40' ' ' TRP . 1.1 tt -115.05 90.34 3.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.55 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.0 tttm -87.91 139.61 30.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.12 0.486 . . . . 0.0 111.78 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.58 HD23 ' HB3' ' A' ' 50' ' ' TYR . 0.1 OUTLIER -132.76 127.85 35.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.897 179.24 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -115.84 150.99 36.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.218 -179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.481 ' CD1' ' CE1' ' A' ' 50' ' ' TYR . 0.4 OUTLIER -89.59 38.13 0.9 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.207 179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.56 HD12 ' HG2' ' A' ' 49' ' ' GLU . 1.2 mt 47.53 28.48 1.19 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.325 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.46 179.968 . . . . . . . . 0 0 . 1 stop_ save_